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Abstract
The human epsilon globin gene has multiple sites of 
RNA initiation. Of these, the most abundant are the 
transcripts originating from the - 2 0 0  promoter giving a 
cap: -200 ratio of 20:1 in RNA prepared from the erythro­
leukaemic cell line K562 and 5-10 week embryos.
A series of epsilon globin gene recombinants were 
introduced into a range of cell lines to compare the 
transcriptional profile with that obtained in the K562 
cell and to identify putative regulatory regions. This 
approach led to the following observations.
1) Epsilon globin gene activity in stably and acutely 
transformed non-erythroid and MELtk- cells display a 
distinct tendency towards greater use of the - 2 0 0  
promoter. Even recombinants with up to 6 kb of 5 1 
flanking DNA, cap: -200 ratios varied from 4:1 in mouse 
LAtk-, 1:1 in BHKtk- and 0:1 in MELtk- cells.
2) The major epsilon globin promoter (51- -100/CCAAT/
ATA-cap-31) is not sufficient to support optimal levels of 
cap site expression in stably transformed BHKtk- cells.
3) However when this structure was extended by the cis 
-linkage of 350 bp's of endogenous DNA, optimal cap site 
expression was restored.
4) When this recombinant was further extended by 1468 
bp's, the cap: -200 ratio dropped from 4:1 to 1:20 in 
acutely transformed mouse LAtk- cells. Interestingly, 
this fragment contains two upstream promoters at -900 and 
-1480 bp's.
Using a functional assay system another putative
regulatory region has been identified over 2 kb upstream
of the major promoter. A 6.67 kb Eco RI fragment which 
contains a potential Z-DNA element and the most distal 
promoter at -4500 bp's markedly increases the expression 
of the bacterial Tn5 aph(II) gene from the epsilon globin 
promoter.
Additionally, several lines of evidence has been 
presented which suggest that the major and - 2 0 0  promoters 
can be regulated independently by both exogenous cis 
linked sequences (SV40 origin and enhancer) and viral 
trans acting factors.
Based on these findings it is proposed that these 
minor promoters particularly the - 2 0 0  are
transcriptionally active during early embryonic 
erythropoietic devlopment. During this period canonical 
cap site activity may in part be repressed by some sort of 
transcriptional interference mechanism. The switch from 
the upstream promoters occurs in later development 
mediated by an embryonic erythroid trans acting factor as 
experimentally demonstrated by the switch in cap: - 2 0 0
ratio from 1 :20 in non-erythroid cells to 20:1 in K562 
cells transformed with a mutated epsilon globin gene 
recombinant to distinguish it from the endogenous gene.
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Biology of the Human Globin System,
1:1:1 Background
To acquire information about patterns of differential 
gene expression, most efforts have centred on the study of 
individual genetic systems. The main focus of this thesis 
is the epsilon globin gene of the human 3 globin gene 
cluster which has a specific association with the tightly 
regulated developmental pathway of haematopoiesis. The 
INTRODUCTION will be concerned with the structure and 
expression of the human globin genes (for recent reviews 
see [1] and [2]). Despite the importance, interest and 
relevance of haematopoiesis, a detailed account of the 
development of the red blood cell which involves the 
switching on and off of batteries of genes governing the 
synthesis of membrane proteins, enzymes, non-haem proteins 
in addition to haemoglobins is outwith the scope of this 
thesis (for a comprehensive review see [3]).
Globin genes are a feature of all vertebrates and 
insects. Moreover their ubiquitous nature extends to the 
plant kingdom where a similar protein to haemoglobin 
called leghaemoglobin is found in the root nodules of
- 3 -
leguminous plants such as Soybean [4]. However this does 
not imply that the primordial globin gene was derived from 
pre-plant life forms, as it remains a possibility that the 
globin gene was introduced into plants by an insect or 
some ancestral animal form.
Globins are luxury proteins of crucial physiological 
importance. Their accessability in the blood minimises 
sampling problems. This has contributed in determining 
the structure of the haemoglobin molecule and in the 
establishment of detailed biochemical structure/functional 
relationships [5]. The availability of globin message of 
high abundance ( > 90% total mRNA population in the 
reticulocyte) and purity has advanced the isolation of 
globin genes by recombinant DNA technology as discussed in 
1:1:2 and 1:1:4.
The genetics of human globins is relatively well 
understood. The various haemoglobinopathies characterised 
by abnormal gene structure and function have been 
particularly useful in classical genetic analysis. Among 
the range of molecular lesions of the globin loci, the 
thalassaemias have by far been the most extensively 
studied (for a comprehensive review, see [6 ]).
The human globin gene system provides an excellent 
model to study some of the fundamental problems of the 
regulation of differential gene expression at the 
molecular level.
Four outstanding features of human globin gene 
expression invite investigation.
- 4 -
Firstly, although low levels of globin gene specific 
transcripts have been detected in the fibroblast [7], Rous 
Sarcoma Virus infected fibroblasts [8 ], a few human 
leukaemias [9] and in certain non-erythroid cell lines 
[1 0 ], the overwhelming majority of data suggests that 
normal globin gene activity is restricted to the red blood 
cell and a defined range of its precursors. The 
reticulocyte contains ~150,000 copies of globin mRNA which 
represents 90% of the message population, in sharp 
contrast non erythroid tissues such as brain and liver, 
have less than one copy per cell measured on a population 
basis i.e. tissue specific regulation.
Secondly the type of globin gene expressed varies with 
the stage of development i.e. embryo, foetus and adult. 
Thus the globin genes are subject to strict temporal 
regulation during normal development.
Thirdly in man there are six different globin genes 
located on two chromosomal loci termed a and 3- The a 
family consists of a and £ genes. The 3 locus members are 
the 3 , 6 , y and e genes. As depicted in Fig. (1), this 
generates considerable phenotypic diversity resulting in 
the formation of six functional proteins to accomodate the 
changing physiological conditions experienced at different 
stages of development. The composition of haemoglobin 
tetramers independent of the developmental stage consists 
of two a type and two 3 type polypeptides. Since these 
loci are on different chromosomes a correct balance of 
chain production must operate, otherwise precipitation of
- 5 -
Site Of 
Erythropoiesis
\blk Sac-
Liver
Marrow
lo-
40
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Haemoglobin 
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• - l i k e
chain ch a in
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Go we i 2
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Figure 1
A schematic representation of differential 
globin gene expression during ontogeny showing 
the changing anatomical site of erythropoiesis 
and the type of haemoglobin synthesised. 
Reproduced and modified from [6].
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the protein would result [11]. Therefore the regulated 
production of functional haemoglobin protein is entirely 
dependent on an effective coordinate control programme, 
i.e. coordinate regulation.
Finally the number of functional globin genes remains 
constant in all cell types throughout development. This is 
inconsistent with a gene amplification or diminution 
mechanism operating during ontogeny. Furthermore detailed 
restriction mapping of the a and 3 globin gene loci from 
erythroid and non-erythroid DNA do not show any pattern 
differences so arguing against any gene rearrangement or 
translocation as a mechanism to account for globin gene 
regulation [1 2 ] unlike the events leading to 
immunoglobulin expression during B-lymphoid cell 
differentiation [13].
1 :1:2 Globin Gene Expression During Development
The globin genes have a well defined ontogeny (see [6 ] 
for review). In man, as illustrated in Fig. (1) the 
anatomical site of erythropoiesis changes with development 
from embryo to foetus to adult. These differences are 
reflected in the types of haemoglobin produced in the 
erythrocyte as depicted in Fig. (1).
The production of red blood cells is initially 
observed in the mesenchyme of the yolk sac around two 
weeks gestation. These cells remain nucleated throughout 
their life span of approximately twelve weeks. The
- 7 -
earliest detectable haemoglobin is Gower 1 (C 2 e 2 ) which 
contains two epsilon chains from the 3 globin gene locus 
and two zeta (5 ) polypeptides encoded in the a globin gene 
cluster. Around five weeks gestation the liver becomes 
the major site of haemoglobin synthesis, splenic 
erythropoises is also recognisable at this period. A few 
weeks after the onset of hepatic erythropoiesis embryonic 
chain synthesis is gradually replaced by the adult a and 
the foetal y polypeptides to give HbF(ci2 Y2 )* Prior to this 
transition two minor haemoglobins are synthesised i.e. 
Gower 2 ( 0 2^Z2^ an(  ^Portland 1 (C 2 ^2 ^ • Hepatic erythro­
poiesis progressively declines after twenty weeks 
gestation with a concomittant increase in red cell 
production in the bone marrow. During this period the 
level of splenic erythropoiesis markedly decreases. Prior 
to birth, production of y chains falls and is replaced by 
3 or 6 polypeptides to form (*2 32 (HbA) and 012^2 { * * ^ 2  ) 
respective the latter accounts for less than 2 % of total 
haemoglobin production.
Early theories seeking to explain these events 
proposed the existence of specific embryonic, foetal and 
adult haematopoetic cell lineages. Much of the basis for 
those ideas stemmed from the observation that certain 
globin genes were apparently restricted in their 
expression to cells of unique developmental origin such as 
epsilon globin gene activity in yolk sac tissue. 
Sophisticated analytical techniques have essentially 
disproven this and have shown that haematopoetic stem 
cells appear to have a developmental clock, the mechanism
- 8 -
of which is not understood [14]
Accordingly the main question arising from an account 
of differential globin gene expression can be divided into 
two separate but overlapping parts. First, what are the 
underlying mechanisms responsible for the generation of a 
haemoglobin synthesising erythrocyte from the
haematopoetic stem cell? Secondly, what determines the 
type of haemoglobin produced in the erythrocyte? Implicit 
in our comprehension of this is the elucidation of the 
mechanisms involved in commitment, tissue specifity, 
temporal and coordinate regulation.
1 :1:3 Molecular Organisation of the Human Globin Genes
Cell fusion experiments have located the a globin gene 
cluster to the short arm of chromosome 16 at coordinates 
(16p12 - 16pter) [15] [16]. Similar studies have mapped 
the 8 globin gene family to the short arm of chromosome 11  
at coordinates ( 1 1 pi 1 - 11p15), but its precise location 
is uncertain [17] [18] [19].
All members of both human globin loci have been 
molecularly cloned from human genomic lambda phage 
libraries; the a gene, the C gene [2 0 ], the adult 8  
genes, [21] [22] the foetal genes [23] [24] and the
embryonic epsilon globin gene [25] (See Fig. (2)). In 
addition, the entire 8 globin gene cluster has been 
isolated in a series of four overlapping cosmids [26].
The a globin gene cluster as depicted in Fig. (2) is
- 9 -
Prototypic 6 Gldbin Gene Suucture
1 30 31 104 105 146 codon NO
Chromosome Tl
> 5 5  kb
>30kb
OC2 k OC1
Chromosome 16
1 31 32 99 100 UlcodonNO
Prototypic OC Globin Gene Structure
Figure 2
Molecular Organisation of the Human Globin 
Gene Loci on Chromosomes 11 and 16. The solid 
triangles show Alu I repetitive sequences and 
orientation. The hatched boxes denote Kpn I 
family members and orientation. Protypic a 
and 3 globin gene structures are shown, solid 
and open boxes depict exons and introns 
respectively. The a-like globin genes 
contain introns of approximately 95 and 125 
bp's between codons 31 and 32 and 99 and 100 
respectively. The prototypic 3 globin gene 
contain introns of approximately 125-150 and 
800-900 bp's between codons 30 and 31 and 104 
and 105 respectively..
- 10 -
contained within a 30 kb stretch of DNA comprising of one 
embryonic £ and two adult a 2 and a-j genes. The physical 
linkage was determined by the structural analysis of 
lambda recombinants [20]. The organisation 5' - £-\p£-i|KX - <*2 
a1~3 ' , parallels the order of sequential expression during 
ontogeny.
The organisation of the 3 type genes was determined by
the detailed structural analysis of the appropriate lambda
recombinants, reviewed in [27] and by genomic blotting
experiments [28] [29]. As shown in Fig. (2) their
A Garrangement 5 - £ - y ~ Y “ <5-3-3' reflects their normal
order of expression during red blood cell development.
Fig. (2) shows that the human globin gene loci contain 
three pseudogenes, the physiological function of which, if 
any is not understoodj for a brief review, see [30]. These 
elements are a structural feature of a number of animal 
globin gene clusters including mouse [31], goat [32] and 
rabbit [33]. A pseudogene has an obvious evolutionary link 
to a normal gene but does not produce a functional 
protein. It is widely accepted that pseudogenes arose by 
duplication followed by sequence divergence [34]. The 
nature of the alteration responsible for the aberrant 
expression is variable [30].
The protein coding information in the human globin 
genes like many other cellular genes is not contiguous but 
is interrupted by non-coding intervening sequences [35]. 
Both the a and 3 globin type genes contain two introns and 
three coding exon regions. Fig. (2) shows the introns of
- 11 -
the five 3 globin genes mapping at identical positions as 
do the three a globin type genes. This gross structure is 
highly conserved, even the plant leghaemoglobin genes 
display this pattern [4]. Rather surprisingly however 
the twelve different globin genes of the midge Chironomus 
thuromi thummi lack intervening sequences [36].
The complete nucleotide sequence for all members of 
the a and 3 globin gene clusters has been elucidated; a 
[37], C [38], 3 [39], 6 [40], y [41] and epsilon [42] [43] 
[44] [45]. As depicted in Figs. (3) and (4) the proximal 
five flanking region of 3 genes like a number of other 
protein coding genes contain two highly conserved promoter 
signals [47]. The Hogness or TATA Box [48] (pATA a A AG ) 
which is referred to in globin genes as the ATA Box is 
located~30 bp's from the major initiation site and is 
flanked by short GC stretches. The second conserved domain
is the CCAAT Box [49] mapping 80 bp's 5' to the cap
site. This is duplicated in the human y globin genes and 
diverges in the hypo-functional 6 globin gene i.e. CCAAC. 
Except for the 6 globin gene and the a type globin genes 
all other globin transcriptional units contain a C rich 
motif around 1 0 0  bp's upstream of the cap site with the 
consensus sequence CACC. This is a feature of other 
animal 3 globin genes [50] [51].
As shown in Fig. (4) the prototypic globin gene, the 
5' non-coding region consists of the stretch of DNA 
between the cap site which is well conserved (Fig. 3) and 
the ATG codon. This distance is approximately 50 bp's and
- 12 -
- 1 0 0  CCAAT AT A Cap
-130 - 1 2 0 ____  - n o  - 1 0 0  -90 -80 -70 -60 -50 -40 -30 - 2 0  - 1 0
 ^ f i I  ^ r i
h u m a n  fr TCACTTAGACCTCACCC-TGTGGAG-CCACACCCTAGGGTTGGCCAATCT--ACTCCCAGGAGCAGGGAGCGCAGGAG-CCA............... GCGC-TGGGaTAAAAGTCAGGGCAGAGCCATCTATTCCTTACA
I  I I I I I  I I
RA88 IT  11 TCACCCAGACCTCACCd-TGCAGAG-CCACACCCTGGTGTTGGCCAATCT--ACACAC-GGGGTAGGGAr7ACATAGT-TCA............... GGACTTGGGCATAAAAGGCAGAGCAGGG-CAGCTGCTCCTTACA
A I I I I I I | |
GOAT 6 CCAnCAAGCCTUCCC-TGTGGAA-CCACAACTTGGCACGAGCCAATCTGCTCACA--GAAGCAGGGAGGGCAGGAG-GCA...... . . . . . . . . . . GGGC-TGGGCATAAAAGGAAGAGCCGGGCCA6CTGCTGCTTACA
I  I  I  I  I I  | |
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Figure 3
Comparison of the 51 flanking region of a 
range of 8- globin genes in relation to the 
human epsilon globin gene which is enclosed. 
Areas of homology shown are the Cap Site, the 
ATA Box, the CCAAT Box and the C-rich -100 
motif. Reproduced from [2].
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Figure 4
Structure and Expression of Human Globin 
Genes. A shows the various promoter 
signals. B illustrates the gross structure 
of the globin genes in addition to the highly 
conserved sequences for splicing and 
polyadenylation involved in nuclear
processing. C depicts the different stages 
of the flow of information from gene to 
protein. Reproduced and modified from [46].
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contains no other open reading frame. In common with a 
variety of other Pol II genes, the globin leader sequence 
has a short conserved region located - 1 0 bp's downstream 
of the cap site with the consensus sequence CTTPyTG [521.
Comparison of the exon/intron boundary on a number of 
divergent genes have identified 5' and 3' splice consensus 
sequences C/A AG+GT G/A AGT and (Py)6 NCAG+GG/T [53].
In common with other cellular genes the 3' 
untranslated region of the globin genes contain the highly 
conserved AATAAA [54] which is a signal involved in the 
endo-nucleolytic cleavage of RNA and its subsequent 
polyadenylation.
The 3' flanking region of the globin transcriptional 
unit represents the most highly divergent area. This is 
well illustrated by the two y globin genes which differ by 
around 15% in this region [27]. Much of the human genome 
is repetitive [55]. These sequences can be classified into 
two types. The first are short nucleotide runs, the 
physiological function of which is unknown [56]. The 
second class of repeat elements are longer in length and 
are interspersed throughout the eucaryotic genome as well 
as the 3 cluster. Two sequence families have been 
described in the 3 locus viz the Alul and Kpnl families. 
As depicted in Fig. (2) the 3 cluster contains eight Alul 
members [57] [58] [59]. The a globin locus features three 
Alul elements [60]. There are two Kpnl members, one 
between the epsilon and Y  globin genes [61] and the other 
3* to the 3 globin gene [62] as outlined in Fig. (2).
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1:1:4 The Molecular Structure of the Human Epsilon
Globin Gene
The human epsilon globin gene was originally isolated 
by Proudfoot and Baralle [25]. Hindlll digested normal 
and thalassaemic DNA was probed with radiolabelled 
rabbit 3 globin DNA. This cross hybridised to all 3 globin 
type genes including the embryonic gene. DNA corresponding 
to these autoradiographic signals was eluted from the 
agarose gel and the enriched fractions were cloned 
into Hindlllrestricted lambda vector [63]. The gene was 
isolated as an 8 kb fragment. Since then the epsilon globin 
gene has been cloned in a Charon 4A lambda vector [21] and 
in a cosmid [26]. Structural analysis as depicted in Fig.
(2 ) shows that the epsilon globin gene has the same 
structural pattern as the prototypic 3 globin gene. As 
outlined in Fig. (3) it bears considerable homology to 
other 3 genes especially in the proximal 5* flanking 
region. The entire coding and flanking sequences upto - 16 
kb from the cap site have been determined [45]. As shown 
in Fig. (4) the epsilon globin gene has a tripartite 
promoter structure (5' - 100/CCAAT/ ATA - cap-3') which it 
shares with the actively expressed y and 3 globin genes. A 
notable structural landmark of the epsilon globin gene 
domain is the two Alul members separated by 916 bp's, the 
proximal 1 kb upstream of the site of initiation as 
depicted in Fig. (2). Another feature of the epsilon 
globin gene is a region of alternating purine-pyrimidine
- 16 -
residues within a 995 bp's Sst I fragment - -6.5 kb 
upstream of the cap site.
Under certain physiological conditions these can adopt 
a Z DNA form [64].
1:2 Regulation of Globin Gene Expression
Differential globin gene regulation can be regarded as 
a series of events involving the sequential unfolding of a 
complex genetic programme during haematopoiesis in which 
expression of the globin genes are regulated in a tissue 
specific, coordinate and temporal manner. Despite the 
wealth of information on the genetic organisation and 
molecular anatomy of the globin loci our understanding of 
the logic of control and the underlying molecular 
mechanisms involved in these regulatory phenomena remain 
rudimentary.
Globin genes are transcribed by RNA Polymerase II. In 
general, genes transcribed by RNA Polymerase II can be 
regulated at one or more defined levels during gene 
expression [65]. The major steps of the intracellular 
information transfer are mRNA biogenesis; transport of 
message to the cytoplasm, turnover in the cytoplasm and 
protein synthesis which can involve post-translational 
processing. Prior to the onset of any of these events DNA 
replication should be considered as having an important 
role in gene expression especially quantal cycle division 
[6 6 ]. Excluding replication, this integrative scheme of
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regulation has formed the basis of the cascade regulation 
hypothesis [67]. Therefore it is important to determine 
which level or levels the expression of globin genes are 
controlled.
1:2:1 Replication
Replication plays an integral part in differential 
gene expression. Orthodox opinion is that guantal cell 
cycles direct cell populations along different
developmental pathways [6 6 ]; replication would be expected 
to have a similar function in haematopoiesis. Template 
duplication per se can be envisaged to influence the 
mechanisms responsible for 'gene activation* and 
subsequent transcription. During S phase the nucleosomes 
show a distinct association with the continuously
synthesised strand, this effectively leaves the nucleosome 
depleted lagging strand more accessible to cellular 
control factors and the transcribing machinery [6 8 ].
DNA synthesis appears to be essential during the late 
stages of red blood cell development. Conkie et al [69] 
have demonstrated a cell cycle dependence on the induction 
of haemoglobin synthesis in butyric acid treated MEL cells 
(Murine Erythroleukaemic cells transformed with the Friend 
virus [70]). A similar effect was reported by Gambari et 
al [71]. Smithies [72] has recently formulated a model 
emphasising the importance of replication on the 
regulation of globin gene expression., He has postulated
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that 3 globin gene activity is mediated by the
differential use of a series of replicons in the 3 globin 
gene cluster. The tenets of this hypothesis are that 
four 3 globin gene replicons are selectively utilised at 
different stages of development and in different cell 
types. Smithies [72] proposes that when upstream replicons 
are used the proximal globin gene is activated. These 
origins and structural sequences are termed 
homo-directional in that both DNA synthesis and
transcription occur in the sjune direction. When
heterodirection (downstream) replicons are favoured the 
proximal gene is repressed. For example, during embryonic 
development the 5 1 epsilon and the 3' 3 replicons are
activated, this ensures e expression and repression of the 
adult and foetal genes. This model has been applied with 
mixed success to various thalassaemic conditions where the 
appropriate replicon is mutated or absent so offering a 
physiological explanation for the abnormal expression. 
Smithies [72] however does not put forward any ideas on 
the regulation of this differential use of replicons.
A recent study has raised doubts about the necessity 
for DNA synthesis during cell differentiation. Chiu and 
Blau [73] examined the activation of muscle genes in human 
fibroblastxmouse muscle somatic hybrids. Activity was 
assayed in the presence and absence of the replication 
inhibitor cytosine arabinoside. Heterokaryons irrespective 
of whether a complete cell cycle had occured had 
comparable levels of the muscle protein MM creatine
- 19 -
kinase. This finding questions the role of quantal 
division during differentiation.
1:2:2 Transcription
Groudine and Weintraub [74] reported that in 20-30 
hour chick erythroblasts, the globin genes are 
transcriptionally silent as measured by the lack of 
haemoglobin synthesis and the insensitivity of the gene to 
DNase I treatment. Two generations later the chromatin 
adopts an active conformation implied by an increased 
susceptibility to nuclease digestion; in addition 
haemoglobin is detected at 36 hours. These observations 
infer that globin gene activation during red blood cell 
development initially involves an alteration in the 
configuration of the chromatin around the globin genes 
prior to the onset of transcription.
Hoefer et al [75] examined mouse 3 globin transcripts 
by analysing nascent labelled RNA from MEL nuclei which 
had previously been cultured in the presence of the 
inducer DMSO (Dimethysulphoxide). This treatment elevates 
haemoglobin production between 10 and 30 fold. This value 
correlates with a concomi t ant increase in the rate 
of 3 maj globin mRNA synthesis. Moreover the chromatin in 
the vicinity of this gene is DNase I sensitive.
Curtis and Weissman determined the length of the mouse 
3 globin RNA precursor molecules by hybridisation studies 
with pulse labelled RNA and immobilised cDNA [76]. These
-  2 0  -
authors described a 15S precursor which is processed to 
the 9S mature message. In this scheme, the primary 
transcript initiates around 50 bp's upstream of theATG, 
site and terminates at the polyadenylation signal. In 
contrast Bastos and Aviv [77] using a similar experimental 
design strategy and Renyaud et al [78] detected larger 
precursors of around 28S for the mouse and avian 8 globin 
genes respectively, the latter data are particularly 
convincing as those molecules were measured by 
heteroduplex mapping. This difference could be explained 
by 5' or 3' extension or both. Transcripts which extend 
beyond the 3' terminus, can be accounted for by a read 
through type of mechanism however extension at the 5' end 
is difficult to imagine since the 5' termini are capped. 
Capping requires the covalent linkage of the a phosphate 
of GTP to the a and 8 groups of the 5' terminus [79]. Thus 
cleavage of the RNA at the phosphodiester bond can only 
give an a moiety which means the GTP donating both 
the a and 8 phosphates. An alternative to this has been 
described by Abraham et al [80]. This involves the 
formation of a pyrophosphate group by the addition of a 
phosphate group prior to capping. This appears to be a 
specialised case and the overwhelming majority of capped 
molecules appear to be synthesised as previously outlined.
An alternative to an abnormal capping mechanism would 
be chain initiation at site(s) upstream of the canonical 
cap site so yielding a mixed population of transcripts. 
Hoefer and Darnell [81] using pulse labelled RNA from 
induced MEL cells described such a 5' heterogenous
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population with around 20% of mouse 8 globin RNA 
initiating upstream of the major cap site. These 
transcripts however were not accurately mapped, hence 
nucleolytic cleavage could not be discounted. In addition 
it was not known whether these molecules were capped. 
These authors also detected transcripts mapping downstream 
of the polyadenylation signal. In sharp contrast Grosveld 
et al [82] could not detect any rabbit 8 globin precursor 
larger than 16S. A possible explanation for these 
inconsistent findings is the different experimental 
techniques employed to assay for primary transcripts. 
Some systems maybe more sensitive in detecting non 
processed molecules. Moreover the data cannot rule out 
instant processing from some larger precursor(s) which 
eventually are processed to the 15S and 27S species.
Further evidence for the existence of large globin RNA 
molecules comes from a study by Ross et al [83] with the 
chicken 8 globin RNA and its association with the nuclear 
matrix. Over 90% of 8 globin specific RNA transcripts are 
found in the nuclear matrix complex. This structure has 
been proposed to be a platform for a number of important 
cellular events including nuclear processing [84]. High MW 
(Molecular Weight) chicken 8 globin RNA which extends into 
the embryonic domain has been shown to be complexed with 
the matrix structure.
In vitro run-off transcription assays involving both 
S1 Nuclease mapping and primer extension on 
cloned £, e and 8 globin gene fragments demonstrated that
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the transcripts exclusively originated from their 
respective major cap sites [85]. Furthermore these RNA 
species had the same 5' cap structure as authentic mRNA.
In contrast Allan et al [8 6 ] [10] described RNA
initiation sites upstream from the main start site in the 
human epsilon globin gene. RNA was prepared from the human 
erythroleukaemic cell line K562 which expresses embryonic 
and foetal globins [87] [8 8 ] and human embryonic livers of
5-10 weeks gestation. Epsilon globin gene specific 
transcripts were assayed by a combination of S1 nuclease 
and primer extension mapping techniques. Over 10% of the 
RNA molecules originated from a specific site located 270 
bp's upstream from the initiation codon (the - 2 0 0
promoter). Extended studies using probes spanning over 5 
kb of 5' sequence identified upstream initiation regions 
at -65, -270, -900, -1480 and -4500 bp's from the
ATG codon .(see Fig10) These minor initiation sites account 
for around 10-15% of the total epsilon transcript 
population. In addition the transcripts which yielded 
enough material for analysis were shown to be capped 
arguing against endonucleolytic cleavage of a larger 
precursor. The physiological significance of these' 
alternate cap sites is not understood. Of more importance 
is that they may reflect some local perturbation in the 
chromatin structure surrounding the epsilon globin gene as 
is generally accepted to be the case with DNase I 
hypersensitive sites. DNase I mapping of the epsilon gene 
in K562 cells shows a strong correlation between upstream 
initiation and nuclease sensitivity [89] [90]. Moreover
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the major upstream start site at -270 bp's contains an S1 
hypersensitive site [91]. Non-canonical cap site 
initiation has also been detected in the human y and 8  
globin genes. Using a similar experimental approach 
Grindlay et al [92] and Ley et al [93] mapped transcripts 
in the y globin gene between 50 and 100 bp's upstream from 
the major cap site. 8 globin gene transcripts originated 
between 140 and 170 bp's from the canonical cap signal.
In many of the sequenced Pol II gene major cap sites 
are preceded by the conserved promoter signals TATA and 
CCAAT. Extensive computer sequence searches were 
undertaken to determine if any of the upstream regions of 
the 8 type globin genes had these promoter domains in 
their vicinity. Despite some close fits with certain 
upstream sites, no unifying pattern emerged. This would 
seem to rule out a pre-requisite for the TATA and CCAAT 
Boxes for Pol II transcription. This is the case with 
certain viral genes [94] [95], and the GC rich promoters 
of a range of house keeping genes such as the human 
adenosine deaminase [96] and mouse dihydrofolate reductase 
(DHFR) [97] genes which are characterised by one or more 
Sp1 binding sites with the recognition sequence GGGCGG 
[98]. Alternatively these upstream promoters may be 
recognised by RNA polymerase III
1:2:3 Nuclear Processing
Nuclear processing is regarded as a passive event in
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the control of globin gene expression. Krainer et al [99] 
have looked at the splicing patterns in wild type and a 
series of mutant human 8 globin templates which had the 
normal acceptor/donor conserved splicing sequences [53].
When assayed in an in vitro HeLa cell extract system 
all RNAs were correctly processed. Thus it would appear 
that the globin primary transcript does not require the 
presence of authentic 5' and 3' or a polyadenylated 3' end 
to be faithfully spliced. Furthermore these workers [99] 
showed that a capped 5* terminus was not required for 
correct splicing, however without this modification the 
uncapped transcripts are spliced less efficiently and 
accurately.
1 :2:4 Nuclear-Cytoplasmic Transport
Chan [100] looked at the transport of chick embryonic 
globin RNA from the nucleus to the cytoplasm. He showed 
that newly synthesised RNA was retained exclusively in the 
nucleus for around 24 hours. Complete transport to the 
cytoplasm occurs within the next 24 hour period. The 
relative amounts of globin RNA in the nuclei and the 
cytoplasm change in a reciprocal manner, while the total 
amount of cellular globin RNA does not vary much during 
erythroid maturation. However it should be emphasised 
that confirmation of these data is still lacking. This 
apart, these findings support a hypothesis proposing that 
during the late stages of erythroid differentiation
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transcription of the globin genes precedes activation of a 
regulatory transport mechanism. Interestingly a recent 
study by Therwath et al [101] showed that Avian 
Erythroblastosis Virus (AEV) transformed immature chick 
erythroid cells have a different globin gene transcription 
pattern from adult erythroid tissue. Adult globin specific 
RNAs are exclusively confined to the nucleus and are 
unprocessed forming a 7-8 kb aA globin transcript while 
the contiguous aD globin gene specific RNA is essentially 
undetectable. In addition transcripts from the 
unlinked 8 globin gene locus are difficult to detect. 
These findings can be interpreted to support those of Chan
[100]. An alternative explanation is that they are not
transported because they are not correctly processed
1:2:5 Message Stability
Transcriptional regulation alone cannot account for 
globin message being the most abundant species in the red
blood cell. This domination is reflected in the
stability of globin mRNA compared to the non-globin 
population. An early study on the ti of globin mRNA in 
MEL cells showed a dramatic decrease from 60h to 17h 
after induction [102]. To explain this Aviv [102] proposed 
that non globin messages are degraded at a greater rate 
during the late stages of erythroid development. However 
Volloch and Houseman [103] using modified tissue culture 
conditions which physically stabilise the MEL cell during
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chemical induction calculated the ti of globin was ~60h in 
the terminal differentiated cells, while non globin half 
lives were ^30h. Differential mRNA degradation has also 
been considered as a mechanism in potentiating the levels 
of different haemoglobins in the erythrocyte. This could 
possibly influence globin switching by varying the 
stability of one globin species relative to another. Ross 
and Sullivan [104] investigated this by estimating the t^ 
value for y and 3 mRNAs in cultured human reticulocyte. 
Both species had similar turnover rates of 27-29 hours, 
which is inconsistent with the above postulate.
1:2:6 Translation
Selective translation of globin specific messages at 
the expense of other mRNA can be envisaged as a feasible 
mechanism in regulating the level of haemoglobin in the 
erythrocyte. There are two size classes of 
ribonucleoprotein particles (RNPs) in the red blood cell. 
Globins are associated with a 20S species and the other 
RNAs belong to the larger 35S structure. The larger RNP 
group contains a small RNA species which inhibits protein 
synthesis in vitro [105]. Vincent et al [106] have 
suggested that translational repression of the 35S class 
occurs during the late stages of erythroid development so 
effecting an increase in the synthesis of haemoglobin at 
the expense of non-globin in proteins. Differential 
translation in a similar fashion to selective stability as 
previously outlined may feature in the switching of globin
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genes. Sullivan and Ross [107] examined this in the 
foetal/adult switch. These workers found that the
translation capacity of reticulocytes has a half life of
6 - 8  hours and y and 8 protein synthesis parallel this 
decay. Furthermore it appears that the protein 
synthesising apparatus and not the abundance of message is 
quite limiting for globin production.
1:2:7 Conclusion
To conclude, the weight of experimental evidence 
suggests that globin genes are principally regulated at 
the level of initiation of transcription (1:2:2). However 
data exists which can be interpreted to support the notion 
that in addition to this transcriptional regulation,
globin genes are sequentially regulated after initial 
synthesis of the primary transcripts. These putative 
control levels being cytoplasmic transport (1:2:4), 
message stability (1:2:5) and translation (1:2:6) is 
consistent with some of the ideas within the framework of 
the Cascade Hypothesis of gene regulation [67].
1:3 The Conformation of Globin Genes in Chromatin
DNase I Hypersensitive Sites (DHS's) within isolated 
nuclei or chromatin have greater sensitivity to enzymatic 
probes and are associated with the binding of the non 
histone proteins (high mobility group) HMG 14 and HMG 17
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[108]. It is envisaged that these DHS's perturb the
regular nucleosomal array which in turn alter the
accessibility of the DNA of these regions to both cis and 
trans acting factors (for review see [109]). The approach 
of DNase I probing chromatin prepared from 
erythroleukaemic cell lines (see 1:7:2) and from
erythropoietic tissue at various stages of ontogeny has 
yielded valuable information in the identification and 
mapping of putative regulatory regions of the globin
transcriptional unit. Several examples illustrate this 
success.
Groudine et al [110] investigated the chromatin 
conformation of the yA - YG - 6  - 8 cluster in foetal and
adult erythropoietic tissue and in the HEL and K562 cell
lines which produce y globin mRNA but not 8 . The DNase I 
profile obtained with foetal liver cells showed 5' DHS's 
located ~200 bp's upstream of the four genes. However this 
pattern was not observed in the analysis of adult bone
marrow in this case. In addition a DHS was detected in 
the large intron ~800 bp's 3' to the polyadenylation site. 
The hypersensitive regions were restricted to the adult
genes. The HEL cell displayed a similar DNase I digestion 
profile to the foetal liver tissue. Furthermore, although 
y globin mRNA levels increased in haemin treated K562 cells 
no difference in the DNase I digestion was observed. In a 
similar type of study Lachman and Mears [111] described 
DHS's in 100 bp's 5' to the cap site of the yA and y G 
globin genes of K562 cells. Although the 8 globin gene was
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DNase I sensitive compared to the insulin gene only the 
transcriptionally active foetal globin genes have DHS's. 
These studies as did the earlier work of Weintraub and 
Groudine [112] suggest that globin genes in erythroid cell 
nuclei exhibit an increase in overall sensitivity of 
the 8 globin gene domain may reflect a change in local 
higher chromatin structure from the repressed conformation
of the 300 A fibre (solenoid) to the activated 1 0 0  A
structure, the conformation supposedly of the globin gene 
domains in all erythropoietic tissue [113]. The chromatin 
structure around the epsilon globin transcriptional unit 
in the K562 cell has been independently determined by 
Zhu et al [89] and Tuan and London [90]. These workers 
found that the DNase I hypersensitivity profile
corresponded with the major and upstream RNA initiation 
sites described by Allan et al [1 0 ] [8 6 ] at - 270, - 900,
- 1480 and - 4500 bp's. In addition a further DHS is 
located -6500 bp's upstream of the major cap site. This 
region has two notable structural features. The first is a 
long AT rich region which includes a consecutive stretch 
of 28Ts. The second structure consists of a potential Z 
DNA forming element of (AC)-j 2 (A T )g jSee Fig 10.
These experiments and a similar pattern of
differential DNase I sensitivity during globin ontogeny in 
chicken [114] suggest that the formation of a DNase I 
hypersensitive site within the derepressed 100 A 
conformation represents a primary event in globin gene 
regulation. However the appearance of a DHS or the
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pre-activation of the globin gene is not by itself a 
sufficient condition for the transcription of the globin 
gene, a further event(s) must occur. As a further 
illustration Groudine and Weintraub [115] demonstrated 
that chicken embryo fibroblasts infected with a Rous 
Sarcoma Virus (RSV) temperature sensitive (ts) mutant 
caused the formation of DHS's in the a and 3 globin gene 
domains and the production of globin specific transcripts 
when the temperature was reduced from 41 °C to 36°C. On 
adjusting the temperature back to 41°C globin gene 
transcription ceased, however, the DNase I
hypersensitivity remained. Moreover they were maintained 
in the fibroblast for up to 2 0 generations.
More detailed work on the association with DHS's in 
globin gene regulation has been carried out with the 
chicken globin gene system. Emmerson and Felsenfeld [116] 
have described a specific factor exclusively present in a 
9 day old chick which is involved in the creation of DHS 
in the 5' region of the 6 globin gene. Partially 
purified extracts from erythrocyte nuclei bind to a 
plasmid recombinant containing the hypersensitive region. 
This protein was not detectable in brain or oviduct tissue 
and was almost completely absent in 5 day old chick which 
does not express this gene. McGhee et al [117] located 
the DHS within a 115 bp's MspI fragment mapping 60 to 250 
bp's upstream of the cap site. This region corresponds to 
C rich - 100 region of the 3 globin gene promoter. This 
DHS also contains a S1 Nuclease hypersensitive site which
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is also present in supercoiled recombinants and in in 
vivo reconstituted histone core particles. However this 
S1 nuclease site does not show the symmetry of strand 
cleavage expected for single stranded DNA. Fine mapping
revealed the S1 hypersensitive site to be a long poly G
stretch. Interestingly other S1 sites have also been shown 
to be either homo-purine or homo-pyrimidine in structure 
[119] [120].
1:4 Methylation of Globin Genes
Demethylation of certain CpG residues has been coupled 
to transcriptional activity of a number of genes including 
globin genes (for a recent short review see [1 2 1 ]).
The early experiments of van der Ploeg and Flavell
[1 2 ] on the methylation pattern of the human 3 globin
gene locus from erythroid and sperm tissue showed an 
inverse correlation between methylation and gene 
expression. Since then, Mavilio et al [122] reported on a 
similar relationship in the promoter regions of the human 
e and y globin genes in embryonic erythroid tissue. In 
another related study Busslinger et al [123] using the 
technique of in vitro methylation demonstrated that 
methylation of upstream sequences - 760 to + 100 bp's
prevent transcription of the human 3 globin gene after 
transfection into mouse cells. Furthermore erythroid 
cells cultured in 5' - azacytidine leads to a general 
inhibition of methyl transferase activity [124]. This has
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provided the basis of attempting to switch on the foetal 
globin genes in thalassaemic patients [125], however it is 
contentious whether demethylation per se caused an 
increase in HbF synthesis. In contrast to the above 
findings Weintraub and his colleagues [126] working with 
erythroblasts transformed with a temperature sensitive 
Avian Erythroblastosis Virus, demonstrated non-expression 
of the a globin gene at the permissive temperature despite 
the existence of a DHS and undermethylation of 5' CpG 
residues. Of further intrigue was the observation that 
the 3 globin gene remains methylated under these 
particular circumstances.
The studies on globin gene methylation profiles and 
those of active genes which remain methylated such as 
chicken vitellogenin [127] and mouse dihydrofolate 
reductase [128] make a general conclusion on whether 
demethylation of specific CpG residues is a pre-requisite 
for transcription difficult to evaluate.
1 :5 cis Control Sequences
Globin gene regulation at the molecular level is 
controlled by the interaction of proteins and various 
cellular factors with specific DNA sequences. An initial 
step in the study of these interactions is the 
identification of putative control sequences of the globin 
transcriptional unit. The regulatory sequences can be 
broadly divided into two main types.
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The first are involved in directing the synthesis of 
authentic message. Sequences involved in qualitative 
control are the various functional domains of the promoter 
which are concerned with mRNA initiation and the short, 
highly conserved signals involved with nuclear processing 
(capping, splicing and polyadenylation, see Fig. (4)).
The second group of controlling elements are those 
sequences which govern the quantitative regulation of 
globin gene expression. These await identification and 
seemingly involve both cis linked DNA and trans acting 
genes. These sequences are associated with the 
regulation of globin genes.
1:5:1 The Globin Gene Promoter
Grosveld et al [129] examined the transcription of a 
number of 5' rabbit 8 globin gene deletion mutants in 
vitro in a HeLa cell extract assay system. They found 
that the ATA Box was required for the generation of 
faithful 5 1 transcripts. In contrast mutations in the 
CCAAT Box had no pronounced effect on transcription. This 
pattern is not reflected in vivo. Grosveld et al [130] 
engineered a series of rabbit - 8 - globin gene promoter 
deletion mutants. These templates were covalently linked 
to the SV40 origin of replication region which also 
contains an enhancer. Transcripts were analysed in a HeLa 
cell transient assay system by quantitative S1 Nuclease 
mapping. In the absence of the SV40 DNA, faithfully
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initiated rabbit 8 globin gene transcripts are barely 
detectable which is in agreement with an original
observation by Banerji et al [131]. In contrast to the in 
vivo studies, both the ATA and CCAAT signals are required 
for the synthesis of optimum levels of correctly initiated 
rabbit 8 globin gene transcripts. In addition deletion of 
the ATA Box led to greater heterogenity of transcription 
initiation sites. Corroborative evidence proposing an 
important role for the ATA Box in globin gene regulation 
comes from studies on thalassaemias. There are several 
forms of 8 - thalassaemias as depicted in Fig. (5B)
characterised by mutations in the ATA Box which is
seemingly responsible for decreased transcriptional 
activity [46], In addition, Grosveld and co-workers showed 
that deletions, which extended beyond the CCAAT motif into 
the C - rich -100 region, resulted in a significant
reduction in the level of transcription, these down 
mutations were estimated to be in the order of a fifty 
fold reduction. Furthermore sequences 3' to the ATA Box 
including the major cap site were found to be dispensable 
for transcription. Corroborative evidence for a functional 
tripartite prototypic globin gene promoter structure (5' - 
-100/CCAAT/ATA-cap-31) has been presented by Dierks et 
al [132]. However in contrast to the findings discussed 
above, these workers found that deletion of the ATA Box 
reduced the level of transcription, moreover very little 
5 1 heterogeneity in the start sites of the few transcripts 
which were made were seen.
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Figure 5
A summary of the molecular lesions 
causing 3 Thalassaemia. A shows the large 
deletions represented by the solid black 
lines in relation to the 3-globin gene 
cluster. Hatched boxes indicate that that end 
point of the deletions has not been 
accurately mapped. B represents mutations 
causing 3 Thalassaemia which are point 
mutations and small deletions or insertions. 
Reproduced and modified from [2].
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A comparable study on the behaviour of the 
human 3 globin gene in a transient assay system shows a 
similar transcriptional pattern to the rabbit gene. Green 
et al [133] demonstrated that the detection of authentic 
transcripts depends on the presence of a viral enhancer. 
S1 Nuclease analysis of 5' mutants confirm that sequences 
between 75 and 128 bp's upstream of the cap site are 
necessary for optimal transcriptional activity. As with 
the rabbit gene the region of 5' flanking sequence
contains a double repeat of the C rich -100 element. 
Further evidence for a crucial physiological role for the 
- 1 0 0  region when assayed in stable transformed cells was 
reported by Spandidos [134]. A series of 5' deletion 
. mutants were covalently linked to the HSV-1 tk gene (Herpes 
Simplex Virus Type 1 thymidine kinase gene). These were 
stably introduced into the MEL tk*" cell line. 
Transcriptional levels were determined by Northern
Blotting of total RNA. Adjusting for the variation in copy 
numbers of the donor DNA it was concluded that a region
upstream of the CCAAT Box was required for optimal 
expression. This area corresponds to the location of the 
repeated C rich region. Detailed correlations were not 
possible as the deletion mutants were not sequenced.
Functional domains have been identified in the a 
globin type promoter. Using a-1 globin gene recombinants 
harbouring the SV40 origin of replication Mellon et al 
[135] transformed COS 7 cells and measured the transcripts 
after a 48 hour expression period. COS 7 cells
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constitutively produce T antigen [136] and are permissive 
for SV40 viral replication so ensuring high copy numbers 
of the a gene recombinants. In this system authentic 
globin mRNA is produced at easily detectable levels. 
Deletion mutant studies show that the region between -55 
and -87 which contains the CCAAT motif is required for 
optimal activity.
In contrast the embryonic a globin gene £* is not 
transcribed from the SV40 replication vector in COS 7 
cells or HeLa cells [137]. However low activity levels 
were detected when the SV40 72 bp's enhancer was
covalently linked to the £ globin gene recombinants 50 
bp's upstream of the CCAAT Box. Moreover when this
recombinant was introduced into Xenopus oocyte by 
microinjection, mRNA synthesis dramatically increased. In 
addition authentic transcripts are generated in the 
absence of the SV40 enhancer. These results are somewhat 
different from the behaviour of other globin genes which
are non specifically transcribed in Xenopus oocyte. For
example rabbit 3 globin transcripts originate exclusively 
from vector sequences [138]. These data suggest some 
embryonic factor in the Xenopus oocyte can overcome the 
apparent inactivity of the £ globin gene in Hela or COS 7 
cells.
To conclude, three endogenous cis acting functional 
domains have been identified in the transcriptional unit 
of human globin genes. The ATA and CCAAT signals are 
common to all a and 3 globin genes except the
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hypofunctional 6 globin gene which has a CCAAC signal 
compared to the canonical CCAAT motif as depicted in Fig.
(3) These short conserved elements constitute the core 
promoter which is common to a number of Pol II genes
[47]. In addition the epsilon y and 3 globin genes share a 
C rich -100 element giving these genes a distinct
tripartite promoter structure. The 6 globin gene and 
the a globin locus members lack this element. Finally it 
is interesting that the human a type globin genes and the
epsilon, y and 3 genes of the 3 globin gene cluster which
have similar transcriptional rates in mature erythrocytes 
respond differently to the presence of cis linked viral 
enhancers in short term expression assays. As to what 
significance these differences have in the differential 
expression of the globin genes is unclear.
1:5:2 Enhancer Sequences
Enhancers can be operationally defined as integral cis 
acting functional domains of certain viral and cellular 
transcriptional units which markedly potentiate 
transcription from heterologous promoters relatively 
independent of distance from the gene and orientation in 
relation to it (for a comprehensive review see [139]).
Comparitive sequence analysis of a diverse range of 
enhancer elements reveals a short homologous region termed 
the "core" i.e. TQG^^(G) [140]. Studies with SV40 core 
element point mutations suggests the 5' G is essential for
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optimum activity [140]. A further common structural
element has been identified by Nordheim and Rich [141] who 
surveyed a variety of viral enhancers and found a pattern 
of two pairs of potential Z DNA elements ( ^ 8  bp's) 
separated by between 50 and 80 bp's.
Enhancers display some interesting physiological 
properties.
The expression of enhancer dependent promoters can be 
attenuated by the insertion of other promoters between the 
enhancer and the promoter under study. For example De 
Villiers [142] found that T-antigen expression dropped 
when a rabbit 3 globin promoter was positioned between 
the 72 bp's element and the SV40 promoter.
Although viral enhancers can substitute for one 
another in functional assays [143], Spandidos and Wilkie 
[144] showed that some display a distinct preference for a 
species specific host such as the enhancers of BPV (Bovine 
Papilloma Virus) and MoMuSV (Moloney Murine Sarcoma Virus) 
This preference or requirement for a specific host is a 
restriction on the activity of a number of cellular 
enhancers which act in a highly tissue specific manner 
such as those of the immunoglobulin genes [145] [146]
[147], the chymotrypsin and insulin gene [148] indicative 
of trans factor(s) involvement. This tissue specific mode 
of action of these enhancers is particularly germane to 
globin gene expression.
Enhancers are recognition sequences for cellular 
factors. Scholer and Gruss [149] monitored the expression
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of an SV40 - CAT (Chloramphenicol Acetyl Transferase) 
plasmid in a transient assay system, A reduction in CAT 
activity was observed in the presence of increasing 
amounts of competitor DNA in the form of an SV40 - Neo 
(Neomycin Gene) recombinant.
The mechanism of enhancer action is unknown. A 
favoured model is that of a RNA Polymerase bidirectional 
entry site, where on access the polymerase or some as yet 
unidentified associated factor scans the template and 
initiates at the first promoter it recognises.
The existence of tissue specific enhancers of the 
transcriptional unit of the immunoglobulin [145] [146]
[147], chymotypsin and insulin [148] genes has given rise 
to the intriguing notion that such sequences may be 
associated with the tissue specificity of globin gene 
expression. However, to date no compelling data has been 
presented supporting this idea. Somewhat indirect 
evidence for transcriptional enhancement by globin genomic 
DNA but not tissue specificity has been reported by Di Maio 
et al [150]. These authors have demonstrated that a 
sequence element 3 1 to the human 3 globin gene markedly 
increases the transformation efficiency of mouse cells 
when cis linked to a BPV vector.
1:5:3 Z-DNA
Although the major conformation of DNA in biological 
systems is the B-form, other structures arising from
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unusual sequence arrangement have been identified. 
Prominent amongst these alternative structures is 
left-handed or Z-DNA (see [64] for a general review) 
characterised by a string of alternating purine and 
pyrimidine residues which under certain physiological 
conditions can adopt a left-handed form.
Potential Z-DNA regions have been identified 
throughout the human genome [151]. Nucleotide sequencing 
of the human 3 globin gene cluster has revealed a number 
of alternating purine and pyrimidine tracts of varying 
length from 20 - 60 bp's. These have been mapped ~6.5 kb 
upstream of epsilon globin gene [45], within the large 
intron of the y globin gene [40] and ~2.7 kb and ~0.5 kb 
upstream of the cap site of the human 3 globin gene 
[152] [153].
It has been proposed that left-handed DNA has a 
regulatory role in the expression of Pol II genes [64] and 
Pol III genes [154]. This influence is thought to occur by 
changes in the supercoiling of the DNA due to the B Z
transition which in turn causes a perturbation in the 
conformation of chromatin. Sinden [155] has shown that DNA 
which is transcriptionally silent is not under 
superhelical tension. And although proteins have been 
identified which specifically bind Z-DNA [156] it is not 
known whether such transition alter the three dimensional 
structure of neighbouring DNA in vivo.
A role for Z-DNA involvement in the expression of 
globin genes awaits detailed examination. However Gilmour
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et al [157] have identified a negative effective element 
in the 5' flanking region of the mouse 3 maj globin gene 
within which maps a 53 bp's tract of alternating purine 
and pyrimidine residues. When this segment between 344 and 
1143 bp's upstream of the cap site was linked to the 
mouse 3 maj globin or the human epsilon globin promoter /HSV-1 
tk fused gene, transforming activity in HAT medium (100 yM 
Hypoxyanthine, 0.4 yM Aminopterin, 16 yM Thymidine) [158] 
was essentially abolished. In contrast the repression was 
relieved when the repressor fragment was covalently linked 
to the HSV-1 tk promoter. Difficulties in transforming MEL 
tk- cells halted further investigation into whether this 
phenomenon would be a feature of erythroid cells which 
actively expresses the endogenous gene (R.S. Gilmour Pers 
Comm)
1:5:4 Intergenic DNA
Much of the intergenic DNA of the human 3 globin gene 
locus is repetitive (see Fig. ( 2 ) ) .  Do any of these repeat 
elements have any physiological role in globin gene 
expression?
The 300 bp's Alul members contain the recognition 
signal for RNA Polymerase III [159]. Several of the Alul 
elements are transcribed in vitro [160] [161] [162]. Allan 
and Paul [163] demonstrated the in vivo expression of the 
distal Alul element of the human epsilon globin 
transcription unit in the erythroleukaemic cell line K562
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[87]. Interestingly, the 350 - 400 bp's transcript
originates from the opposite strand and corresponds to the 
in vitro transcript described by De Segni et al [164]. 
These RNA species are non polyadenylated and nucleus 
confined. Of possible regulatory significance is the 
observation that these transcripts have only been detected 
in the K562 cell. However it is unknown if Pol III 
activity is a consequence or cause of epsilon globin gene 
activity in the K562 cell.
Along similar lines, Carlson and Ross [165] have 
identified human 3 globin RNA species which are 
synthesised in vitro from the 5' flanking region between 
-235 and the cap site by S1 Nuclease mapping of run off 
transcripts. These molecules which extend to the coding 
region of the gene were shown to be a amanitin sensitive. 
Although as depicted in Fig. (2) there is not an Alul 
repeat element in this region of the human 3 globin 
transcription unit, there is a region of Pol III homology 
a feature of Alul members. Of particular interest was the 
observation that these transcripts were only present in 
RNA prepared from erythroid tissue.
1 : 6  trans Control Sequences
Although cis - operating mechanisms are of crucial 
importance in the transcriptional initiation of globin 
genes, the events leading from repression to gene 
activation would seemingly involve a series of trans 
acting factors. Despite our almost total ignorance of
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these mechanisms or the regulatory genes involved in the 
sequential activation and expression of globin genes, there 
is considerable evidence supporting the idea of trans 
factor involvement during red blood cell development. 
Three distinct experimental strategies have been employed 
to investigate trans activation of the globin genes. These 
are somatic cell genetics, induction of stably transformed 
MEL cells and elevation of globin gene expression by 
defined viral gene products.
1:6:1 Globin Gene Expression in Somatic Cell Hybrid 
Lines
Deisseroth and Hendrick [166] were able to activate 
the human a globin genes from non-erythroid cells in man x 
mouse somatic cell hybrids. These were prepared by fusing 
diploid human mononuclear lymphocytes with tetraploid MEL 
cells which are APRT (Adenine Phosphoribosyl Transferase) 
deficient, this facilitates selection since the human APRT 
gene is also on chromosome 16 which carries the human a 
globin genes. Hybrid cell lines containing human 
chromosome 16 were treated with DMSO to induce endogenous 
globin gene expression. Upon induction those cell lines 
produced detectable quantities of a globin mRNA and 
protein although at lower levels than the mouse 
equivalent. An, important issue from these studies is that 
the mechanisms responsible for the repression of the 
human a genes in a non-erythroid environment are
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reversible. The mouse erythroid cell can apparently 
overrule this genetic restriction. However it is unclear 
whether this derepression is accomplished in a manner 
similar to the sequential activation which occurs during 
normal ontogeny. In a further study Deisseroth et al 
[167] constructed two series of man x mouse somatic cell 
hybrids each carrying human chromosome 16. One set was 
derived from bone marrow cells and the other from 
haematopoietic non erythroid tissue. In the former series, 
high levels of human a globin message and protein were 
produced. In contrast, the non-erythroid hybrid had a 
lower message content and no a globin chains were 
detected. This implies that exogenous expression in the 
MEL cell hybrids is governed not only by the murine 
erythroid environment but also by the differential state 
of the human donor cell. A further interpretation suggests 
the involvement of cis operating controls so leading to 
the conclusion that the chromatin arrangement in the 
erythroid cell is more readily recognised by the erythroid 
regulatory signals in the mouse.
A parallel study on the tra n s  activation of the human 
3 globin gene was performed by Pyati e t  a l  [168] with 
somatic cell hybrid lines derived from induced MEL cells 
containing human chromosome 11 from lymphoblast cells. An 
interesting observation on the differential activation of 
the human 3 globin type gene was reported by Willing e t  a l  
[169]. These workers showed activation of both the 
adult a and 3 globin genes in MEL x human fibroblast cell
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hybrids. However, the y globin gene sequences remained 
transcriptionally quiescent. This failure to trans 
activate the human globin foetal genes maybe explained by 
the absence of mouse foetal factor(s) equivalent to the 
adult factor(s) since there are no murine foetal globin 
genes.
1:6:2 Induction of Exogenous Globin Gene Expression in 
Transformed MELtk~ Cells
The introduction of cloned mutagenised globin genes 
into animal cells is a powerful analytical technique in 
the identification of cis acting sequences of the 
prototypic globin transcription unit. Despite this it must 
be seriously questioned as being a suitable experimental 
system to examine globin gene regulation.
When the donor DNA is introduced into the recipient 
cell line and subsequently integrated into the hosts 
chromatin it generally adopts a more open or relaxed 
conformation that it does in its endogenous environment 
where it is transcriptionally silent . Recipient animal 
cells such as the mouse L-fibroblast or the Hela cell are 
end stage cells and do not normally undergo any further 
development. In contrast, the MEL cell is an erythroid 
cell which is arrested in red blood cell development at 
the proerythroblast stage [70]. This blockage is affected 
by an integrated Friend virus. In response to a variety of 
chemical inducers including DMSO, HMBA (Hexamethylene
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Bis-acetamide) and Butyric Acid this cell line can undergo 
differentiation which is marked by an increase in the 
expression of the endogenous adult globin genes by 50 -
100 fold. Subsequently the introduction of non-murine 
globin DNA into the MEL line affords an opportunity to 
define the sequences involved in the induction process. 
Two groups have independently investigated the behaviour 
of cloned human globin genes in MEL cells.
Chao et al [170] established transformed MELtk” lines 
containing the intact 3 gene and a 5* mouse/3' human 3 
globin gene. Upon induction both recombinants gave 
elevated levels of transcription as determined by S1 
Nuclease mapping and primer extension mapping. This 
increase in exogenous globin gene activity of 5 - 50 fold 
does not parallel the endogenous level of 50 - 100 fold. A 
possible explanation is that there may be important 
differences in the chromatin structure or more 5'sequences 
are required for this quantitative control.
In a similar, but more comprehensive study, Wright et 
al [171] introduced a series of overlapping tk cosmids 
spanning the entire 60 kb of the human 3 globin gene locus 
into MELtk" cells. Transformed lines were treated with 3mM 
HMBA and transcripts from the induced and non-induced 
cells were quantitated by S1 Nuclease mapping. Only the 
adult 3 globin gene had elevated levels of expression. The 
foetal and embryonic genes showed no difference between 
the induced and non-induced state. This observation 
closely resembles the behaviour of the y globin gene in
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man x mouse somatic hybrids as described by Willing et 
al [169]. These workers failed to detect induction of the 
foetal genes in induced MEL x human hybrids. In contrast, 
Spandidos and Paul [172] have reported induction of the 
human epsilon globin gene in transformed induced MELtk” 
cells on the basis of Northern blot quantitation using a 
3' specific epsilon globin gene probe. However not all of 
the transformed lines gave elevated levels of epsilon 
globin gene expression.
At present the sequences involved in the induction 
process are being investigated by comparing the activity 
of in vitro mutagenised templates with wild type DNA. A 
study by Charnay et al [173] using a series of human 
hybrid genes showed that either the human 8 globin 
promoter or its coding sequences could confer the property 
of inducibility. Wright et al [174] showed that the rabbit 
8 globin promoter could be deleted 58 bp's from the 
cap site without loss of induction, however the level of 
expression was lower in both induced and non induced cells 
compared to the gene with an intact promoter.
The induction phenomenon has been investigated in the 
human erythroleukaemic cell line K562 [87] which on
treatment with 30 - 60 yM haemin results in a 3 - 5 fold
increase in both the rate of transcription and the level 
of accumulation of £ , epsilon, y and a globin mRNA [175]. 
Adult 8 globin message has not been detected in the K562 
cell. As outlined in (1:7:3) the fact that the K562 cell 
contains a functional 8 globin gene, its non-expression is
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presumably explained by the lack of or presence of 
specific trans factors. This expression and induction 
pattern of the endogeneous globin genes is mimicked by the 
equivalent exogenous genes in induced stably transformed 
K562 cells. Although the K562 cell does not carry a 
selectable marker, stably transformed cell lines can be 
generated by co-transforming or covalently linking the 
globin gene recombinant to the aminoglycoside 
phosphotransferase gene Tn5 aph (II) [176] (see 1:7:3) 
which is resistant to the antibiotic geneticin. Kioussis 
et al [177] used a series of hybrfd genes in which the 3' 
half of the rabbit 8 globin gene was covalently linked to 
the 5' half of the human epsilon y and 8 globin gene. 
Upon induction only the epsilon and y globin gene hybrids 
produced elevated levels of expression.
In contrast to the above findings Spandidos [178] 
reported not only expression of an exogenous human 8 
globin gene recombinant but also its co-induction in the 
K562 cell. Transformed K562 cell lines carrying full 
length copies of the epsilon , 6 and 8 globin genes were 
induced by treatment with 1 mM Butyric Acid. Expression 
was quantified by Northern Blotting [179] using 3* probes. 
All three recombinants gave increased levels of activity.
1:6:3 trans Activation of Globin Genes by Viral Proteins
The human a and 8 globin promoters differ in their 
response to a cis linked viral enhancer in a transient
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assay system. A possible explanation for this is that a 
cellular factor interferes with the transcription of the 3  
globin gene in a transient expression system. Possible 
candidates to release this repression are the products of 
the Adenovirus E1A [180] and the Herpes virus a 4 gene 
[181]. These genes which can complement one another [182] 
in co-infection experiments are powerful modulators of 
transcription. The E1A protein is required for the 
activation of all other early adenoviral transcriptional 
units [180], Nevins [183] envisages two possible 
mechanisms for this trans transcriptional activation 
process. The first proposes that the E1A protein somehow 
interferes with the cellular factor which otherwise blocks 
transcription of the adenoviral transcription units. The 
second mechanism suggests that the E1A product, could 
itself be a positive factor or alternatively, it may 
activate a quiescent factor. Moreover its ability to 
induce a heat shock protein [184] has provided credible 
evidence that it may have a similar effect on the 
human 8 globin gene in a transient assay. Green et 
al [133] examined the effect of the E1A and HSV gene
products on the a and 8 human globin promoters in the 
presence and absence of the SV40 enhancer. It was observed 
that these viral proteins can circumvent the necessity of 
an enhancer for optimal levels of 8 globin gene 
expression. Treisman et al [185] showed that this effect 
is maintained in three different experimental conditions. 
The first involves co-transfecting the recipient cell line
- 51 -
with an E1A recombinant. The second is by viral
transfection. The third is by transforming the human 
embryonic kidney line 293 [186]. This established cell
line constitutively expresses the E1A protein and can 
complement E1A mutants. Although this protein produced 
from the 293 cell can trans activate the exogenous globin 
genes, it does not derepress endogenous transcriptional 
units. This indicates that there are other forms of 
control in the activation of the endogenous quiescent gene 
and that this repression cannot alone be alleviated by the 
E1A protein. A further interpretation is that at some 
stage, possibly in the latter events of haematopoiesis, 
a trans effector, which has E1A like properties, is 
involved in the sequential activation of the 0 globin 
gene.
Although the E1A protein bypasses the need for a 
recognised enhancer in the expression of the 0 globin gene 
in short term assays, the mechanisms of activation of the 
enhancer and E1A appear to be fundamentally different. To
determine the nucleotide requirement of each of these 
mechanisms. Green et al [133] examined the activity of a 
series of 5' deletion mutants of the human 0 globin gene. 
The enhancer dependent (cis - control) promoter require 
sequences up to 128 bp's upstream of the cap site, i.e. 5' 
—100/CCAAT/ATA - cap - 3' for optimal activity. In
contrast, the E1A dependent promoter (trans - control) is
fully active on a template with 36 bp's of 5' flanking DNA
i.e. 5' - ATA/ - cap - 3'.
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1 :7 Aims of Project
The broad aim of this project was to identify putative 
regulatory sequences within the human 0 globin gene 
cluster. With this in mind a Charon 4A human genomic 
library kindly supplied by Dr. T. Manaitis [22] was 
screened for human globin genomic sequences. However this 
library proved to be incomplete in terms of globin 
sequence representation. The human epsilon globin gene 
isolated by Proudfoot and Baralle [23] was made available 
to this laboratory and became the focus of study. The 
epsilon globin gene like other members of the 0 globin 
gene cluster, has a well defined ontogeny (see 1:1:2). It 
is the first 0 type globin gene to be expressed and its 
location at the 5' end of the locus Fig. (2) may provide 
an opportunity to map the 5' of the cluster. Moreover its 
expression can be monitored in vivo in the inducible human 
erythroleukaemic cell line K562 as discussed in (1:7:3).
The weight of experimental evidence suggests that 
globin genes, once activated during ontogeny are primarily 
regulated at the level of the initiation of transcription 
(1:2:2 ).
Consequently an understanding of the transcriptional 
control mechanisms may provide some clues to the 
elucidation of the complexities of tissue specificity, 
coordinate and temporal regulation of the globin genes.
At the outset of this project several methodologies 
were available to study the transcription of the globin
- 53 -
genes.
1:7:1 Experimental Approaches to Study Globin Gene 
Expression
The thalassaemias can be considered natural mutants of 
the human globin gene loci [6 ]. As shown in Fig. (5A), the 
molecular lesions responsible for 0 thalassaemias can be 
broadly divided into those extensive deletions resulting 
in the Hereditary Persistence of Foetal Haemoglobin (HPFH) 
in which the foetal genes are expressed in adult life [6 ] 
[46] and those local lesions due to point mutations or 
small deletions/insertions resulting in a range of 
promoter and nuclear processing mutants as listed in Fig. 
(5B). Although these mutants provide; a useful source of 
material for the identification of putative regulatory 
signals and regions,the juxtapositioning effect of large 
scale deletions must be recognised when proposing a 
unifying hypothesis linking lesion and control. 
Furthermore it is interesting that no trans thalassaemic 
mutants have been identified, arguably indicative that the 
diffusible regulatory molecules are of a general type in 
their mode of action such as E1A [183].
Finally it must be extremely doubtful if the 
thalassaemia approach would be useful in the study of 
human epsilon globin gene transcription, since any lesion 
of physiological significance in the epsilon globin 
transcription unit would be very difficult to identify due
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to the operational problems in such a screening programme. 
Moreover if the mutation was homozygous it would likely be 
lethal.
Another considered strategy was to examine the 
conformation of the chromatin surrounding the globin genes 
in erythroid and non-erythroid tissue and also in the 
erythroleukaemic cell lines. This, as previously 
discussed (1:3), can lead to the identification of 
putative regulatory regions in terms of differential 
sensitivity of chromatin to nuclease probes. This approach 
has the advantage that transcription can be monitored at 
all stages of development.
1:7:2 Human Globin Gene Expression in Erythroleukaemic 
Cell Lines
The human erythroleukaemic cell lines including the 
K562 [87], HEL [187] and the KMOE [188] in addition to the 
murine MEL cell [70] provide, an opportunity to examine 
the influence of erythroid trans acting factors on the 
transcriptional behaviour of the human epsilon globin 
gene.
The K562 cell line established by Lozzio and Lozzio 
[87] was derived from a patient in the terminal blast 
crisis stage of chronic myeloid leukaemia. The K562 cell 
can be regarded as having a mixed phenotype, mainly 
myeloid with a few erythroid characteristics. All globin 
genes are expressed in the K562 cell except the adult 6
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and 0 [8 8 ]. The mechanism responsible for this block is 
not understood. Two lines of evidence tend to discount 
mutation. K562 DNA gives the same restriction endonuclease 
pattern around the 0 globin gene as wild type erythroid 
and non-erythroid DNA [189]. Donovan-Peluso et al [190] 
isolated the 0 globin gene from a Charon 21A/K562 library 
and cloned into the expression vector pBSV which contains 
the SV40 enhancer [191]. This was transfected into HeLa 
cells and assayed after an expression period of 48 hours. 
S1 Nuclease mapping and Northern Blotting showed that the 
transcripts were identical from those of a normal 0 globin 
gene in terms of site of initiation and the size of the 
processed product. Although the £, a, epsilon and y 
globin genes are readily expressed in the K562 cell, the 
level of activity increases 3 - 5 fold after treatment
with a range of low MW inducers such as haemin, and 
butyric acid [175] [192] [193].
The HEL (Human Erythroleukaemic Line) was isolated by
Martin and Papayannopoulou [187]with the peripheral blood
of aHodgkins disease victim who subsequently developed
A Gerythroleukaemia. This line mainly produces y and y 
chains and low amounts of epsilon and £ embryonic 
polypeptides. No 0 globin chains have been detected [187]. 
As was the case with the K562 cell these is no evidence at 
the Southern Blotting level for mutation in the 0 globin 
genomic domain. The HEL line is capable of both 
spontaneous and chemical induction (20 yM haemin).
The K562 and HEL cells appear to be frozen at the
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embryonic/foetal switch and consequently do not express 
the adult 3 globin gene. In contrast, the KMOE cell 
isolated by Okano [188] from a patient with acute 
erythremia,expresses the adult 3 globin gene is inducible 
in the presence of Cytosine-3-D-Arabinofuranoside (Ara-C).
Accordingly these three erythroleukaemic cell lines 
which span the three gene switches of normal ontogeny may 
provide a rewarding experimental system to study the 
molecular mechanisms which govern these events.
However the physiological suitability of these cell 
types must be questioned. The expression of the globin 
genes in the non-induced state is indicative that a number 
of regulatory events have already occurred. Even the 
silent 3 globin gene in the K562 cell is DNase I sensitive 
[194]. In addition concern must be recognised on the 
neoplastic nature of these cell lines - do these cell 
types mirror the structure and regulation of globin 
chromatin during normal differentiation?
1:7:3 Human Globin Gene Expression In Transformed Animal 
Cells
The combined technologies of reverse genetics and in 
vitro mutagenesis of cloned cellular sequences have 
provided a powerful assay system in the search for 
putative regulatory elements. This technology has been 
responsible for determining the physiological importance 
of a number of sequences including promoter regions,
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enhancers and processing signals. In vivo
transcriptional assays measure gene activity in the living 
animal cell where the foreign cellular gene is transcribed 
by the host's RNA Polymerase system.
A variety of methods are available to introduce 
foreign DNA into eucaryotic cells. The most extensively 
used and best characterised technique is the calcium 
phosphate precipitation of DNA (see 2:4:2) pioneered by 
Graham and van der Eb a number of years ago [195]. This 
technique can also be performed with whole chromosomes 
[196].
DNA can also be introduced into animal cells via 
liposomes [197], by DEAE - dextran [198] and by protoplast 
fusion [199]. More recently retroviral vectors have been 
constructed which package the donor DNA in vitro prior to 
transfection [200]. Genes can also be introduced directly 
into the cell nuclei by a variety of methods including 
microinjection [2 0 1 ], and by electrical stimulation of the 
membrane (electroporation) [202] [203] [204]. In addition 
DNA can be introduced directly into the oocyte [205] and 
germ cells [206], the latter resulting in transgenomes.
Independently of how the DNA enters the cell, the 
biological activity of the donor DNA can be assayed either 
after a short expression period of usually between 36 and 
48 hours, this method is termed short term, transient or 
acute transformation. Alternatively expression can be 
determined after a longer period commonly in the region of 
1 to 3 weeks, termed long or stable transformation.
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In transient expression experiments, the
transcriptional activity of the donor DNA is assayed 
directly by analysis of RNA or by measuring the protein 
product. When the exogenous DNA is fused to a gene coding 
for an enzyme, the amount of protein in the cell can be 
regarded as a measure of the regulatory sequences driving 
expression of the gene encoding for the enzyme. Suitable 
genes for this purpose include amongst others CAT [207], 
XGPRT (Xanthine Guanine Phosphoribosyl Transferase)
[208] and HSV-1 tk [209].
In addition expression can be estimated by 
immunofluorescence of the SV40 T-antigen [210]. The 
physical form of the donor DNA is thought to be episomal 
some of which form mini chromosomes [211]. Immediately 
after uptake the copy number is high, around 2 0 , 0 0 0  to 
100,000 copies per cell. This peaks around 48 hours after 
which the number drops dramatically. The mechanism 
responsible for this is unknown. When the foreign DNA 
encodes for a selectable marker such as tk, transformed 
cells can be generated by growth in the appropriate 
selective medium usually over a 1 - 3 week period.
The conformation of donor DNA in biochemically 
transformed cells is a debatable issue. Current opinion 
subscribes to the view that it becomes integrated into the 
host's genome. Although the details of this mechanism are 
essentially unknown, some sort of non-reciprocal 
homologous recombination process is thought to occur 
resulting in the formation of a series of head to tail
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concatenate structures [212]. In constrast some authors 
have reported that foreign sequences can exist as free 
forms [213] [214]. This has been well documented for BPV 
derived recombinants but is considered to be a specialised 
case since BPV specifically encodes for PMS (Plasmid 
Maintenance Sequences) [215].
Long term transformation is possible using two 
alternative strategies. Firstly, the DNA of interest can 
be engineered into a plasmid already containing a 
selectable marker. Alternatively the cloned DNA may be 
co-transformed with marker DNA. Upto 90% of the transformed 
colonies contain the non selectable DNA [216]. Readily 
available deficient cell lines include APRT [217], HGPRT 
(Hypoxanthine Phosphoribosyltransferase) [218], Galacto-
kinase [129] and DHFR (Dihydrofolate Reductase) [220].
The two markers used during the course of this project 
were HSV-1 tk [221] and Tn5 aph(ll)[176] (see 2:4:3 I).
For technical details and for a comprehensive review 
of these gene transfer techniques except electroporation 
and the use of transgenomes, see Spandidos and Wilkie 
[222]
1:7:4 Experimental Plan
The experimental method chosen to study human epsilon 
globin gene expression was reverse genetics. Two 
different in vivo transcriptional assay systems were to be 
employed.
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First, to compare directly epsilon globin gene 
activity in K562 cells and to identify sequences in the in 
vivo transcription of this gene, a series of recombinants 
derived from the lambda clone Xl&Qe were to be constructed 
Such plasmids would then be used to stably transform tk 
deficient cell lines and epsilon globin gene specific 
expression studied by S1 Nuclease mapping.
The second assay system was the hybrid selectable gene 
technique. In such circumstances it can be contended that 
the different levels of transcriptional activity of the 
linked gene is a function of the fused globin DNA.
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2:1 Materials
2:1:1 General Suppliers
All chemicals used were of Analar grade and supplied 
by BDH Chemicals unless otherwise stated.
All radioisotopes including 'Nick-Translation1 kits 
were obtained from the Radiochemical Centre, Amersham 
International.
Restriction endonudleases and enzymes employed in the 
manipulation of DNA were purchased mainly from BRL Gibco 
(Europe), P-L Biochemicals Inc., Biolabs and 
Boerhinger-Mannheim.
Tissue culture medium, supplements and serum were 
obtained from Gibco (Europe) or Flow Laboratories.
Sterile disposable plastic flasks of growth areas 25, 75
2
and 175 cm the culture of animal cells were supplied by 
Falcon a n d ’Nunc.
Ingredients of bacterial and bacteriophage media viz 
Tryptone, Yeast and Agar were obtained from Difco 
Laboratories.
2:1:2 Standard Buffers
Common multipurpose buffers referred to throughout the 
Materials and Methods and Results Sections of this thesis 
include the following.
Tris-HCl was prepared by dissolving Tris base (2-amino
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2 -hydroxymethy 1-1 ,3-propanediol) in dist 1 ^ 0  (distilled water)
followed by the addition of cone HC1 (concentrated
hydrochloric acid) until the desired pH was attained.
T.E. Buffer (Tris-EDTA)(Ethylene diamino trichloro - acetic
acid) comprises of {1mM tris HC1 pH 8.0 0.1mM EDTA}.
T.B.E. Buffer (Tris-Borate EDTA) is {89mM tris base/89 mM
boric acid/1mM EDTA pH 8.3}. 20 x SSC (Saline Sodium
Citrate) is {3M NaCl/0.3M Sodium Citrate}.
These buffers and others mentioned throughout the text
were sterilised by autoclaving at 15p.s.i. (Pounds Square 
-1
Inch ) for thirty minutes. For small volumes and 
solutions containing heat labile compounds, filter 
sterilisation through an 0.2 ym Aerodisc (Gelman U.K.) was 
carried out.
2:1:3 Equipment
2:1:3(I) Centrifugation
Micro-centrifugation of 1.5ml Eppendorf tubes at 
~12,000 rpm ( 8000g) were performed in a Eppendorf 5414, 
and IEC Centra-35 or a MSE-Micro Centaur. Centrifugation 
below 5,000rpm was carried out in a MSE Coolspin. A 
Sorvall RC5B model was used for spins up to 15,000rpm. 
For ultracentifugation between 35,000 and 40,000rpm, the 
Diamon IEC 60, the MSE Superspeed 65 or the MSE Prepspin 
50 models were used.
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2:1:3(II) Spectrophotometry
Spectrophotometric determinations of nucleic acid 
concentration and the optical density of bacterial 
cultures were estimated using a Varian 634 with a Model 
9176 Chart Recorder or a Cecil CE594.
2:1:3(III) pH Measurement
pH values were determined with a Kent EIL 7045/4C 
Model.
2:1:3(IV) Scintillation Counting
Radioactivity measurements were performed on a LKB 
1215 Rackbeta Liquid Scintillation Counter.
2:1:3(V) Photography
Both agarose and polyacrylamide gels were photographed 
with a Polaroid MP4 Land Camera using Polaroid type 55 or 
type 57 film under a UV transilluminator (Ultra Violet 
Products Inc. Model TL-33). Autoradiographs were 
automatically developed in a Kodak-X-Omat Processor Model 
ME-1A.
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2:2 Routine Procedures
2:2:1 Purification and Precipitation of Nucleic Acids
Distilled phenol was made 0.1% Hydroxyquinoline and 
0.2% 8 -Mercaptoethanol (6ME). This was neutralised by 
the sequential addition of 1M and 1OOmM tris HC1 pH 8.0 to 
give a standard equilibrated phenol solution. 
Phenol:Chloroform (CHCl^) was prepared by adding an equal 
volume of CHCl^ : Isoamyl alcohol 24:1 (v/v) to distilled 
phenol/0.1 % Hydroxyquinilone/0.2% 8 ME. This was
neutralised as outlined above. Nucleic acid solutions 
were extracted with an equal volume of phenol or phenol: 
CHCl^- The upper aqueous phase was separated by 
centrifugation in a Microcentifuge (2:1 :3(I )). Ether 
extractions were carried out to remove traces of phenol or 
CHCl^ in the aqueous phase. The sample was mixed with 
four volumes of diethyl ether. Micro-centrifugation for 
30 seconds separated the upper ether layer from the 
nucleic acid solution. This was heated for ten minutes at 
65°C to evaporate any remaining ether.
Extractions with butan-2-ol were employed to reduce 
the volume of the DNA solution by the sequential addition 
of an equal volume of butan-2 -ol followed by vortexing and 
brief micro-centrifugation until the desired volume was 
attained. The sample was finally ether extracted to 
remove traces of butan-2-ol. It should be noted that the 
salt concentration increases with volume reduction.
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Organic extractions were invariably followed by 
precipitation of the nucleic acid in 200mM NaAc (sodium 
acetate) and three volumes of ice cold ethanol. This was 
left either in dry ice for thirty minutes or overnight at 
-20°C. The nucleic acid was pelleted by
micro-centrifugation for four minutes, washed in 70% 
ethanol and dried under vacuum in a Modulyo Edwards Freeze 
Drier.
The above procedures were followed where organic 
extractions or ethanol precipitations are referred to in 
the Materials and Methods.
2:2:2 Deionisation of Formamide
Formamide which reduces the melting temperature (Tm) 
of a hybrid was used extensively in hybridisation 
solutions involved in Southern Blotting, Northern 
Blotting, RNA Dot Blotting and S1 Nuclease Mapping, 
initially had to be purified as contaminants interfere 
with the hybridisation process. This was achieved by 
treating Formamide (Fluka) with AG 501 - x 8 (D) ion-
exchange resin (Bio-Rad) with constant agitation for two 
hours at 4°C. The formamide was filtered through a Whatman 
No.1 filter.
2:2:3 Nick Translation
Two methods were employed to radiolabel DNA by the
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'Nick Translation* technique. The first protocol is based 
on a modification of the method of Rigby et al [223]. A 
50 ul reaction mixture was prepared containing {0.25pg DNA 
/2.5 iiM of dATP, dGTP and dTTP/50yCi a ^ d C T P  (400 ci/mmol) 
/1 x Nick Translation Buffer (50mM Tris-HCl pH 7.2, 1OmM
MgSO^, 10mM DTT, 50 yg/ml BSA)}. This was followed by the 
addition of 1 yl (0.1 yg/ml) DNase I and five units of E 
coli DNA Polymerase I (Boeringher-Mannheim) and incubated 
for two hours at 12°C. The mixture was then applied to a 
1XSSC equilibrated G50 Sephadex (Pharmacia) column (0.8 x 
40 cm). 1 ml fractions were collected and 10 yl aliquots 
counted in Packard insta-gel scintillation fluid 
(2:1:3(IV)). Yields varied from 2 - 8 x 1 0 ^  cpm/pg DNA.
The second approach, used the Amersham International 
Nick Translation Kit N 6000. 0.25 - 0.5 yg of DNA was
incubated with 4 yl of Solution 1 (Nucleotide/Buffer 
Solution}, 1 yl of Solution 2 {Enzyme Solution}, 50 yCi
d CTP in a final volume of 20 yl. This was incubated and 
separated as detailed in the first method. Yields were of 
a similar order as above.
2:2:4 Filter Hybridisation Conditions
Nitrocellulose filters after Southern Blotting 
(2:5:2), RNA Dot Blotting (2:6:3) and Northern Blotting 
(2:6:4) were prehybridised and hybridised according to the 
following protocol which is a modification of the 
conditions reported by Wahl et al [224].
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Prehybridisation was carried out overnight in a 
shaking waterbath at 42 °C in sealed plastic bags
containing {50% Deionised Formamide (v/v ) / 6  x SSC/ 5 x 
Denhardt's solution [225] [1 x Denhardt's = 0.02% Bovine
Serum Albumin Fraction V (BSA); 0.02% Ficoll 400; 0.02%
Polyvinylpyrolidone (PVP) (all Sigma)]/50mM Sodium
phosphate (NaHPO^ ) pH 6.5/1% Glycine/250 yg/ml} heat 
denatured sonicated Salmon Sperm DNA (Sigma).
After prehybridisation the bag was drained and 
replaced with a solution of {50% Deionised Formamide/6 XSSC 
/1 x Denhardts Solution/50mM NaHPO pH 6.5/ 100yg|ml heat 
denatured sonicated Salmon Sperm DNA} Approximately 2-5 x 
1 0  ^counts per minute (c.p.m.) of nick translated probe was
7
added for a Southern Blotted filter and 1 - 3 x 1 0  c.p.m. 
for a RNA blot. The filters were agitated overnight at 
42°C.
After draining the plastic bags, the filters were 
initially rinsed in 2XSSC. This was followed by two
thirty minute washes at 65°C in 2XSSC/0.1% SDS (Sodium 
Dodecyl Sulphate). Depending on the expected degree of 
cross hybridisation the stringency was increased to
finally two thirty minute washes at 65°C in 0.1 X SSC/0.1% 
SDS. The filters were finally rinsed in the appropriate 
SSC concentration, blotted on 3MM paper, air dried and 
exposed to Kodak XRS X-ray film in the presence of a 
Dupont Kronex intensifying screen at -70°C.
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2:2:5 Analytical Gel Electrophoresis
Depending on the size of the expected diagnostic bands 
restricted DNA was electrophoresed through an agarose or 
polyacrylamide gel.
DNA samples either in restriction enzyme buffer or in 
T.E. after ethanol precipitation were mixed with 1/1Oth 
volume of gel loading dye {0.1% bromophenol Blue/30% 
sucrose/10mM Tris - HC1 pH 8.0/0.1mM EDTA}. The samples 
were electrophoresed either in:
a) a horizontal 0.5 - 2% agarose (BRL) gel in 1 x { 
50mM Tris - HC1/20 mM NaAc/ 1 mM EDTA pH 7.8} or 
1 x T.B.E. The DNA was visualised under u.v. after 
staining in a 0 .1 yg/ml solution of ethidium bromide 
(EtBr).
b) a vertical neutral polyacrylamide gel containing
i
{6 % acrylamide - 2% bis - acrylamide/1 x T.B.E./0.004% 
ammonium persulphate/0.001 % N fN,N ,N - tetramethyl 
ethylene diamine (TEMED)}. The DNA was visualised as 
above.
Running conditions varied with convenience.
2:2:6 Isolation of DNA From Low Melting Point Agarose 
Gels
Low Melting Point Agarose (BRL) was solublised in 1 x
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T.B.E. by heating, chilled and poured at 4°C. Migration 
of DNA is slower through low melting point agarose than 
standard agarose and accordingly was routinely 
electrophoresed in 1 x T.B.E. overnight. The bands were 
visualised under u.v., execised and placed in 2 volumes of 
T . E .
This was heated to 70°C for 10 minutes, extracted 
three times with tris equilibrated phenol, ether extracted 
and ethanol precipitated.
2:2:7 Isolation of DNA From Neutral Polyacrylamide Gels
Bands from a 4 - 6 % neutral polyacrylamide gel were 
excised and transferred to a heat sealed blue tip plugged 
with siliconised glass wool. The gel slice was crushed 
with a nineteen inch gauge needle and incubated overnight 
at 37°C in 400 ul of gel elution buffer {0.1% SDS/0.2M 
NaAc}. The DNA was eluted by piercing the tip and 
collected by gravity. A further 400 ul of gel elution 
buffer was added and collected. The volume was reduced by 
treatment with butan-2 -ol, phenol and ether extracted and 
ethanol precipitated.
2:3 Molecular Cloning
2:3:1 Screening of Human Charon 4A Genomic 
Library
A partial Haelll/Alul Charon 4A human genomic library 
was kindly supplied by Dr T. Maniatis [22]. This was 
screened with nick-translated human £ and y globin c
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DNA probes [226] [227] using a modification of the
procedure of Benton and Davis [228].
For an average insert size of~20 kb, the number of
pfu's (plaque forming units) required to give a 99%
probability of sequence representation is ^ 1 0  ^ pfu's as
estimated from the Clarkeand Carbon equation [229]. ~10
10pfu's were mixed with~3 x 10 of exponential phase LE 392 
cells [230] in 1 mM MgSO^ and left at room temperature 
for ten minutes to allow phage absorption. The mixture 
was added to 45°C 0.7% L-agar and aliquoted onto 20 x 14cm 
petri dishes containing 1.2% L-agar. The plates were 
incubated overnight at 37°C to give 50,000 pfu's per 
dish. The plates were refrigerated for at least two hours 
prior to blotting.
Autoclaved 0.4 ym filters (Millipore) marked for auto­
radiograph alignment were gently placed on correspondingly 
marked petri dishes and left for two minutes at room 
temperature to absorb the phage followed by a duplicate
impression. The filters were denatured by blotting on 1.5M 
NaCl/0.5 M NaOH saturated 3 MM paper for five minutes at 
room temperature. Neutralisation followed by soaking in 
3 M NaCl/0.5 tris pH 8.0 for ten minutes. The filters were 
dried, baked, prehybridised, hybridised, washed and 
autoradiographed as detailed in (2:2:4).
After initial screening autoradiographs with a
duplicate hybridisation signal were aligned to the
2
corresponding petri dish and an area of 1 cm excised,
resuspended in 2 ml of phage buffer {100 mM NaCl / 8  mM
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MgS04 7H2 0/100 mM tris-HCl (pH 7.5) 0.01% Gelatin} and
left overnight at room temperature. This was plated out 
and screened as previously described. This procedure was 
repeated until £ 90% of the plaques gave a corresponding 
hybridisation signal.
DNA was prepared from positive clones by a
modification of the procedure of Yamamoto et al [231]. A
single plaque was expanded until enough phage was 
generated to lyse 20 x 14 cm L-agar plates. The petri 
dishes were scrapped and the agar washed with 50 ml of 
phage buffer and agitated for fifteen minutes. The agar 
was pelleted by centrifugation (10,000 rpm/10 minutes/4°C) 
in a Sorvall RC5B. The supernatent was made 0.5 M NaCl 
and 10% (w/v) PEG 600 (Polyethylene glycol) and left to 
dissolve on ice for two hours. After centrifugation (6,000 
rpm/30 minutes/4°C) the pellet was resuspended in 10 ml of 
phage buffer by gentle passage through a syringe and 19"
gauge needle. 0.71 g of CsCl (caesium chloride) (BRL- 
Gibco) was added per ml of suspension and centrifuged 
(40,000 rpm/24 hours/4°C). The white phage DNA band was 
carefully removed by a Pasteur pipette and extensively 
dialysed against 5 mM tris/2 mM MgSO^ . The solution was 
extracted with phenolrCHC^ and ethanol precipitated.
2:3:2 General Cloning Strategies
The recombinants constructed for study in this thesis 
can be divided into three broad categories. The first as
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described in(3:l) of the Results involves the construction 
of a series of plasmid chimeras derived from the phage 
recombinant A788e [25] containing the human epsilon
globin gene and AM3 isolated from the human Charon 4A 
genomic library which contains the human 6 and 8 globin 
genes. The other two class of plasmid recombinants are 
detailed in(3:3)of the Results.
The first concerns the insertion of human globin 
genomic fragments into vectors derived from pre-existing 
plasmids kindly supplied by Dr J. Lang [232] in this 
laboratory. The final series of recombinants involve the 
construction of a series of Tn5 aph (El) plasmids driven by 
different promoters, the engineering of which in some 
cases involved the use of synthetic molecular linkers. 
Accordingly due to the wide range of cloning procedures it 
has been decided to give an account of general or common 
recombinant DNA manipulations. Finally in cases where 
specific manipulations were undertaken these will be 
outlined in (2:3:3.)
2:3:2(I) Dephosphorylation of DNA
Plasmid or phage DNA was digested with the appropriate 
restriction endonuclease using conditions recommended by 
the suppliers. The reaction was generally heat-killed by 
incubation at 65°C for five minutes. This was followed by 
one phenol : CHCl^ extraction and ethanol precipitation. 
Calf Intestinal Phosphatase (CIP) (Boerhinger-Mannheim)
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catalyses the removal of 5 1 phosphate groups from DNA. 
CIP is supplied as an ammonium sulphate suspension. This 
was centrifuged in a Microfuge and the supernatent diluted
■i
in dist H20 to 0.01U \iT . This concentration of enzyme 
will remove the terminal phosphates from 1 . pmole of 5* 
end of DNA in a 50 yl reaction mixture containing {5 yl 10 
x CIP Buffer (0.5 M tris pH 9.0, 1OmM magnesium chloride 
(MgCl2 )r 1 mM zinc chloride (ZnCl 2 ), 10 mM spermidine
(Sigma Co), 0.01 U CIP yg~^DNA}. This was incubated at 
37°C for thirty minutes. A second equivalent aliquot of 
enzyme was added and the above incubation conditions 
repeated. The reaction was terminated by heating the 
mixture at 6 8 °C for fifteen minutes. This was followed by 
two phenol : CHCl-3 extractions and one diethyl ether
extraction, ethanol precipitated, washed in 70% ethanol, 
dried and resuspended in TE, ready for ligation.
»
2:3:2(11) Ligations
A DNA molecule with identical cohesive or blunt-ended 
termini can undergo circularisation or concatenation in 
the presence of T 4 DNA Ligase. Two parameters termed j 
and i [233] determine which event will be favoured. j
describes the effective concentration of two ends of the
same DNA molecule and is derived from the equation j = 
(3/2*rrlb) ends/ml where 1 is the length of the DNA in cms, 
b is the length of randomly coiled DNA and varies with
ionic strength. Parameter i is a measure of the
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concentration of complementary termini and is given by the
_ o
equation 1 = 2No M x 10 ends/ml where No = Avogadro's No 
and M = molarity.
When j = i the probability of a DNA molecule colliding 
either with the other end of the same molecule or another 
is equal. Thus when j > i circuralisation is favoured 
such as in the construction of pMX (see 3:1:2(11). in 
conditions of i > j concatenation will be the more 
frequent event.
Cloning experiments with two or more different 
molecules, the vector plasmid was routinely phosphatased 
(2:3:2) to reduce the probability of self - ligation and 
the ligation reaction driven by insert DNA usually at a 
range of increasing molar ratios from 1:1 to 1:5. For 
around 5 pmoles of vector ends,the DNA's were incubated 
in ligation buffer {6 6 mM tris - HC1 pH 7.6, 6 . 6  mM MgCl 2 r 
10 mM dithiothreitol (DTT), 0.4 mM adenosine triphosphate 
(ATP)} in the presence of 0.5 - 2.0 units of T 4 DNA Ligase 
at 22°C for one hour, or overnight at 42°C. The reaction 
was heat killed by incubation for 15 minutes at 65°C.
For blunt - end ligations such as in the construction 
of the pMX promoter delection mutant series (see 3:1:3), 
more T4 DNA ligase was used, usually a 10 fold increase 
than that required for "sticky" end ligations, in addition 
the incubation period was longer, routinely overnight.
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2:3:2(111) Molecular Linker Ligations
It was sometimes necessary to change the restriction 
recognition site to another to permit cloning into a 
particular vector such as in the construction of pN3V 
(see 3:3:2(IV)). Protruding 5 1 ends were flush - ended by 
treatment with Klenow enzyme. This large fragment of 
bacterial DNA polynerase I has 5* ->3' polymerase activity 
and 3 1 5 1 exonuclease activity. Restricted DNA, usually
~1 yg in a 25 ill reaction volume was incubated at 22°C 
for 30 minutes in the presence of {1 yl of each 2 mM dNTP,
2.5 yl 10 x Nick Translation Buffer (0.5 M tris pH 7.2, 
0.1 M MgSC>4 , 1 mM DTT, 500 ygml-  ^BSA)} and 2 units of 
Klenow enzyme. The reaction was heat killed at 70°C for 5 
minutes.This wasextracted with phenol: CHCI3 , diethyl
ether, ethanol precipitated and the DNA recovered from a 
gel to ensure the separation of dNTP's which can interfere 
with subsequent ligations. The blunt - ended DNA was 
converted to the desired restriction site by the ligation 
of kinased molecular linkers [234]. Linkers are small 
oligonucleotides of 8 - 1 2 bp's and accordingly it is easy 
to achieve a high concentration of ends which drive the 
blunt - end ligations. Optimum conditions are between 20 
and 50 yg/ml. Around 0.5 yg of blunt - ended DNA was 
ligated to a 50 fold excess of linkers in the presence of 
1 x Ligase Buffer and two units of T 4 DNA Ligase. This 
was incubated for six hours at 22°C or overnight at 4°C, 
heat killed, phenol : CHCI3 extracted and ethanol
- 79 -
precipitated. The linkered DNA was then digested with a 
large excess of the appropriate enzyme ( 1 0  - 2 0  fold).
After several hours digestion the DNA was ethanol 
precipitated after the standard extraction procedure and 
the DNA separated from any remaining linker molecules by 
gel separation.
2:3:2(IV) Preparation of Competent HB101 Bacterial Cells
Cells competent for DNA uptake were prepared from the 
E coli K12 strain HB101 [235] using a modification of the 
method of Mandel and Higa [236]. A 1L culture was prepared 
according to the following protocol. A single colony was 
seeded into 10 ml of L-broth and was incubated overnight 
with agitation at 37°C in a Gallenkamp Orbital Incubator 
until the OD 600 was~0.6. The culture was chilled on ice, 
centrifuged in a Sorvall RC5B (5,000 rpm/10 minutes/4°C) 
and left on ice for thirty minutes. The cells were
harvested as above and resuspended in 500 ml of 50 mM 
CaCl2 , left on ice for fifteen minutes and centrifuged as 
previously outlined. The pellet was resuspended in 50 ml 
of (50 mM CaCl 2 /15% glycerol), dispensed into 1 ml
aliquots and stored in liquid nitrogen for up to six
months without significant loss in a transformation 
efficiency of around 1 - 5 x 10^colonies per 1 yg pBR322.
2:3:2(V) Transfection of Competent HB101 Competent Cells
Ligated DNA, the amount of which was determined by the
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anticipated number of ampicillin resistant colonies was 
made up to 200 yl with transformation buffer (50 mM CaC^/ 
10 mM tris-HCl pH 8.0). Competent HB101 cells were 
removed from liquid nitrogen storage and thawed on wet 
ice. A 200 yl aliquot was added to the DNA and the
mixture left on ice for 25 minutes to allow DNA uptake.
The cells were then heat shocked for two minutes at 42°C 
in a water-bath. The sample was immediately transferred 
to a bijou containing 2 ml L-broth and incubated at 37°C
for sixty minutes without shaking. 2 x 2 0 0  yl aliquots 
were spread over 1.2% L-agar on 9 cm petri dishes
containing 100 yg/ml ampicillin (Sigma). The plates were 
dried, inverted and incubated overnight at 37°C.
2:3:2(VI) Screening Bacterial Colonies
Colonies were picked with a flamed loop and incubated 
overnight with vigorous agitation in 2 ml of L-broth 
containing 100 yg/ml ampicillin. Plasmid DNA was prepared 
from these cultures according to the method reported by 
Birboim and Doly [237]. 1 ml aliquots in 1.5 ml
eppendorf tubes were microfuged for thirty seconds and the 
pellet resuspended by vortexing in 1 0 0  yl of lysis buffer 
{2 mg/ml lysozyme (Sigma)/25 mM tris - HC1 pH 8.0/10 mM 
EDTA/50 mM glucose). This was left on ice for thirty 
minutes followed by the addition of 200 yl alkaline/SDS 
solution (0.2 N NaOH/1% SDS) which was incubated on ice
for a further five minutes. The clear viscous solution
-  8 1  -
was neutralised by the addition of 150 yl 3M NaAc pH 
4.8, incubation was continued on ice for sixty minutes. 
The resultant heavy coarse precipitate was pelleted by 
microcentrifugation for four minutes. 400 yl of the 
supernatent was precipitated in the presence of 1 ml of 
cold ethanol at -20°C for thirty minutes. The pellet was 
harvested by microcentrifugation for three minutes and 
resuspended in 100 yl {0.1 M NaAc/0.05 M tris-HCl pH 
8 .0 } and precipitated by the addition of 2 0 0  yl of ice 
cold ethanol for ten minutes at -20°C. This was 
microfuged, washed in 70% ethanol and dried. The pellet 
was dissolved in dist H 2O and was ready for restriction 
enzyme digestion analysis. Where diagnostic fragments 
were less than 600 bp's the samples were treated with 
pancreatic RNase. DNA in 36 yl of dist H 2O was incubated 
with 4 yl 1 mg/ml pancreatic RNase (heat treated at 100°C 
for ten minutes) at 37°C for thirty minutes. Following 
this the samples were subject to analytical gel 
electrophoresis.
2:3:2(VII) Large Scale Preparation of Plasmid DNA
This protocol is based on the method of Birboim and 
Doly [237] modified by Ish-Horowicz [238]. From an 
overnight 50 ml culture an aliquot was added to 500 ml 
L-broth containing 100 yg/ml ampicillin to give an initial 
OD600~0.05. Incubation at 37°C in an orbital shaker 
followed until the OD600 increased to~0.6. The culture
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was amplified in the presence of chloramphenicol (Sigma) 
at 170 yg/ml, incubation was continued overnight.
The cells were harvested and washed in 50 mM tris-HCl 
pH 7.8 in a Sorvall RC5B (10,000 rpm/10 minutes/4°C). The 
pellet was resuspended by gentle passage through a 19" 
gauge needle in 25 ml of lysis buffer {5mg/ml of lysozyme 
in 25 mM tris-HCl pH 8.0/10 mM EDTA/50 mM glucose} and 
left on ice for thirty minutes. This was followed by the 
addition of 40 mis alkaline/SDS {0.2 M NaOH/1% SDS}, 
gently mixed and left on ice for five minutes. The 
solution was neutralised by the addition of 20 ml of 3M 
KAc pH 4.7, this was vigourously shaken and incubated on 
ice for a further fifteen minutes and centrifuged (8,500 
rpm/5 minutes/4°C). The supernatent was filtered through 
two layers of sterile gauze. 0.6X volume of cold 
propan-2 -ol was added to the clear supernatent and 
immediately centrifuged as above. The pellet was dried 
over nitrogen gas and resuspended in 6 . 8  ml T.E.
After the addition of 7.2 g CsCl and 0.6 ml 10 mg/ml 
EtBr the solution was centrifuged (40,000 rpm/40 hours/ 
20°C). The plasmid band was removed by pipetting and 
extracted five times with an equal volume of propan-2 -ol. 
The solution was extensively dialysed against T.E. in a 
collodian bag (Sartorius), ethanol precipitated, washed in 
70% ethanol, dried and resuspended in T.E.
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2:3:3 Specific Manipulations
2:3:3(I) Bal 31 Nuclease Treatment
Bal 31 Nuclease, which degrades both termini of linear 
DNA was employed to digest from the Xbal site of pMX (see 
Fig. 13) to create a series of promoter deletion mutants 
(see 3:1:3). Although the rate of removal of nucleotides 
can be calculated from a formula [238] it was decided to 
estimate this empirically by following the protocol 
outlined by Legerski et al [239] and suggested by the 
commercial suppliers of the enzyme (Gibco - BRL).
20 yg of pMX was digested with Xbal, phenol extracted, 
ethanol precipitated and resuspended in distilled H2 O. A 
reaction mixture containing the linearised DNA in 1 x 
(12 mM CaCl2 / 1 2  mM MgCl2 / 2 0 0  mM NaCl/20 mM tris - HC1 pH 
8.0/1 mM EDTA} was incubated at 30°C after the addition of 
an appropriate amount of enzyme. 2 yg aliquots were 
removed at different time points and quenched by adjusting 
the EDTA to a final concentration of 20 mM. Bal 31 
Nuclease is dependent on the presence of calcium ions for 
catalytic activity. 1 yg aliquots of these time points 
were doubly digested with PvuII and Bam H1 and gel 
electrophoresed. Samples which retained the PvuII 
promoter site at coordinate 8557 bp's and extended beyond 
the Bam H1 promoter site at coordinate 8360 bp's (see Fig. 
11) were blunt-end ligated and transformed into HB101 
cells.
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2:3:3(11) Maxam and Gilbert Sequencing
The pMX promoter deletion series generated as outlined 
above (2:3:3(I)) were sequenced by the method of Maxam and 
Gilbert [240]. The strategy was to 32p en(j label at the
promoter PvuII site and sequence upstream and compare it
to the published wild type sequence [42].
20 yg PvuHdigests of pMX promoter deletion DNA's were
phenol extracted, ethanol precipitated, washed in 70%
ethanol and resuspended in 11 yl of dist H2 O. To this was
added 15 yl of 2XT4 Polymerase Buffep {130 mM tris pH
8.0/13 mM MgCl2/10 mM DTT}, 3 x 1 yl of 2 mM dNTP's, 
3275 yCi a P dGTP and 1.5U T4DNA Polymerase. The reaction 
was incubated at 11°C for three hours. The end labelled 
DNA was separated from the non-incorporated nucleotides by 
a rapid ethanol precipitation, two minutes on dry ice. 
The DNA precipitate was rinsed in 70% ethanol and 
resuspended in dist H 20. Depending on the restriction map 
of the deletion mutant (see Fig. 14) the PvuII labelled 
digest was treated with Smal, EcoRI, Hindlll, PstI or Sail 
and electrophoresed on an agarose gel. The labelled 
fragment was electroeluted into a dialysis sac and ethanol 
precipitated. The DNA was resuspended in 60 yl of dist 
H2 0  and aliquoted for the five sequencing reactions 
according to the Maxam and Gilbert [240] method described 
in [241 ].
2:3:3(111) Thal/EcoRI Digestion of Recombinant DNA
The restriction endonuclease enzyme Thai with the
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recognition sequence GC+GC [242] has twenty three sites in 
pBR322. In contrast its frequency in eucaryotric DNA is 
very low. This difference was exploited in the molecular 
cloning of the EcoRI human globin genomic fragments of 
pHR10 and pHR11 in the neomycin based vector pNeV (see 
3:3:2(VI)). The pAT153 (pBR322) derived recombinants pHR10 
and pHR11 were initially treated with Thai at 60°C for 
the appropriate time. The reaction mixture was 
transferred to a 37°C water bath and digested with EcoRI. 
This strategy essentially isolates the globin genomic 
fragment and consequently reduces the number of possible 
recombination events.
2:4 Transformation of Cultured Animal Cells
All transformation procedures and cell handling 
techniques essentially follow those extensively described 
by Spandidos and Wilkie [222].
2:4:1 Cell Lines and Culture Conditions
tk deficient cell lines used throughout this study 
were: the fibroblastic mouse LA tk- [221], BHK tk- (Baby 
Hamster Kidney) [243] were obtained from the Institute of 
Virology, University of Glasgow. The MEL tk~ clone 
F4-12B2 was a gift from Dr Ostertag of the University of 
Hamburg. The human fibroblast 143 tk" line [244] derived 
from the Kirsten Ras Murine Sarcoma Virus transformed line
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R970 [245] was a gift from Dr Bacchettir McMaster
University, Ontario. The other cell lines employed were 
the human erythroleukaemic line K562 [87] (1:7:2). The EJ 
cell line is a bladder carcinoma cell line [246] and was 
supplied by Dr A. Balmain (Beatson Institute).
All sterile tissue culture techniques were performed 
in a laminar flow hood. Cells were passaged by sucking 
off the medium, washing with P.E. (Dulbeccos Phosphate 
Buffered Saline(PBS)/1 mM EDTA. The cells were removed by
o
the addition of 1 ml of 0.25% trypsin solution per 75 cm 
flask. Fresh medium was added and the cells harvested by 
centrifugation in a bench MSE at 2,000 rpm for five 
minutes. The pellet was resuspended and grown in SLM 
(Special Liquid Medium - Gibco Europe) supplemented with 
4 mM glutamine and 15% Foetal Calf Serum. The flasks were 
made 5% CO 2 by gassing and incubated in a hot room at 
37°C.
Transformed and wild type MEL tk- cells were 
trypsinised and replated at 10^ cells/ml in a 75 cm^ flask 
in 20 ml of SLM/HAT medium. A filter sterile 500 mM stock 
solution of HMBA (a gift from Boyd Hardesty) was prepared 
by heat dissolving (37°C) 1 g of powdered HMBA in 10 ml of 
serum free SLM. This was added to the reseeded cells at a 
final concentration of 3-5 mM. A red pellet indicative of 
a successful induction was obtained after a 3-4 day 
incubation period.
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2:4:2 Calcium Phosphate Co-Precipitation of Donor DNA
Donor DNA was introduced into the previously described
cell lines for both long and short term transformations by 
2+ 3-the Ca PO 4 coprecipitation technique of Graham and van der 
Eb [195] as modified by Wigler et al [247]. Donor DNA and 
high MW salmon sperm DNA (if required) at 40 yg/ml in T.E. 
was mixed with CaCl2 at a final concentration of 250 mM. 
This was gently added to an equal volume of 2 x HBS (Hepes 
Buffered Saline) {1 x HBS = 140 mM NaCl/25 mM HEPES
(Sigma) (N-2-Hydroxyethylpiper - azine-N-2-ethanesulphonic 
Acid)/0.75 mM Na 2 HPC>4 (disodium hydrogen phosphate) pH 7.1} 
giving a final DNA optimum concentration of 20 lig/ml 
which co-precipitates in the presence of 125 mM C a C ^ . 
After this gradual addition,the mixture was immediately 
vortexed and left at room temperature for thirty minutes 
after which period a fine precipitate forms.
2:4:3 Long Term Transformation
Exponentially growing cells were harvested by 
trypsinisation, counted and reseeded at a density 
appropriate to that cell line. For a 25 cm 2 growth area
/T
the following densities were adopted; BHKtk- 0.5 x 10 ,
mouse LAtk- 1 x 10^, MELtk" 1 x 10^, human 143tk” 0.3 x
1 0 K562 1 x 10^ and EJ 1 x 10®. The cells were incubated 
overnight at 37°C and replaced with fresh medium the 
following day. After co-precipitation of the DNA, the
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mixture in a volume of 500 yl was slowly added to the
recipient cell line containing 5 ml SLM. The flasks were
2+  2-incubated overnight to allow absorption of the DNA-Ca PO4  
precipitate. The following day the medium was replaced
with pre-warmed medium and incubated for a further 24 
hours to allow the cells to recover.
2:4:3(I) Selectable Biochemical Markers
Two selectable biochemical markers were employed 
throughout the study viz HSV-1 tk [221] and Tn 5 aph (II) 
[176]. Thymidine kinace (tk) catalyses the conversion of 
thymidine to TMP (thymidine monophosphate) in the salvage 
pathway as depicted in Fig. (6 ). During de novo synthesis 
orotic acid is converted to dUMP. Thymidylate synthetase 
catalyses the production of TMP from this nucleotide 
precursor. dTMP production in the de novo pathway is 
blocked when the cells are cultured in medium containing 
HAT [158], Aminopterin inhibits carbon metabolism by 
inhibiting DHFA (Dihydrofolic Acid) to THFA 
(Tetrahydrofolic Acid). Hypoxanthine serves as a substrate 
for the salvage pathway. Under these conditions both 
pathways are perturbed, the salvage by mutation and the de 
novo by inhibition. For a cell to survive, exogenous tk
DNA must be present. This selection system has two 
potential drawbacks. Firstly, TMP levels are controlled to
an extent by feedback inhibition. Secondly, TMP being a
relatively small molecule can easily pass from cell to
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De novo
Orotic acid Salvage
TdR
blocked by 
aminopterindUMP
thymidine
kinase
thymidylate 
synthetase,
dTMP
dTTP
DNA
Figure 6
Metabolic synthesis of dTMP via the Salvage 
and de novo pathways. TdR = Thymidine, DUMP 
= Deoxyuridine Mono- phosphate, dTTP = 
Thymidine Triphosphate, DHFA = Dihydro- folic 
Acid, THFA = Tetrahydrofolic Acid. Kindly 
reproduced from [232].
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cell via gap junctions [248] which can lead to the 
formation of secondary colonies. Cells grown under HAT 
selection were replaced with fresh HAT/SLM medium every 
three days. Colony formation varied with the recipient 
cell line. BHK tk" and human 143 tk“ cells required about 
twelve days, MEL tk- took about fourteen days while the 
mouse LA tk" line required eighteen to twenty one days.
The bacterial transposon Tn5 encodes for the
aminoglycoside 3 1 - phosphotransferase gene aph(II) which 
phosphorylates aminoglycosidic residues [176]. This enzyme 
confers resistance to bacteria grown on the presence of 
the aminoglycosidic antibiotics such as kanamycin and 
neomycin. Geneticin, commonly referred to as G418
(BRL-Gibco) will also kill animal cells [176] so serving 
as a dominant selectable marker which in theory can 
transform any cell line. Unlike the HSV-1 tk selection 
system, Tn5 aph(II)activity is not subject to feed-back 
inhibition, neither should its protein product cross feed 
non transformed cells. Geneticin was stored at -20°C at a
stock concentration of 20 mg/ml. The amount required to
kill cultured cells was empirically determined. Effective 
killing concentrations were: mouse LA tk- 200 - 400 ug/ml, 
BHK tk- 400“ 600 ug/ml, MEL tk" 800- 1000 ug/ml, human 143 
tk" 400 - 500 ug/ml, K562 800-1000 ug/ml, EJ 600-
800 ug/ml. The variation arose with changes in the 
commercial batches since geneticin is not available as a 
pure compound.
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2:4:3(11) Selection in 0.9% Methocel Medium
0.9% Methocel SF12/HAT medium was prepared by 
dissolving 3 g of Methocel (Fluka) in 200 ml dist H 2O and 
sterilised by autoclaving giving a clear solution after 
storage at 4°C for twenty four hours. This was heated to 
37°C prior to the addition of 22 ml 10 x Hams SF12, 4.0 ml 
50 x Essential Amino Acids, 4 ml 0.1 M sodium pyruvate,
2.5 ml 200 mM Glutamine, 5.0 ml 7.5% sodium bicarbonate
10,000 units of Penicillin and 100 ml Foetal Calf Serum 
giving a final serum concentration of 30%.
Methocel medium has the advantage over selection in 
liquid medium in that the medium is not changed during 
selection which decreases the likelihood of secondary 
colony formation. Colonies can be directly picked by a 
Pasteur or pipetteman.
2:4:3(111) Selection in Liquid Medium
After co-precipitation of the DNA, recovery and 
selection, the selection procedure was continued until the 
antibiotic resistant colonies were clearly visible. The 
medium was removed and the cells washed with P.E. The top 
of the flask was removed by incision with a heated 
scalpel. The marked colony was enclosed in a stainless 
steel cloning ring of 0.8 cm diameter. The cells were 
removed after the addition of 250 ill 0.25% typsin solution 
and transferred into a 25 cm2 flasking containing
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selection medium.
2:4:3(IV) Quantitation of Colony Numbers
As discussed in 3:3 of the RESULTS, globin genomic 
fragments and a variety of promoters were relatively 
assessed by their abilities to drive the expression of the 
selectable marker genes HSV-1 tk and Tn5 aph (II). Upon 
clear visualisation of the antibiotic resistant colonies 
the flasks were drained, washed with PBS to remove any 
remaining medium and fixed for thirty minutes at room 
temperature in cold methanol. The colonies were stained 
in 10% Giemsa Stain (prepared in dist H2 O) for thirty 
minutes. The stain was removed and the flasks rinsed in 
tap water, drained and dried in the hot room. Colony 
numbers were expressed in terms of transformation
/r
efficiency as the No. of antibiotic resistant colonies 10 
cells”^, ug-  ^ DNA, or as a transformation ratio relative 
to a "control" recombinant which assumes a ratio of 1 .0 0 0 .
2:4:4 Short Term Transformation
Short term transformation experiments were carried out 
using the maximum amount of donor DNA which for a 75 cm^ 
flask containing 20 ml of medium was 40 yg. After 
co-precipitation of 40 yg of donor DNA, the 2 ml solution 
at 2 0 yg/ml was slowly added to a confluent exponential 
growing recipient cells seeded twenty four hours earlier.
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The following day the medium was replaced and the cells 
left for a further forty eight hours to transiently 
express the foreign sequences. After this period the 
cells were harvested by trypsinisation and resuspended in 
cold PBS. Upon cetrifugation the pellet was resuspended 
in a guanidinium based buffer and stored at -20°C awaiting 
RNA preparation.
2:5 The Detection and Conformation of Donor DNA in 
Transformed Cell Lines 
2:5:1 Preparation of High Molecular Weight DNA
High MW DNA from cultured animal cells was prepared 
using a modification of the method initially described by 
Gross-Bellard et al [249]. This protocol outlines the 
method used to prepare high MW DNA from 1-3 x 10^ cells on 
a growth area of 75 cm . The medium was aspirated and the 
cells washed three times with cold PBS. This was followed 
by the addition of 10 ml {10 mM tris-HCl pH 8.0/10 mM 
EDTA/10 mM NaCl/0.5% SDS} and left for twenty minutes at 
room temperature after which the viscous solution was 
transferred to a 25 ml plastic universal container. 
Proteinase K made up in the above buffer was added to give 
a final concentration of 1 0 0  yg/ml and gently agitated at 
37°C overnight.
The lysate was transferred to a 50 ml plastic conical 
centrifuge tube and extracted sequentially with tris 
equilibrated phenol, phenol : CHCI3 and CHCI3 . The DNA 
was spooled and resuspended in 10 ml T.E. DNase I free
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heat treated RNase was added to give a working 
concentration 50 yg/ml. The solution was incubated at 
37°C for four hours. Thereupon it was made 0.5% SDS and 
digested overnight with proteinase K as described above. 
The solution was extracted as outlined above. The DNA was 
spooled, washed in 70% ethanol, redissolved in T.E., 
extensively dialysed against T.E. and re-precipitated in 
ethanol.
2:5:2 Southern Blotting Analysis
The transfer of DNA from agarose gels to nitro 
cellulose paper was carried out according to the method 
of Southern [250]. 10-20 yg samples of high MW genomic
DNA prepared from cultured animal cells was digested with 
the appropriate restriction endonuclease under conditions 
of excess enzyme over a three to six hour period. In 
addition, plasmid DNA was also digested to provide a full 
length reference profile. The samples were
electrophoresed on a 1 % agarose gel in {1 x 50 mM 
tris-HCl/20 mM NaAc /1 mM EDTA pH 7.8} until the marker 
dye was off the bottom of the gel. All manipulations on 
the gel were carried out at room temperatures with gentle 
agitation. The gel was depurinated in 0.25 N HC1 for 
fifteen minutes to facilitate the subsequent transfer of 
the higher MW fraction of DNA.
This step was repeated. The gel was briefly washed in 
dist H2 O to remove the acid. This was followed by two
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fifteen minute washes in denaturation buffer {0.5M 
NaOH/1 M NaCl}. The gel was rinsed in dist H 2O and 
neutralised by two thirty minute periods in neutralisation 
buffer {0.5 M tris-HCl pH 7.4/3 M NaCl}.
The gel was placed onto a glass plate covered with two 
pieces of 20 XSSC saturated Whatman 3 MM paper. Saran 
wrap or aluminium foil was placed around this area to 
maximise transfer from the gel to the nitrocellulose and 
to ensure the 3 MM paper did not dry out. The 
nitrocellulose filter (Sartorius) presoaked in 2 XSSC was 
carefully placed onto the treated gel taking care no air 
bubbles were trapped beneath. Two dry sheets of Whatman 
3 MM sheets were placed on the filter in addition to a six 
inch block of dry paper towels or tissues. This was 
weighted down and transfer occured over a 4 - 6 hour
period. The filter was gently teased away from the
agarose gel, air dried and baked for 2 hours at 80°C.
Prehybridisation, hybridisation and washing conditions 
were as detailed in (2:2:4).
2:6 The Transcription of Donor DNA in Transformed Cell
Lines
2:6:1 Preparation of Total Cellular RNA
Two methods were employed to prepare total cellular 
RNA from cultured animal cells.
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2:6:1(I) Caesium Chloride Gradient Method
A cell pellet from a confluent 75 cm^ flask containing 
1 - 3 x 1 (7 cells was resuspended in 2.5 ml { 5 M
Guanidinium Thiocynanate (Fluka)/50 mM tris - HC1 pH 7.0/ 
50 mM EDTA/5% ( v / v ) 3ME}, vortexed and passed through a 
Dounce homogeniser. Alternatively it was stored at -20°C. 
The solution was made 2% sacrosyl and heated to 50°C for 
^2 minutes. This was loaded onto a 1.2 ml cushion of {5.7M 
CsCl/50 mM EDTA pH 7.0 - refractive index 1.3925 - 1.4025} 
in a 6 x 4.2 ml Diamon I.E.C. tube and centrifuged (35,000 
rpm/15°C/24 hours). The supernatent containing the DNA 
was carefully removed and the RNA pellet resuspended in 
250 y1 sterile dist H2 0 and mixed with an equal volume 
of {4 M LiCl (Lithium Chloride ) / 8  M urea} and left 
overnight at 4°C. This was microfuged for 30 minutes at 
4°C. The supernatent containing any contaminating DNA was 
discarded and the RNA pellet resuspended in T.E., ethanol 
precipitated, washed in 70% ethanol, dried, redissolved in 
distilled water and lyophilised.
2:6:1(II) Lithium Chloride Precipitation Method
This technique is based on the method of Chirgwin et
al [251] modified by Karrin (Pers Comm). A packed cell
volume of 100 yl was resuspended 800 yl {5 M GuSCN/50 mM
tris-HCl pH 7.0/10 mM EDTA} and 80 yl 3 ME, stored at
n
-20 C or homogenised by passage through a 19 gauge needle
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and left at room temperature for twenty minutes until the 
lysate was completely dissolved. The solution was 
transferred to a 15 ml corex tube, mixed with 5 ml 4M LiCl 
and left overnight at 4°C. The solution was centrifuged 
(6,500 rpm/90 minutes/4°C). The supernatent containing the 
DNA was carefully removed and the RNA pellet washed with
it
3 ml 3M LiCl by passage through a 19 gauge syringe and 
centrifuged (6,500 rpm/30 minutes/4°C). The pellet was 
redissolved in 400 yl of T.E. and extracted initially 
with 0.5 volume of phenol : CHCI3 followed by extraction 
with an equal volume of phenol : CHCI3 , ethanol
precipitated, washed in 70% ethanol, dried, resuspended in 
dist H2 O and lyophilised.
2:6:2 Preparation of Poly A* RNA
Poly A + RNA was prepared according to a modification 
of the method of Aviv and Leder [252] by two cycles of 
oligo dT cellulose chromatography.
0.3 g of powdered oligo dT cellulose (BRL-Gibco) was 
placed in a Biorad plastic column and equilibrated with 5 
x 1 ml aliquots of 1 x Binding buffer {0.5M NaCl/10 mM 
tris - HC1 pH 7.5/0.5% SDS/1 mM EDTA}. Lyophilised total 
cellular RNA was dissolved in sterile dist H 2O by heating 
to 65°C for five minutes. An equal volume of 2 x Binding 
buffer was added and the sample applied to the column. 
The column was washed with 6 x 1  ml aliquots of 
1 x Binding buffer, these eluted fractions which contain
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mainly ribosomal, tRNA and Poly A "  RNA were discarded. 
The Poly A + population bound to the column was eluted by 
the sequential addition of 6 x 1 ml aliquots of Elution 
buffer (10 mM tris-HCl pH 7.5/0.05% SDS/1 mM EDTA }. 
Sample numbers 2 to 6 were pooled. The column was 
re-equilibrated with 5 ml 2 x Binding buffer. The Poly A+ 
solution was loaded followed by two series of 5 x 1  ml
aliquot washes of 1 x Binding buffer and 1 x Binding 
buffer - SDS. The Poly A + RNA was eluted by 6 x 1  ml
aliquots of sterile dist 1^0. The fractions were read at 
^D 260* In mos^ instances, numbers 2, 3 and 4 contained 
over 95% of the absorbing material. These samples were
pooled, ethanol precipitated, washed in 70% ethanol,
resuspended in sterile dist H 2O and lyophilised. Yields 
varied from 1 to 4% of the total population. The column 
was sequentially washed with 5 ml volumes of 1 x Binding 
buffer, 0.1 N NaOH, sterile dist H 2O and ethanol. The 
column was stored at -20°C.
2:6:3 RNA Dot Blotting Analysis
RNA dot blotting was essentially performed as 
described in Spandidos et al [253]. Lyophilised RNA was
redissolved in dist H 2O at a concentration of 4 mg/ml.
2
4 yl aliquots were applied to 1 cm areas on nitrocellulose 
filters (Sartorius) which had been previously pre-treated 
with 20 XSSC and air dried. The filter was baked at 80°C 
for 3 hours. Prehybridisation, hybridisation and washing
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conditions were as previously described (2:2:4).
2:6:4 Northern Blotting Analysis
As detailed in Spandidos and Paul [172] 20 y g
aliquots of lyophilised RNA was taken up in {50% 
deionised formamide/2.2M formaldehyde/1 X MOPS buffer (40 
mM morpholinopropanesulphonic acid, 10 mM NaAc, 1 mM EDTA
pH 8.0)} and heated at 55°C for 15 minutes. This was 
made 10% glycerol and loaded onto a 1% agarose gel in {1 
X MOPS/2.2 M formaldehyde}. After electrophoresis at"* 
~3V/cm for ~4 hours the gel was sequentially soaked in 1 X 
MOPS for 2 x 1 5  minute periods. This was followed by two 
30 minute periods in 20 X SSC. The RNA was blotted onto a 
nitrocellulose filter in a similar fashion as detailed in 
Southern transfer (2:5:2) except for the duration of the 
transfer which was around 4 to 6 hours. The filter was 
gently removed from the agarose, washed in 3 X SSC, air 
dried and baked at 80°C for 3 hours. Prehybridisation, 
hybridisation and washing conditions were as detailed 
elsewhere (2:2:4)
2:6:5 S1 Nuclease Mapping
S1 Nuclease mapping studies were carried out according 
to the method of Berk and Sharp [254] as modified by
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Weaver and Weissmann [255]. The DNA probe was prepared by
dephosphorylating with Bacterial Alkaline Phosphatase
32
(BAP) and end-labelling with PydATP in the presence of T4 
Polynucleotide Kinase (T4PK) as detailed in [256].
2:6:5(I) Preparation of 5' End Labelled Single Stranded 
Probe
The two probes used in the S1 Nuclease mapping studies 
were prepared from the recombinant pMX [172]. A 371 
bp MboII fragment was isolated from a 6 % neutral 
polyacrylamide gel following digestion of a gel isolated 
1080 bp Xbal/Bglll fragment. A 652 bp's BamHI fragment 
was prepared by gel isolation after a Bam H1 pMX digest.
Gel isolated DNA as a dried ethanol precipitate (0.5 - 
2 yg) was resuspended in 50 yl of 50 mM tris-HCl pH 8 .8 . 
0.05 - 0.2 units of BAP were added and the mixture 
incubated at 65°C for thirty minutes. The reaction was 
stopped by making the solution 1 mM EDTA. The mixture was 
extracted twice with an equal volume of phenol : CHC1 3 ,
once with ether, ethanol precipitated, washed in 70% 
ethanol and dried.
The dephosphorylated DNA was taken up in 2.5 yl 10 mM 
tris-HCl pH 8.0 and was followed by the addition of
17.5 yl of Kinase Buffer 1 {20 mM tris-HCl pH 9.5/1 mM 
Spermidine/0.1 mM EDTA}. This was denatured at 90°C for 
two minutes and immediately placed on ice. 2.5 yl of 
Kinase Buffer 2 {500 mM tris-HCl pH 9.5/100 mM MgCl2 /50 mM
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DTT/50% glycerol (v/v)} was added, followed by 20 - 80
units of T4PK (P-L Biochemicals). This mixture was 
transferred to 125 - 250 yCi ^ PyPATP (Specific Activity
> 5000 Ci/mmol) which had been dried down to a volume of
2.5 yl. The solution was incubated for thirty minutes at 
37°C and stopped by the addition of 10 yl 0.1 M EDTA and 
ethanol precipitated in the presence of 20 yg tRNA carrier 
(P-L Biochemicals) for two minutes on dry ice, microfuged 
and dried.
The dried pellet was resuspended in 50 yl of strand 
separation Buffer {30% DMSO/1 x TBE/bromophenol blue and 
xylene cyanol marker dyes}. The sample was denatured at 
90°C for three to four minutes and electrophoresed for 
eighteen hours through a 5% neutral polyacrylamide gel at 
150 V/5 mA. The separated labelled strands were visualised 
by autoradiography. The -ve strand was exised and isolated 
as previously described (2:2:7)
2:6:5(11) Hybridisation and S1 Nuclease Treatment
RNA prepared from transformed cells 30 - 60 yg or from 
K562 cells 1 -5 yg and the single stranded end labelled DNA 
were lyophilised under conditions of probe excess. The 
pellets were redissolved in 10 yl of Formamide 
Hybridisation Buffer {80% deionised formamide/0.4 M NaCl/ 
1 mM EDTA/40 mM Pipes (Piperazine -N, N -bis [2-ethane- 
sulphonic acid] pH 6.4)}. This was transferred to a 
replicoted glass capillary, heat sealed and placed in a
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test tube of water. This was heated at 90°C for ten 
minutes and quickly transferred to the hybridisation water 
bath, which for these experiments was at 58.5°C and left 
overnight. After hybridisation the capillaries were placed 
into tubes containing ice cold ethanol. The glass was 
opened by diamond cutting and flushed out with 235 yl 
of {250 mM NaCl/0.03M NaAc pH 4.6/0.001 M ZnSO^ (zinc 
sulphate)/20 yg/ml sonicated Calf Thymus DNA (Sigma)} 
and transferred to an eppendorf 1.5 ml tube containing
3,000 - 5,000 units of S1 Nuclease (Boeringher-Mannheim) 
and incubated at 37°C for two hours. This was followed by 
extraction with phenol : CHCI3 and ethanol precipitation on 
dry ice for thirty minutes in the presence of 20 yg tRNA 
carrier. Upon microcentrifugation the pellet was washed in 
70% ethanol and dried.
2:6:5(111) Denaturing Polyacrylamide Gel Electrophoresis
The samples were resuspended in 5 yl of loading buffer 
{80% deionised formamide/1 x TBE/bromophenol blue and 
xylene cyanol marker dyes}, denatured by incubation at 
90°C for 3 minutes and immediately placed on ice. The S1 
Nuclease resistant hybrids were sized by electrophoresis 
on a 6 % denaturing polyacrylamide gel.
A 60 ml gel mix containing 6 % acrylamide, 2% - bis 
acrylamide, 8 M urea in 1 x T.B.E. ws polymerised as 
detailed in (2:2:5). This was immediately placed between 
2 x (40 x 20cm) Sylglas sealed glass plates separated by
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0.5 mm spacers. Prior to loading the samples, the gel was 
pre-run at 42 Watts constant power (1400 V and 30 mA) for 
1 hour. The samples were electrophoresed for 3 hours
by which time the bromophenol blue had travelled the
length of the plate. In later experiments an aluminium 
plate was clipped onto the front plate which gave straight 
bands on autoradiography. The plates were separated, the
gel covered with a thin plastic bag covering and set up 
for autoradiography.
The size of the S1 products were estimated by
comparing their migration with that of end labelled 
markers. Routinely used markers throughout this study 
included pBR322/HinfI(1631, 517, 506, 396, 344, 298, 221/ 
220, 154 and 75 bp's); pAT153/HinfI (1631, 517, 396, 298, 
221/220, 154, 145 and 75 bp's); PhiX/HinfI(1 353, 1078,
872, 603, 310, 281, 271, 234, 194, 118 and 75 bp's);
pBR322/HaeIII(587, 540, 504, 458, 434, 267, 234, 213, 192, 
184, 124/123, 104, 89 and 80 bp's).
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The results are subdivided into three sections. (3:1) 
deals with the molecular cloning and description of the 
basic globin genomic recombinants used throughout this 
study. The other two sections are concerned with the in 
vivo expression of these genomic clones and their 
derivatives in transformed animal cells. (3:2) gives an 
account of the S1 Nuclease mapping of human epsilon globin 
gene specific transcripts from a variety of templates. 
Finally (3:3)describes the development of a functional 
assay system in which the rate of transcription of a 
number of globin DNA's is measured by the ability of these 
fragments to drive expression of the selectable marker 
genes HSV-1 tk or Tn5 aph (II).
3:1 Cloning of Basic Human Globin Gene Recombinants
3:1:1 Subcloning of Eco RI Globin Genomic Fragments of 
The Human B Globin Gene Cluster into pAT153
A partial Haelll/Alul human genomic X bacteriophage 
library was kindly made available by Dr T. Maniatis [22]. 
This was screened for genomic globin sequences with 
radiolabelled 3 and y globin cDNA probes [226][227] using 
a modification of the Benton and Davis method [228] as 
described in the Materials and Methods (2:3:1). The 
library was fully screened as calculated from the Clarke 
and Carbon equation [229] on three separate occasions.
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From this five clones designated XM2, 3, 5, 9 and 10 were 
plaque purified. As schematically shown in Fig. (7) EcoRI 
digests of these five X clones confirm they are identical 
to or are derived from the previously published clone 
H3G-2 which was isolated from the same library [22]. This 
is a 14.45 kb Eco RI fragment containing the adult 3 and 6 
globin genes. Around this period it was learned that this 
gene bank was incomplete in terms of globin sequence 
representation.
The five Eco RI fragments of AM3 were subcloned into 
the Eco RI site of pAT153 [257]. As detailed in [57] the 
strategy is depicted in Fig. (8 ). AM3 DNA was digested to 
completion with Eco RI and treated with alkaline 
phosphatase to minimise fragment concatenation. This 
mixture was then ligated to Eco RI treated pAT153. In 
expectation of a high background due to pAT153 
self-ligation, positive recombinants were identified by a 
Grunstein-Hogness hybridisation [258] using radiolabelled 
AM3 DNA (data not shown). Of the thousand or so colonies 
picked over fifty gave a hybridisation signal. This 
shotgun approach was adopted due to the problems 
experienced at that time in obtaining ligatable fragments 
from agarose gels.
The Eco RI fragments spanning the embryonic and foetal 
regions of the human 3 globin gene cluster were subcloned 
from a series of overlapping X clones [21] into the Eco 
RI site of pAT153 by Mrs G. J. Grindlay in this laboratory 
as depicted in Fig. (9).
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Figure 7
Schematic Eco RI mapping of plaque purified 
lambda phage recombinants XM2, 3, 5 , 9 and
10 isolated from a partial Alul/Haelll 
human genomic foetal liver library in 
relation to the previously published globin 
genomic recombinant H-3-G-2 [22], a 14.45
kb fragment containing the adult 6 and 3  
globin genes.
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Figure 8
Subcloning of Eco RI genomic fragments 
of AM3 isolated from the human lambda 
genomic library [22] into the Eco RI site of 
pAT153 as detailed in [57].
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Figure 9
Subcloning of Eco RI genomic fragments 
spanning the human 3 globin gene cluster 
intp pAT153. A shows the Eco RI map of > 55
kb of the 3 globin gene locus. The Eco RI 
sites are indicated by vertical bars, the 
size of each fragment is given in kb. Each 
fragment has a designated pHR (Human 
Recombinant) Number from pHR10 to pHR26. B 
depicts the series of overlapping lambda 
genomic recombinants from which the Eco RI 
fragments were isolated [21]. C Each 
Eco RI fragment was subcloned into pAT153.
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3:1:2 Construction of Human Epsilon Globin Genomic 
Recombinants Derived from the Bacteriophage 
Recombinant \788e
An 8 kb human genomic fragment containing the human 
epsilon globin gene within a phage recombinant termed 
A788e was made available to this laboratory [25], Fig (10) 
shows a restriction endonuclease enzyme map of this 
fragment in addition to the two pATl53 human epsilon 
globin gene recombinants pHR10 and pHR11.
Three recombinant plasmids derived from A788e were 
constructed. The first, pTKHeG Fig. (11) contains the 
entire 8 kb genomic fragment which is convalently linked 
to pTK-1 [209] which encodes for a 3.5 kb Bam H1 fragment 
containing the HSV-1 tk gene which allows the stable 
transformation of tk deficient animal cell lines. This 
recombinant was presumed to have all the cis-acting 
and trans recognition sequences required for regulated 
expression. The second recombinant, pMX Fig. (11) derived 
from pTKHeG was designed to eliminate both Alul repeat 
elements to test for the significance of these structures. 
The third chimera in this series pTKH63e Fig. (12) derived 
from pMX and the recombinant phage AM3 was constructed to 
test the influence of cis-linked y and 3 adult globin 
genes on epsilon globin gene expression. The details of 
each of these constructions have been published [172].
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Figure 12
A schematic outline of the cloning strategy 
involved in the construction of pTK-1 [209] 
based recombnant pTKH63e containing the 
human e, 6 and 3 globin genes as detailed in 
[172].
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3:1:2(I) Construction of pTKHeG
The 8 kb Hindlll fragment containing the epsilon 
globin gene was cloned into pTK-1 as schematically 
outlined in Fig. (11). Hindlll digested, alkaline 
phosphatased treated pTK-1 was ligated to Hindlll 
cut A788e. Positive colonies were identified by Hindlll 
digestion. The orientation of the insert with respect to 
the HSV-1 tk gene was determined by Bam H1 digestion.
3:1:2(11) Construction of pMX
The construction of pMX derived from pTKHeG is 
schematically represented in Fig. (11). The two Alul 
repeat elements map within a 4.715 kb Xbal fragment. 
pTKHeG was digested with Xbal and self-ligated at a low 
j/i ratio to favour circularisation. Positive clones were 
identified as a single 10.45 kb linear Xbal fragment.
3:1:2(111) Construction of pTKH53e
The Eco RI human recombinant phage AM3 contains the 6 
and 3 globin genes encoded within a ~10.8 kb Xbal 
subfragment. As depicted in Fig. (12) Xbal digested A.M3 
was ligated to Xbal, alkaline phosphatased pMX to generate 
the 21.3 kb triple globin gene recombinant pTKH63e. The 
orientation of Xbal insert was determined by a Bam H1 
digestion.
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3:1:3 Construction of pMX Promoter Deletion Mutants
(pMXAn)
A series of epsilon globin gene promoter mutants were 
engineered as a means to identify the putative functional 
domains of the epsilon globin gene promoter. Reverse 
genetics has been successfully used for the delineation of 
the promoter for a variety of cloned Pol II genes [47]. 
The cloning strategy employed in the generation of the pMX 
deletion mutants is depicted in Fig. (13). The putative 
functional domains of the epsilon globin gene promoter map 
within a 197 bp 5 *-Bam H1/PvuII-3' fragment. Fig. (14A) 
shows the tripartite structure 5 1-100/CCAAT/ATA-cap-31. 
Bal31 Nuclease was used to generate deletions from Xbal 
linearised pMX. This enzyme displays two separate forms of 
catalytic activity [239]. It has a highly specific single 
stranded endodeoxyribonuclease and exonuclease activity 
that catalyses the removal of small oligonucleotides or 
mononucleotides from each terminus of double stranded DNA. 
In addition Bal31 is highly specific for single stranded 
DNA in a manner analogous to S1 Nuclease. Despite the non 
synchronous nature of these functions at any given time 
point during Bal31 treatment up to 70% of the digested 
DNA molecules will have flush ends at both termini. This 
strategy was chosen in preference to a combined approach 
of Exonuclease V and S1 Nuclease. The Bal31 nuclease 
reduces the number of enzymatic manipulation steps. After 
establishing the digestion conditions empirically, pMX was
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Figure 14
Structural Analysis of pMXAn series. 
A shows the sequence break points of pMXAs 
1, 3, 4, 5, 6, 1 and 8 in relation to the 
putative functional promoter domains. B 
depicts the size of deletion of pMXA1 
pMXA12 as determined by restriction enzyme 
analysis. The black bars give an estimate of 
the size of deletion from the Xba I site. 
Restriction enzyme sites shown are E 
= Eco RI, H = Hindlll, S = Smal, X = Xbal, B 
= Bam H1 and P = Pvull.
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incubated with the enzyme at 30°C and samples removed at 
different times, quenched, blunt end ligated and 
transformed into HB101 cells. Alkaline extracted DNA from 
transformed bacterial colonies were assayed by restriction 
endonuclease analysis for digestion of the Bam H1 site at 
the distal end of the promoter and retention of the Pvull 
site at the cap site end. Fifteen clones were selected, 
designated pMXA2- pMXA16. In addition a control was chosen 
in which the deletion mapped just beyond the Pvull site, 
termed pMXA1.
3:1:3(I) Restriction Enzyme Mapping of pMXAn Series
As shown in Fig. (14B) the extent of Bal31 digestion 
was determined by treating the deletion DNA's with Smal, 
Hindlll or Eco RI, From this an approximate estimation 
on the size of the excised DNA could be determined. The 
deletions ranged from 700 bp*s for pMXA14 to 900 bp's 
for pMXA13.
3:1:3(11) Sequence Analysis of pMXAn Series
To map these promoter deletions the Maxam and Gilbert 
DNA sequencing technique was employed. This was undertaken 
in collaboration with Dr J. K. Vaas and Ms M. A. Stinson 
of the Beatson Institute. The sequencing strategy was to 
end label at the Pvull site (except for pMXA1) and 
sequence upstream of this until the obtained sequencing
-  1 2 2  -
differed from that of pMX. Fig. (14A) shows the 
break points between plasmid and epsilon globin gene 
sequences for mutants pMXA2 to pMXA8 . A3, A7 and A8 have 
the three putative functional domains, i.e. -100, CCAAT 
and ATA; A4 maps at the end of 'C rich 1 -100 region and A5 
lacks a CCAAT motif. According to size estimates coupled 
to limited sequencing data pMXA1 maps just beyond the 
Pvull site.
3:2 Transcriptional Analysis Of Human Epsilon Globin 
Gene Recombinants In Transformed Animal Cells
Two sets of epsilon globin gene recombinants Fig. (15)
(1) pTKHeG, pMX and pTKH6 8 e and (2) the pMX deletion 
mutant series were introduced into (BHKtk~), mouse LAtk“ , 
human 143 t k - and MELtk” cells by the Graham and Van Der 
Eb [195] calcium phosphate precipitation technique as 
described in detail in (2:4:2). HAT resistant colonies were 
picked and expanded into clonal established transformed 
cell lines.
The notation describing the transformed cell lines 
used throughout the text is:-
BHKtk~ e.g. B/pTKHeG-1,2 etc
Mouse LAtk~ e.g. LA/pMX-1,2 etc 
Human 143tk~ e.g. 143/pMX-1,2 etc
MELtk" e.g. MEL/pTKH68e-1,2 etc
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Alu Repeats
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H HSV-ltk DNA
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pMXAn
> pTKH6pC
•108 kb
Figure 15
Line diagram showing the pTK-1 based epsilon 
globin gene recombinants pTKHeG, pMXr
pMXAn and pTKH63e. The open boxes 
represent the globin genes, the black line
depicts human globin flanking D N A ,  the solid
black line shows HSV-1 tk D N A . Restriction 
enzyme sites shown are H = Hindlll, X
= Xbal, B = Bam H1 and P = Pvull.
- 124 -
3:2:1 The Physical Status Of Globin Donor DNA In Stably
Transformed Animal Cells
To confirm that these colonies were not tk revertants
—  6(reversion frequency is low e.g. MEL < 1 0  ) and to
investigate the physical status of the foreign DNA the
following series of experiments were undertaken.
As a representative example of one of those, high MW 
DNA [249] prepared from mouse LAtk" , BHKtk- and MELtk- 
cells transformed with pTKHSfte was digested to completion 
with Eco RI, transferred onto nitrocellulose paper by the 
method of Southern [250] and hybridised to nick-translated 
pTKHSfte. Fig. (16) shows that all transformed cell lines 
give a hybridisation signal except B/pTKH63e-1 Fig. (16) 
lane 1). The hybridisation profile corresponds to 
the Eco RI digestion pattern of the donor plasmid. The 
higher MW bands maybe indicative of sequences which have 
become integrated internally into the host's DNA.
The full length copy pattern is consistent with the 
majority of donor plasmid sequences in stably transformed 
cells as suggested by Folger et al [212] to be in the form 
of integrated concatenates generated by a homologous 
recombination mechanism. It should be recognised however 
that these experiments [2 1 2 ] were performed by direct 
microinjection of the DNA into the host's nuclei.
An estimate of the donor DNA copy number for these 
transformed cell lines is presented in Table (1). This was 
determined by comparing the band intensities in the
- 125 -
Fi g u r e  16
Southern blotting analysis of pTKH63eDNA 
from stably transformed BHKtk-, mouse LAtk- 
and MELtk- cells. 10 yg of High MW DNA from 
transformed cell lines was digested with Eco 
RI, electrophoresed on a 1% agarose gel, 
transferred to a Sartorius nitrocellulose 
filter by the method of Southern [250] and 
hybridised to nick-translated pTKH63e. Lane 
1 (B/pTKH63e-1 ), lane 2 (B/pTKH63e-2) , lane 3 
(LA/pTKH63e-1), lane 4 (LAtk-), lane 5 
(MEL/pTKH63e-1 ), lane 6 (MEL/pTKH 6 3 £ -2 ) , lane 
7 (MELtk-), laneP represents 500 pg of Eco 
RI digested pTKH63e.
- 1 2 6 -
Table (1)
Estimated pTKH53e plasmid copy no. per stably 
transformed cell.
Transformed Cell Line Copy No. Fig. (16) coord.
B-pTKH63e-1 <1 Lane 1
B-pTKH63e-2 6 Lane 2
LA-pTKH63e-1 > 1 0 Lane 3
MEL-pTKH63e-1 5 Lane 5
MEL-pTKH63e-2 5 Lane 6
1 - Estimates based on comparative signal intensity. 
Lane P (fig. (16)) contains 500 pg Eco RI "digested 
pTKH6 6 e.
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Southern blots of the donor plasmid relative to the 
pattern in the transformed cell lines. Copy number ranged 
from 1 to 2 0  per cell which is in agreement with estimates 
reported by others [172] [253].
This variation in copy number and the possibility of 
the exogenous sequences forming a mixed population of 
integrated concatenates, rearranged forms, episomes makes 
the task of interpretation of recombinant DNA expression 
in transformed cells difficult. Does the copy number 
influence the level of transcriptional activity ? - does
the chromosomal location effect transcription ?. Such 
points should be borne in mind.
3:2:2 S1 Nuclease Mapping Of Human Epsilon Globin Gene 
Transcipts Of pTKHeG and pMX In A Variety Of 
Stably Transformed Cell Lines
Total cellular [251] and PolyA+ RNA [252] was prepared 
from a variety of tk“ cell lines transformed with the 
recombinant plasmids pTKHeG, pMX and pHSfte. The presence 
of epsilon globin gene specific transcripts was determined 
by the RNA dot blot hybridisation technique [253] (data 
not shown). In addition nuclear processing of these 
transcripts was confirmed by Northern blotting [179] in 
which Poly A + transformed RNA co-migrated with the fully 
processed 9S message from K562 cells (data not shown).
To obtain more detail on the structure of these RNA 
molecules and to compare this with the. transcriptional
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profile of the epsilon globin gene in the K562 cell, S1 
Nuclease mapping studies were undertaken. The S1 Nuclease 
mapping procedure is a powerful analytical technique to 
fine map to the nucleotide level, the termini and splice 
junctions of transcripts. The S1 Mapping protocol used 
throughout this thesis as described in the Materials and 
Methods (2:6:5) essentially follows the method of Berk and 
Sharp [254] as later modified by Weaver and Weissman 
[255].
3:2:2(I) Preparation of End Labelled Single Stranded S1 
Hybridisation Probes
As schematically illustrated in Fig. (17) two probes 
were earmarked for use in the S1 Nuclease mapping 
experiments. Each is derived from pMX. Probe I is the 
371 MboII bp fragment spanning the 5' terminus of the 
gene. Fig. (17) shows RNA molecules which initiate at the 
canonical cap site i.e. 53 and 55 bp's upstream of the 
first codon give two protected bands at 129 and 131 bp's. 
Transcripts originating from the -200 region [8 6 ] generate 
a S1 hybrid of 344 bp's.
Probe II is the 652 bp Bam H1 fragment covering the 
promoter region to the second exon. This was used to map 
splicing regions. As depicted in Fig. (17) correctly 
spliced transcripts give a S1 product of 207 bp's - this 
is equivalent to the distance between the Bam H1 site of 
the second exon to the intron/exon boundary. Non
- 129 -
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M 200
1
ap M
Pnobe
371bps 32.
344bp’s
131 bp’s 
129bp’s Protected
Fragments
Bam H1
-2(p0 B cap B
Probe 652bp’s 32.
208bps
470bp's Protected
----------------------- ) Fragments
Figure 1 7
Hybridisation probes used in S1 Nuclease 
mapping experiments. Both probes were 
prepared from pMX. I, pMX was digested 
with Bglll and Xbal which liberates a 1114 
bp fragment which was gel purified. This was 
subsequently digested with Mboll and the 371 
bp's fragment isolated by polyacrylamide gel 
electrophoresis. II, the 652 bp Bam H1 
fragment was isolated by 6 % polyacrylamide 
gel electrophoresis after digesting pMX 
with Bam H1. M denotes Mbo II and B 
shows Bam H1 sites.
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processed molecules will extend beyond this. These probes 
were 5' end labelled as described elsewhere (2:6:5(I)) and 
strand separated on 5% polyacrylamide gel as shown in 
Fig. (18). The position of the (-ve) strand which cannot 
be predicted is a function of the secondary structure of 
the DNA. For the Mboll DNA this was confirmed by Maxam 
and Gilbert sequencing [240] and shown to be the top band. 
The (-ve) strand of the Bam H1 probe was identified by a 
series of pilot experiments including hybridisation of 
K562 RNA to both strands, this approach led to the bottom 
fragment being designated as the (-ve) strand. In addition 
to the strand-separated population, variable amount of the 
DNA reaneals as illustrated in Fig. (18). This was 
routinely re-cycled to increase yields.
3:2:2(11) S1 Nuclease Mapping of 5' Termini of Human 
Epsilon Globin Gene Transcripts in Non-Induced 
K526 Cells
Human epsilon globin gene transcription in the K562 
cell has been extensively investigated by Dr Allan and her 
colleagues [10] [8 6 ] in this laboratory using the S1 
Nuclease mapping technique. It was considered important to 
verify her findings and establish the S1 Nuclease mapping 
technique since all intended S1 Nuclease mapping 
experiments with epsilon globin gene recombinants were to 
be interpreted and analysed in relation to the 
transcription profile of that obtained in the K562 cell.
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Figure 18
Strand separation of hybridisation probes. 5' 
end labelled double stranded fragments were 
denatured in 30% DMSO and separated on a 
neutral 6% polyacrylamide gel. The strands 
were identified by autoradiography, excised 
and extracted overnight at 37°C in Gel 
Elution Buffer. The -ve strand of the Mboll 
probe (I) is the upper band while the lower 
signal is the -ve strand of the Bam H1 probe
(II). Non- separated double stranded (ds) DNA 
migrate further than the strand-separated 
pair for each probe.
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Total cellular RNA was prepared as described in the
Materials and Methods (2:6:1) from non-induced K562 cells. 
Using experimental conditions already well established in 
this laboratory and outlined in the Materials and Methods 
(2:6:5) the K562 RNA was hybridised to the 5' end-labelled 
single stranded 371 bp MboII probe (Figs. (17) and (18)) 
to map the 5' termini of the epsilon globin gene 
transcripts. The hybrids were treated with S1 Nuclease and 
the products separated on a 5% polyacrylamide gel and
directly autoradiographed as depicted in Figs. (19) and
(20).
Fig. (19) lanes 1, 2 and 3 corresponds to 10 yg of RNA 
with increasing amounts of probe and lanes 4, 5, 6 and 7 
represent a fixed input of probe with rising amounts of 
RNA viz 0.1, 1, 5, and 20 yg.
The transcriptional profile described by Allan et al
[8 6 ] with the MboII probe is illustrated in lane 7. The
full length protected fragment can be explained by 
hybridisation to transcripts which originate upstream of 
the MboII [8 6 ] or by the probe self-annealing to the 
contaminating +ve DNA strand. The remainder of the 
signals coincide with RNA species with different 5* 
termini. The strongest hybridisation band is the doublet 
of protected fragments at 129 and 131 bp's which 
correspond to the heterogenous canonical cap site 
initiation at +53 and +55 bp's respectively as originally 
predicted on the basis of sequence by Baralle et al [42]. 
The other S1 products represent RNA species which
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Figure 19
S1 Nuclease mapping of the 51 termini of 
epsilon globin mRNA prepared from non-induced 
K562 cells. RNA which was made up to 60 yg 
with yeast tRNA was hybridised at 58.5°C to 
the end-labelled (-ve) MboII strand of 
approximate specific activity of 200,000 cpm 
Ug . The hybrids were treated with 3,000 
units S1 Nuclease for 2 hours at 37°C and the 
products analysed on a 6% polyacrylamide 
denaturing gel. Lane P gives the position of 
the 371 bp's MboII probe. Lane M 
end-labelled pAT153/HinfI markers.
10 yg K562 RNA and 10 ng probe.
10 ug K562 RNA and 20 ng probe.
10 ug K562 RNA and 30 ng probe.
0.1 ug K562 RNA and 30 ng probe.
1 ug K562 RNA and 30 ng probe. Lane 6,
K562 RNA and 30 ng probe. Lane 7, 20 ug K562 
and 30 ng probe.
is the
Lane 1 ,
Lane 2,
Lane 3 /
Lane 4,
Lane 5,
, 5 og
- 1 3 4 -
1 2 3 4  5
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Figure 20
S1 Nuclease mapping of the 5' termini of 
epsilon globin mRNA prepared from non-induced 
K562 cells under limiting probe conditions. 
Experimental conditions were as outlined in 
the legend to Fig. (19). Lane 1 , 10 yg K562
RNA and 10 ng probe. Lane 2, 10 yg K562 RNA 
and 5 ng probe. Lane 3, 10 yg K562 RNA and 1 
ngprobe. Lane 4, 10 yg K562 RNA and 0.1 ng 
probe. Lane 5, yeast RNA and 1 ng probe.
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originate upstream from the cap site. The predominant S1 
hybrid at 344 bp corresponds to the -200 promoter and 
represents the major non canonical cap site transcript. 
Its ratio to the cap site of 18:1 (see Table (1)) is in 
accord with the figure reported by Allan et al [8 6 ]. The 
minor initiation sites are faintly detectable in lane 7 
Fig. (19) and coincide with a series of RNA molecules 
which originate between the cap site and the - 2 0 0  
promoter.
In Fig. (19), lanes 1, 2 and 3 give an identical
signal profile to lane 7 indicating that probe excess 
conditions have been realised. This is particularly 
important since the - 2 0 0  hybrid having more sites of 
nucleation is more readily formed than the cap site hybrid 
implying that in circumstances when the probe is limiting 
a false cap site: - 2 0 0  ratio may result as illustrated in 
Fig. (20). Fig. (19), lanes 4 to 7 representing the 
titration of RNA with a fixed amount of probe show that 
between 1 and 5 yg of non induced K562 RNA is readily 
detectable.
3:2:2(111) S1 Nuclease Mapping of 5* Termini of Human 
Epsilon Globin Gene Transcripts in Stably 
Transformed: A BHKtk- Cells, B Mouse LAtk~ 
Cells, C Human 143 tk~ Cells and D MELtk” 
Cells
The overall aim of these studies was to compare
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the transcriptional profile of the epsilon globin gene in 
transformed cells with the previously described pattern in 
the K562 cell. Such an approach would possibly lead to 
the identification of putative regulatory sequences 
involved in the expression of the epsilon globin gene. 
This strategy could be divided into a series of separate 
questions.
(1) Is there any significant difference in the cap: 
- 2 0 0  ratio in the recombinants compared to epsilon globin 
gene activity in the K562 cell?
(2) Is there variation in the activity of the 8 kb genomic 
plasmid pTKHeG compared to pMX from which the two Alul 
repeat elements have been excised?
(3) Can functional promotor domains be identified by 
comparing the expression of the deletion mutant series 
pMXAn?
(4) Are these transcripts processed correctly?
To tackle some of these points a series of S1 Nuclease 
mapping experiments were performed on RNA prepared from 
various transformed cell lines.
For this series of S1 Nuclease mapping experiments the 
following conditions were employed. 60 yg of total 
cellular RNA was hybridised to the single stranded MboII
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probe, the hybrids were treated with S1 Nuclease as 
detailed elsewhere (2:6:511).
A. BHKtk” Cells
Fig. (21) illustrates the activity of two transformed 
BHKtk” cell lines viz B/pTKHeG-1 and B/pMX-1 in comparison 
with epsilon globin gene expression in non-induced K562
cells. Lanes 1 , 2  and 3 depict 1, 10 and 20 yg of K562
RNA with the same amount of MboII probe. The cap:- 200 
ratio at 1 yg suggests probe excess conditions have been 
attained. Lanes 4 and 5 show B/pTKHeG-1 at increasing 
probe amounts and the same number of counts are 
represented in Lanes 6 and 7 for B/pMX-1. A striking 
feature of this experiment is the marked difference in the 
cap:- 200 ratio between the K562 cell and the BHKtk”
transformed cell. To quantify this, the appropriate
regions of the gel corresponding to the transcription 
signals were excised and Cherenkov counted. The data are 
presented in Table (2). The value for 1 yg K562 RNA 
(Fig. (21), lane 7) corresponds to the published findings 
of Allan et al [8 6 ]. In contrast, the transformants gave a 
cap:- 200 ratio of around 1:1. However it should be 
emphasised that these ratios are only approximate as it is 
difficult to accurately excise these bands, especially the 
- 2 0 0  signal due to its proximity to the full length probe 
signal.
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Figure 21
S1 Nuclease mapping of the 51 termini of
epsilon globin mRNA prepared from BHKtk- 
cells stably transformed with pTKHeG and 
pMX. Experimental conditions were as outlined 
in the legend to Fig. (19). Lane 1, 1 yg
K562 RNA and 30 ng of probe. Lane 2, 10 yg
K562 RNA and 30 ng of probe. Lane 3, 20 ug
K562 RNA and 30 ng of probe. Lane 4, 60 ug
B/pTKHeG-1 RNA and 30 ng of probe. Lane 5, 
60 ug B/pTKHeG-1 RNA and 50 ng probe. Lane 
6, 60 ug B/pMX-1 RNA and 30 ng of probe. 
Lane 7, 60 ug B/ pMX-1 RNA and 50 ng of
probe. Lane M is the end labelled
pAT153/Hin fl markers.
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B. Mouse LAtk Cells
Fig. (22) shows the S1 Nuclease product profile of the 
mouse LAtk“ transformed cell lines, LA/pTKHeG -1 and -2 
(lanes 2 and 3) and LA/pMX -1 and 2 (lanes 4 and 5). Lane
1 shows the familiar K562 pattern which differs from the 
four transformants. In addition, compared to the BHKtk- 
transformed cell lines (Fig. (21)), the mouse LAtk- 
transformants appear to produce relatively more major cap 
site initiated transcripts. Again as with the BHKtk- 
transformants there are no discernible differences in the 
activity of pTKHeG compared to pMX. The bands
corresponding to the major and - 2 0 0  promoters were excised 
from the autoradiograph and the signal intensity estimated 
by Cherenkov counting as depicted in Table (2) giving an 
approximate cap:- 200 ratio of 4:1 which is significantly 
higher than that recorded for equivalent BHKtk"
transformants.
C. Human 143 tk“ Cells
The distribution of the 5' termini of the epsilon
globin gene transcripts in the 143tk- cell transformed
with pTKHeG and pMX is depicted in Fig. (23). Lanes 1 and
2 show 5 yg K562 RNA with increasing probe levels. Lanes 
3, 4 and 5 correspond to the activity of the transformed 
cell line 143/pTKHeG-1 in the presence of increasing 
amounts of the MboII probe and lanes 6 , 7 and 8 show
- 141 -
bp’s M 1 2 3 4 5
267-
234-
213-
192-
184-
124
123
Figure 22
S1 Nuclease mapping of the 5' termini of 
epsilon globin mRNA prepared from mouse LAtk- 
cells stably transformed with pTKHeG and 
pMX. Experimental conditions were as outlined 
in the legend to Fig. (19). Lane 1, 5 yg of
K562 RNA and 25 ng probe. Lane 2, 60 yg
LA/pTKHeG-1 RNA and 25 ng probe. Lane 3, 
60 yg LA/ pTKHeG-2 RNA and 25 ng probe. 
Lane 4, 60 yg LA/pMX-1 RNA and 25 ng probe. 
Lane 5, 60 yg LA/pMX-2 RNA and 25 ng probe. 
Lane M depicts pBR322/HaeIII end labelled 
markers.
- 142 -
-200
cap
Figure 23
S1 Nuclease mapping of the 5' termini of 
epsilon globin globin mRNA prepared from 
human 1 43tk- cells stably transformed with 
pTKHeG and pMX. Experimental conditions were 
as outlined in the legend to Fig. (19). Lane 
1 , 5 yg K562 RNA and 25 ng probe. Lane 2 ,  
5 yg K562 RNA and 50 ng probe. Lane 3, 60 yg
143/pTKHeG-1 RNA and 10 ng probe. Lane 4, 
60 yg 143/pTKHeG-1 RNA and 20 ng probe. Lane 
5, 60 yg 143/pTKHeG-1 RNA and 30 ng probe. 
Lane 6, 60 yg 143/pMX-1 RNA and 10 ng probe. 
Lane 7, 60 yg 143/pMX-1 RNA and 20 ng probe. 
Lane 8, 60 yg 143/ pMX-1 and 30 ng. Lane M 
depicts Phi X/Hin fl end labelled markers.
-  1 4 3  -
the same conditions for the transformed cell line
143/pMX-1. Only at the highest amounts of probe input
(lanes 5 and 8 ) can the major cap signal be seen. The 
strong signal just below the band corresponding to
initiation from the - 2 0 0  promoter made it impossible to 
excise. However, by eye and with cross reference to 
another experiment (See Fig. (39)) the cap:- 200 ratio 
appears to be around 1 :1 .
D. MELtk- Cells
Total cellular RNA from two pTKHeG transformed MELtk-
lines (Fig. (24)) and three pMX MELtk- lines (Fig. (25))
were S1 Nuclease mapped. Examination of these films shows 
a considerable shift towards the apparent exclusive use of 
the -200 promoter. This dramatic reduction in the cap:-200 
ratio may be accounted for by the adult MELtk- cell 
actively expressing an adult trans factor which leads to 
repression of the major promoter of the human epsilon 
globin gene. Alternatively this ratio may be an 
experimental artefact resulting from cross hybridisation 
of the endogenous 3 globin RNA with the epsilon globin 
MboII probe. Despite there being some homology in the 5* 
regions of these genes the stringent hybridisation 
conditions of 58.5°C/80% formamide would not favour the 
stable formation of such a cross-species hybrid. Even 
allowing for the excess of mouse 3 globin message over 
human epsilon globin in RNA, the hybrids would have to
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Figure 24
S1 Nuclease mapping of the 51 termini of 
epsilon globin mRNA prepared from MELtk- 
cells stably transformed with pTKHeG. 
Experimental conditions were as outlined in 
the legend to Fig. (19). Lane 1, 5 ug K562
RNA and 25 ng probe. Lane 2, 60 ug MEL/
pTKHeG-1 RNA and 25 ng probe. Lane 3, 60 ug
MEL/pTKHeG-1 RNA and 50 ng probe. Lane 4, 
60 ug MEL/pTKHeG-2 RNA and 25 ng probe. Lane 
5, 60 ug MEL/pTKHeG-2 RNA and 50 ng probe. 
Lane M shows pAT153/Hin fl end labelled 
markers.
W
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Figure 25
S1 Nuclease mapping of the 5' termini of 
epsilon globin mRNA prepared from MELtk- 
cells stably transformed with pMX. 
Experimental conditions were as outlined in 
the legend to Fig. (19). Lane P gives the 
position of the 371 bp's MboII probe. 
Lane 1, 60 ug MELtk- RNA and 25 ng of probe. 
Lane 2, 60 ug MEL/pMX-1 RNA and 25 ng probe.
Lane 3, 60 ug MEL/pMX-1 RNA and 50 ng probe.
Lane 4 ,  60 ug MEL/pMX-2 RNA and 25 ng probe.
Lane 5, 60 ug MEL/pMX-2 RNA and 50 ng probe.
Lane 6 ,  60 ug MEL/pMX-3 RNA and 50 ng probe.
Lane M depicts Phi X/Hin fl end labelled 
markers.
- 146 -
resist the S1 Nuclease nicking activity at the mismatch 
sites which form "bubble structures". Moreover, as 
discussed in the co-induction studies (See 3:2:4(11)), and 
confirmed in Figs. (34) and (35), RNA from both induced 
and non-induced non-transformed MELtk- cells fail to give 
any S1 hybrids.
The results from these series of S1 Nuclease mapping 
experiments are presented in summary in Table (3).
3:2:2(IV) Splicing of Human Epsilon Globin Gene 
Transcripts in Stably Transformed BHKtk" Cells
The Bam H1 652 bp's probe shown in Fig. (17) was 
employed to investigate splicing of the exon regions of 
the epsilon globin RNA transcripts. Spliced RNA molecules 
will give a protected fragment of 207 bp's which 
corresponds to the distance between the Bam H1 site in the 
second exon to the exon/intron boundary.
Fig. (26) is a representative example of this 
processing and shows the S1 product profile of BHKtk- 
cells transformed with pMX (lane 1) and pTKHeG (lane 2). 
Lane 3 confirms that the signals from the transformed RNA 
co-migrate with that obtained with K562 RNA giving a 
signal less than the 2 2 0  bp's marker.
These experiments suggest that the highly conserved 
splice acceptor/donor site of the epsilon globin gene is 
recognised by the splicing enzymatic machinery of the 
BHKtk- cell to yield a correctly spliced transcript. This
- 147 -
Table (3)
Summary of S1 Nuclease mapping data showing the 
distribution of 5' termini of the epsilon globin gene 
transcripts in K562 and stably transformed cells.
Cell line Approximate cap: -200 ratio
K5621 2 0 : 1
K562 18:1
Transformed MELtk - 2 0 : 1
Transformed 143tk- 1 : 1
Transformed BHKtk- 1 : 1
Transformed Mouse LAtk- 4:1
1 - Literature value [8 6 ]
2 - Values do not significantly vary
between pTKHeG and pMX
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Figure 26
Splicing of epsilon globin gene transcripts 
in stably transformed BHKtk- cells. Total 
cellular RNA prepared from non-induced K562 
cells and BHKtk- cells stably transformed 
with pTKHeG and pMX was hybridised at 
58.5°C to the end-labelled (-ve) Bam H1 
strand of approximate specific activity of 
400,000 cpm yg-^. The hybrids were treated 
with 3,000 units of S1 Nuclease for 2 hours 
at 37°C and the products analysed on a 6% 
polyacrylamide denaturing gel. Lane P depicts 
the 652 bp's Bam H1 probe. Lane 1, 60 yg
B/pTKHeG-1 RNA and 50 ng probe. Lane 2, 
60 yg B/pMX-1 and 50 ng probe. Lane 3, 5 yg
K562 RNA and 50 ng probe.
-  1 4 9  -
is consistent with the processing of other Pol II genes in 
foreign cells such as the rabbit 0 globin in mouse Ltk~ 
cells [259 ].
3:2:3 S1 Nuclease Mapping of Human Epsilon Globin Gene 
Transcripts of pMX Deletion Mutants in Stably 
Transformed BHKtk" Cells
Initially three deletion mutants were examined. pMXA4 
retains the entire prototypic 0 globin gene tripartite 
promoter structure and pMXA5 which lacks the CCAAT motif 
(See Fig. (14A)). To determine the 5* termini of these 
templates total cellular RNA's from these BHKtk“ 
transformed cell lines in conjunction with B/pTKHeG-1 and 
B/pMX-1 were hybridised to the 371 bp's MboII fragment. 
The range of S1 products are represented in Fig. (27). 
Lanes 1 and 2 show the previously described 1:1 cap:- 200 
ratio for pTKHeG and pMX compared to 20:1 for K562 (lane 
7). No protected fragments are detected from B/pMXA1 
(lane 6 ) and B/pMXA4 (lane 5). The former result is not 
unexpected considering the extent of deletion in the A1 
plasmid. The failure to detect any signal in the latter 
is consistent with the data on the Southern analysis of 
B/pMXA4 and shows that only the 2075 bp PvuII fragment 
harbouring the HSV-1 gene could be detected (data not 
shown).
In contrast B/pMXA5 (lane 4) gives two protected 
fragments. The main band running just above the 154 bp's
- 1 50 -
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Figure 27
S1 Nuclease mapping of the 5* termini of 
epsilon globin mRNA prepared from BHKtk- 
cells stably transformed with pMX promoter 
deletion mutants A1 , A4 and A5. Experimental 
conditions were as outlined in the legend to 
Fig. (19). Lane P shows the positioning of 
the 371 bp's MboII probe. Lane 1, 60 yg
B/pTKHeG-1 RNA and 25 ng probe. Lane 2 , 60
yg B/pMX-1 RNA and 25 ng probe. Lane 3, 
60 yg BHKtk- RNA and 25 ng probe. Lane 4,
60 yg B/pMXA5 RNA and 25 ng probe. Lane 5,
60 yg B/pMXA4 RNA and 25 ng probe. Lane 6,
60 yg B/pMXA1 RNA and 25 ng probe. Lane 7,
5 yg K562 RNA and 25 ng probe. Lane M depicts 
pBR322/Hin fl end labelled markers.
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marker maps to the plasmid (pAT153)/epsilon globin gene 
boundary. From the sequence analysis of the pMXA5 
recombinant (Fig. (14A)) this should be 155 bp's in length 
corresponding to the distance between the MboII site of 
the first exon to the deletion breakpoint. The second 
signal coincides with transcripts originating from the 
major cap site. But this is by far the minor species.
The 5' termini of four other mutants viz A2, A3, A8 , 
and Al 1 was determined in an analogous manner.
As depicted in Fig. (28) all the major S1 products as was 
the case for A5 map at a position from the 5' end of the 
MboII probe to the deletion boundary. These deletion 
boundary S1 products remain in conditions of increasing 
probe as illustrated with the constancy of such a band at 
~280 bp's from B/pMXA11 as shown in Fig. (29). Fig. (30) 
shows that transcripts from the mutant templates give a 
spliced S1 product which at the resolution of the 
polyacrylamide gel is indistinguishable from that obtained 
from K562 RNA.
S1 Nuclease mapping of the 5' termini of a series of 
deletion mutants derived from pMX in BHKtk" cells suggests 
that under these particular assay conditions epsilon 
globin gene specific transcripts preferentially initiate 
from the plasmid moiety of the deletion recombinant 
(Figs. (27) and (28)). These S1 products map between the 
MboII site of the first exon and the epsilon globin gene 
plasmid boundary as schematically illustrated in Fig. 
(31 ).
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Figure 28
S1 Nuclease mapping of the 5‘ termini of 
epsilon globin mRNA prepared from BHKtk-cells 
stably transformed with pMX promoter deletion 
mutants A2, A3, A8 and A11. Experimental 
conditions were as outlined in the legend to 
Fig. (19). Lane 1, 5 yg, K562 RNA and 25 ng 
probe. Lane 2, 60 yg B/ pMXA2-1 RNA and 25 
ng probe. Lane 3, 60 yg B/pMXA3-4 RNA and
25 ng probe. Lane 4, 60 yg B/pMXA8-2 RNA
and 25 ng probe. Lane 5, 60 yg B/pMXA11-1
RNA and 25 ng probe. Lane M shows Phi 
X/Hin fl end labelled markers.
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Figure 29
S1 Nuclease mapping of the 51 termini of 
epsilon globin mRNA prepared from BHKtk- 
cells stably transformed with pMXA11 under 
conditions of increasing probe. Experimental 
conditions were as outlined in the legend to 
Fig. (19). Lane P shows the position of the 
371 bp's MboII probe. Lanes 1, 2 and 3
contain 60 yg B/pMXA11 with 25, 50 and 100
ng of probe respectively. Lane M depicts Phi 
X/Hin fl end labelled markers.
*
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Figure 30
Splicing of epsilon globin gene transcripts 
in BHKtk- cells stably transformed with a 
series of pMX promoter deletion mutants. 
Experimental conditions were as outlined in 
the legend to Fig. (26). Lane P shows the 652 
bp's Bam H1 probe. Lane 1 , 60 yg B/
pMXA11-1 RNA and 50 ng probe. Lane 2, 60 yg
pMXA8-2 RNA and 50 ng probe. Lane 3, 60 yg
pMXA3-4 RNA and 50 ng probe. Lane 4, 60 yg
pMXA2-1 RNA and 50 ng probe. Lane 5,5pgK562 
R N A  and 50 ng probe. Lane M shows Phi X/ 
Hin fl end labelled markers.
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Figure 31
Schematic representation of the transcription 
of the human epsilon globin gene from pMX 
promoter deletion templates depicted in A  
showing the S1 protected products which 
correspond t o B  initiation from the canonical 
cap site and C  initiation from the plasmid 
moiety.
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This preferred use of plasmid promoters could arise:
(a) the plasmid promoters are relatively strong and there 
is no termination signal between them and the epsilon 
globin gene, hence transcriptional readthrough
or
(b) deletion of a promoter functional domain, this could 
only be the case if there was such an element located 
between the C-rich-100 region and the Bam H1 site
or
(c) a requirement for sequences upstream of the Bam H1 
site. This observation is strengthened considering the 
activity of pMX in the BHKtk” cell. As shown in Fig. (21), 
up to half of the epsilon globin gene specific 
transcripts, synthesised from this template originate from 
the major promoter region.
Accordingly this experimental approach may not be the 
most suitable strategy to define the functional domains of 
the human epsilon globin gene promoter. It may well be 
more rewarding to engineer a recombinant which contains 
the upstream element, i.e. the 350 bp's 5'-Xbal/Bam H1-3' 
fragment 'from which a series of deletions could be 
generated from the Bara H1 site in a undirectional fashion 
towards the promoter. In addition to identify the 
critical sequences contained within the 5'Xbal/Bara H1-3' 
fragment a series of deletions gradually extending from 
the Xbal site to the Bara H1 recognition sequence may be
- 157 -
useful.
3:2:4 Factors Effecting the Differential Use of the 
Major and -200 Promoters of the Human Epsilon 
Gene in Transformed Animal Cells
To test if this differential use of promoters in the 
transcriptional unit of the human epsilon globin gene is 
of any physiological significance, a series of experiments 
were designed with the purpose of attempting to manipulate 
the cap: - 2 0 0  ratio, arguably a marker for epsilon globin 
gene Expression in a terminally differentiated cell. 
Three experimental strategies were undertaken with a view 
to this aim:
(1) Would the presence of other (3 globin genes be 
influential?
(2) Could the exogenous epsilon globin gene be co-induced 
in transformed MELtk- cells? - if so, which promoter would 
respond?
(3) Can expression be directly effected by the presence of 
a cis linked regulatory element such as the SV40 origin or 
replication and enhancer?
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3:2:4(1) The Influence of els Linked Human Adult 3 
Globin Genes on the Expression of the Human 
Epsilon Globin Gene in Stably Transformed 
Animal Cells
S1 Nuclease mapping of the 5 1 termini of the human 
epsilon globin gene transcripts was performed on BHKtk~, 
mouse LAtk- and MELtk- cells transformed with the triple 
globin gene recombinant pTKH63e Fig. (12). The autoradio­
graph is depicted in Fig. (32).
Lanes 2 and 3 represent the BHKtk- transformants, 
B/pTKH60e-1 does not show any hybridisation which is
consistent with the Southern analysis which failed to 
detect any donor sequences Fig. (16). B/pTKH6$e-2 displays 
a profile similar to that of B/pMX-1 Fig. (21). This trend 
is also observed in the mouse LAtk- and MELtk- cells.
These studies seemingly rule out any obvious influence
of the two adult 8 globin gene under these particular
experimental conditions.
3:2:4(11) Transcription of the Human Epsilon Globin 
Gene in HMBA Induced Transformed MELtk- Cells
It was intended to examine whether MELtk- cells
transformed with epsilon globin gene recombinants were 
co-inducible in the presence of HMBA and if they were, to 
ascertain which of the promoters responded to the inducer. 
Previous studies (this thesis) had established that
- 159 -
P 1 2 3 4 5 6 7  M bps
- 5 0 6
- m
- 2 9 8
221 
220
-154
Figure 32
S1 Nuclease mapping of the 51 termini of 
epsilon globin mRNA prepared from BHKtk-, 
mouse LAtk- and MELtk- cells stably 
transformed with pTKH63e. Experimental 
conditions were as outlined in the legend to 
Fig. (19). Lane P shows the positioning of 
the 371 bp's MboII probe. Lane 1 , 5 ug K562 
RNA and 25 ng probe. Lane 2, 60 yg
B/pTKH63e-1 RNA and 25 ng probe. Lane 3, 
60 ug B/pTKH66e -1 RNA and 25 ng of probe. 
Lane 5, 60 ug LA/pTKHS3e-2 RNA and 25 ng 
probe. Lane 6, 60 ug MEL/pTKH63e-1 RNA and 
25 ng probe. Lane 1 , 60 ug MEL/pTKH68c-2
RNA and 25 ng probe. Lane M shows the 
positioning of pBR322/HinfI end- labelled 
markers.
- * j • «
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epsilon globin gene specific transcripts from non-induced 
transformed MELtk- lines almost exclusively originate from 
the -200 promoter (Figs. (24) and (25)).
Transformed MELtk- cell lines were treated with 3 mM 
HMBA (2:4:1). Total cellular RNA was Northern blotted 
(2:2:4) and hybridised against nick-translated pBR322/M3G 
plasmid [260] which contains the mouse 3 globin gene as 
depicted in Fig. (33). All three pMX lines show a marked 
increase in the expression of the mouse 3 globin gene 
indicative of induction.
In addition to these three cell lines total cellular 
RNA from MEL/pTKHeG-1 and 2 (±) inducer were S1 mapped as
shown in Figs. (34) and (35). No major cap site initiated
transcripts were detected in induced transformants, 
moreover the -200 promoter is not responsive to the 
presence of HMBA.
3:2:4(111) The Effect of Viral Regulatory Sequences on 
Human Epsilon Globin Gene Expression in 
Transformed CV-1 and COS7 Cells
It has been established in some cases that the use of 
upstream promoters of viral genes is coupled to 
replication. Osbourne and Berk [261] confirmed that a 
series of minor transcripts which extend from a site 
upstream of the major cap region of the E1A gene are
directly dependent on the replication of the template.
Cells cultured in the presence of the DNA synthesis
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Figure 33
Northern Blot of RNA prepared from three pMX 
stably transformed MEL tk- cell lines in the 
presence and absence of 3 mM HMBA. 15 yg of 
total cellular RNA was electrophoresed on a 
1% agarose gel, transferred onto a Sartorius 
nitrocellulose filter as detailed in (2:6:4) 
and hybridised to nick-translated mouse 3
-globin/pBR322 DNA. (+) and (-) indicate 
growth in the presence and absence of 3 mM
HMBA as outlined in (2:4:1). Lanes 1 and 2,
MELtk-, Lanes 3 and 4, MEL/pMX-1. Lanes 5 and
6, MEL/pMX-2. Lanes 7 and 8, MEL/pMX-3.
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Figure 34
S1 Nuclease mapping of the 5' termini of 
epsilon globin mRNA prepared from MELtk- 
cells stably transformed with pTKHeG grown 
in the presence (+) and absence (-) of 3 mM 
HMBA. Experimental conditions were as 
detailed in the legend to Fig. (19). Lanes 1 
and 2 ,  60 yg MEL/pTKHeG-1 RNA and 25 ng
probe. Lanes 3 and 4, 60 yg MEL/pTKHeG-2 RNA 
and 25 ng probe. Lane 5, 5 yg K562RNA and
25 ng probe. Lane M depicts the positioning 
of pAT153/HinfI end labelled markers.
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Figure 35
S1 Nuclease mapping of the 51 termini of 
epsilon globin mRNA prepared form MELtk- 
cells stably transformed with pMX grown in 
the presence (+) and absence (-) of 3mM HMBA. 
Experimental conditions were as detialed in 
the legend to Fig. (19). Lane P shows the 
positioning of the 371 bp's MboII probe. 
Lanes 1 and 2, 60 ug MEL/pMX-1 RNA and 25 ng 
probe. Lanes 3 and 4, 60 ug MEL/pMX-2 RNA
and 25 ng probe. Lanes 5 and 6, 60 ug MELtk- 
RNA and 25 ng probe. Lanes 7 and 8, 60 ug
MEL/pMX-3 and 25 ng probe. Lane M shows the 
pAT153/ Hinfl end labelled markers.
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inhibitor Arabinoside C do not produce these RNA species.
As discussed in (1:5:2) viral enhancers increase the 
level of expression of the nearest promoter. Enhancer 
elements are a common structural feature of vectors 
employed in transient expression experiments being 
necessary for the detection of correctly initiated 
transcripts. This observation has led to a classification 
of some Pol II promoters being enhancer dependent or 
independent eg. the human 6 globin and a globin promoters 
respectively [262].
Thus the presence of an origin of replication or an 
enhancer could possibly influence the use of the - 2 0 0  and 
major promoters of the human epsilon globin gene 
particularly in short term transfection experiments.
With this in mind a series of recombinants containing 
the origin of replication and enhancer of SV40 were 
constructed. Fig. (36) shows the "enhancer" recombinants 
pSVEDe-1 and -2, and the "origin" plasmids pSVODe-3 and -4 
These are derived from pHR11 (Fig. (9)) which contains the 
3.751 kb Eco RI epsilon globin gene fragment. The details 
of these constructions have been published, see Allan et 
al [91]. The S1 Nuclease analysis of these recombinants 
in CV-1 and COS-7 short term transformations were 
performed by Dr Allan in this laboratory, for details see 
Fig. (37) which has been reproduced from [91].
This series of experiments suggest:
(i) the activity of the - 2 0 0  promoter is influenced by
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Figure 36
Schematic outline of the construction of 
pSVODc-3 and 4 containing the SV40 origin 
of replication and pSVED-1 and 2 encoding the 
SV40 enhancer and origin. pHR11 containing 
the 3.751 kb epsilon globin fragment was 
digested with Eco RI and treated with 
alkaline phosphatase. This was separately 
ligated to Eco RI digested pSVOD and pSVED to 
yield the above recombinants. Reproduced and 
modified from [91] which also gives details 
of construction.
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Figure 37
The effect of plasmid replication and SV40 enhancer 
sequences on the S1 Nuclease mapping of the 5' termini of 
epsilon globin mRNA prepared from COS 7 and CV-1 cells 
acutely transformed with pSVODe and pSVEDe, reproduced 
from [91].
Cells were transfected with 40 yg per 75 cm flask of 
pSVEDe-1 and -2 and pSVODe-3 and -4. Total cellular RNA 
was prepared 48 hours after transfection and hybridised 
for 16 hours to the 371 bp single-stranded MboII probe at 
55°C. Hybrids were treated with 100Q Units S1 Nuclease 
for 90 minutes at 37°C. The products were denatured and 
separated on 6% polyacrylamide gel. Lane 1, 0.5 yg Poly A 
RNA from induced K562 cells. Lane 2, 2 yg total RNA
from COS 7/pSVODe-4. Lane 3, 2 yg total RNA from COS 7/ 
pSVEDe-3. Lane 4, 2 yg total RNA from COS 7/pSVEDe-2. 
Lane 5, 2 yg total RNA from COS 7/pSVEDe-1. Lane 6, 20 yg 
total RNA from CV-1/pSVODe-4. Lane 7, 20 yg total RNA
from CV-1/pSVODe-3. Lane 8, 2 0 yg total RNA from CV-1/ 
pSVEDe-2. Lane 9 ,  20 yg total RNA from CV-1/pSVEDe-1. 
Lane M show PhiX/Haelll end-labelled markers. All 
hybridisations were performed under conditions of probe 
excess.
M S S
-310
-281
■271
234
194
118
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replication in COS-7 cells when the origin is positioned 
in the opposite orientation from the globin gene.
(ii) only the major promoter is responsive to the 
presence of a cis linked viral enhancer.
(iii) the activity of these two promoter regions can be 
uncoupled.
(iv) the epsilon globin gene component of pHR11 does not 
contain an active equivalent endogenous enhancer element 
when assayed under these conditions.
3:2:4(IV) The Effect of Viral Regulatory Sequences on 
Human Epsilon Globin Gene Transcription in 
Stably Transformed BHKtk~ and Human 143tk“ 
Cell Lines
As discussed in the previous section and illustrated 
in Fig. (37), the presence of a viral enhancer increases 
transcription from the canonical cap site of the epsilon 
globin gene fragment in short-term transfection 
experiments.
To assess if a similar pattern would be obtained in 
stably transformed cells and to compare the 
transcriptional profile with pMX which gives a cap: -200
ratio of around 1:1 in BHKtk-" cells (Table (3)) two 
recombinants were constructed.
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3:2:4(iv)A Construction of pSVODeTK and pSVEDeTK
Previous long term transformation experiments involved 
the use of HSV-1 tk based vectors, eg. pTKHeG, pMX and 
pTKH6 $e which allow selection of transformed colonies by 
growth in HAT medium. pSVODe-3 and pSVEDe-2 lack this 
biochemical marker. To circumvent this problem as 
depicted in Fig. (38), the ~7 kb Hindlll fragment of pMX 
containing the HSV-1 tk gene was isolated by agarose gel 
electrophoresis and inserted at the Hindlll site of 
pSVODe-4 and pSVEDe-1 to give pSVODeTK and pSVEDeTK 
respectively.
3:2:4(lv)B S1 Nuclease Mapping of 5' Termini of Human 
Epsilon Globin Gene Transcripts of pSVODeTK 
and pSVEDeTK in Stably Transformed BHKtk- and 
Human 143 tk“ Cell Lines
pSVODeTK, pSVEDeTK and pMX were stably introduced into 
BHKtk-and human 143tk- cells. Transformed colonies were not 
individually selected but were pooled and expanded into a 
transformed cell line as a mixture. This protocol was 
adopted to reduce the inconsistency which can arise using 
clonal populations. In these circumstances differences in 
copy number, rearrangement of exogenous sequences and site 
of integration can conceivably give rise to inconsistency 
in the behaviour of separate cloned lines. By using a pool
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10-45 kb
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Hind III DIGESTION
E
ALKALINE PHOSPHATASE GEL ISOLATION ALKALINE PHOSPHATASE
OF 1 2  kb Hind III 
HSV-1 tk FRAGMENT
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F ig u r e  38 EHZDSV40 ORIGIN*ENHANCER
A schematic outline of the construction of 
pSVODe-TK and pSVEDe-TK by insertion of the 
7.2 kb Hindlll fragment of pMX containing the 
HSV-1 tk gene into pSVODs and pSVEDe 
respectively.
- 170 -
of transformed colonies this variation can be minimised.
The S1 product profile is presented in Fig. (39), ((A) 
represents a 4-day and (B) an overnight exposure 
respectively) (no data is available for 143/pSVODeTK as 
this transformation was unsuccessful). The pattern of "OD" 
and "ED" type of activity observed in short term 
transfections of CV-1 cells closely resembles that 
obtained in stable transformants. Lanes 2 and 3 of Fig. 
(39) denote pSVODeTK and pSVEDeTK in BHKtk- cells. These 
ratio differences are more obvious in the shorter exposed 
autoradiograph (Fig. (39B)). Of particular interest is the 
similarity in the useage of the major promoter of 
pSVEDeTK and pMX as illustrated in Fig. (39), lanes 3 
and 4 (BHKtk-) and lanes 5 and 6 (143tk- cells). Two issues 
arise from this observation. First it would appear that 
pMX possesses an endogenous non erythroid enhancer like 
element. Second, the epsilon globin, gene component of pMX 
differs from the pHR11 derived recombinants pSVEDeTK and 
pSVODeTK.
3:2:5 A Comparison of the S1 Nuclease Transcriptional 
Profiles of pMX and pHR11 in Acutely Transformed 
Mouse LAtk" Cells
It was decided to investigate this difference in 
expression between pMX and pHR11 in acutely transformed 
mouse LAtk- cells since this line displays a relatively 
high cap: -200 for pMX (Table (3)). Fig. (40) depicts the
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The effect of the SV40 origin and enhancer on 
the S1 Nuclease mapping of the 5' termini of 
epsilon globin mRNA prepared from BHKtk- and 
143tk- cells stably transformed with 
psVODeTK, pSVEDeTK and pMX. Cells were 
transfected with 40 ug of plasmid DNA per 75 
cm flask. After HAT selection the 
transformed colonies were pooled and 
expanded. Hybridisation conditions were as 
detailed in the legend to Fig. (37).
Lane 1, 0.5 yg induced K562 RNA and 25 ng 
probe. Lane 2, 60 yg B/pSVODeTK RNA and 25 ng
probe. Lane 3, 60 ygBjpSVEDeTK RNA and 25 ng
probe. Lane 4, 60 yg B/pMX RNA and 25 ng
probe. Lane 5, 60 yg 143/pSVEDeTK RNA and 25
ng probe. Lane 6, 60 yg 143/pMX RNA and 25 ng 
probe. Lane M shows the positioning of Phi 
X/Haelll end labelled markers. A shows a 
3 day exposure, B an overnight exposure.
1 2 3 4 5 6
Figure 40
S1 Nuclease mapping of the 51 termini of 
epsilon globin mRNA prepared from mouse LAtk- 
cells stably and acutely transformed with 
pHR11 and pMX. Stable transformations were as 
detailed in the legend to Fig. (39). Acute 
transfections and hybridisation conditions 
were as outlined in Fig. (37).
Lane 1, 0.5 yg Poly A+ K562 RNA and 25 ng 
probe. Lane 2, 30 yg LA/pHR11 RNA (Stable) 
and 25 ng probe. Lane 3, 30 yg LA/pMX RNA
(Stable) and 25 ng probe. Lane 4, 30 yg
LA/pHR11 RNA (Acute) and 25 ng probe. Lane 5, 
30 yg LA/pMX RNA (Acute) and 25 ng probe. 
Lane 6, 30 yg tRNA and 25 ng probe.
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S1 product profiles between these plasmids in long term as 
well as acutely transformed mouse LAtk” cells. The
difference in activity is particularly highlighted in 
transiently expressed cells, compare lane 4 (pHR11) and
lane 5 (pMX) and the stable transformants, lane 2 (pHR11)
and lane 3 (pMX).
Fig. (41) shows in annotated form the four structural 
differences between these two plasmids. pHR11 contains 
the 1468 bp's 5 1-Eco Rl/XbaI-3' fragment within which is 
located 5' to the proximal Alul element. Does this region 
have a repressor type which can be overidden by the 
presence of a cis linked enhancer? - compare the activity 
of pSVODe and pSVEDe (Fig. (37)). The second structural 
difference is in the 3' region. pHR11 lacks the 550 bp's 
5'-Eco Rl/HindIII-3' fragment. It is interesting that 
some evidence now exists which subscribes to the view that 
regulatory signals might be located in the 3' flanking 
region of globin genes. Recently Rohrbaugh et al [263] 
proposed that transcription of the rabbit 8 globin gene 
may be regulated in part by sequences in the 3' flanking 
region of the gene by an attenuation mechanism which is 
dissimilar to the procaryotic model [264]. They argue for 
the involvement of two structural elements. An inverted
repeat which can adopt a stem-loop conformation and a 
short RNA transcribed from the opposite strand by RNA 
Polymerase II are located within a region of declining 
transcriptional activity. These workers propose that the 
stem-loop structure and the short transcript may
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pATt53DNA _
(1) X B P 
J I L pHR11
(4)
pMX
Figure 41
Structural differences between the plasmid 
recombinants pMX and pHR11. Restriction 
enzyme sites shown are E = Eco R I , X = Xbal, 
B = Bam H 1 , P = PvuII and H = Hindlll.
(1) pHR11 contains the 14 6 8  bp's
5'-Eco Rl/XbaI-3' fragment containing
the Alul repeat element.
(2) pMX encodes the 466 bp's 5 '-Hindlll
/XbaI-3' fragment
(3) pMX has an extended 3' region in the form
of a 550 bp's 5'-Eco Rl/Hindlll fragment.
(4) pMX is cis-linked to the HSV-1 tk gene
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physically block the movement of RNA Polymerase II 
molecules along the template. Of further interest is the 
observation that the 3' region of the human 3 globin gene 
displays these two structural features.
The third difference between pMX and pHR11 is the 
presence of the 5'-HindIIl/XbaI-31 466 bp's fragment at 
the 5' end of pMX. Finally, pMX contains the 3.5 kb 
Bam H1 fragment of the pTK-1 recombinant which contains 
the HSV-1 tk gene.
3:2:5(I) Construction of pMXAH
To test if the 3' flanking region of the human epsilon
globin gene was responsible for the different activity
between pMX and pHR11, the 550 bp's 5'-Eco Rl/HindIII-3'
3' fragment was excised from pMX.
As schematically outlined in Fig. (42) the 2675 
bp's Eco RI fragment containing the human epsilon globin 
gene was gel isolated, flush-ended and the termini 
converted to Hindlll recognition sites by linker 
ligation. In parallel with this pMX DNA was digested with 
Hindlll, treated with alkaline phosphatase and the 6786 
bp's HSV-1 tk fragment isolated by low melting point 
agarose gel electrophoresis. These Hindlll DNA fragments 
were covalently linked to give the pMX 3' deletion 
recombinant termed pMXAH.
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Figure 42
A schematic outline of the cloning strategy 
adopted in the construction of the pMX 3' 
deletion mutant pMXAH involving the removal 
of the 550 bp's 5*-Eco Rl/HindIII-3* fragment 
from pMX.
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3:2:5(11) Construction of pSXAB
As outlined in Fig. (43) pSX and pMX differ only in 
the orientation of the human epsilon globin gene with 
respect to the HSV-1 tk gene. pSX was constructed by Dr D. 
A. Spandidos in this laboratory by an analagous procedure 
to that described in the construction of pMX (3:1:2(11)). 
By comparing the transcriptional activity of pMX and pSX 
it might be possible to determine the influence of any tk 
read-through effect on the expression of the human epsilon 
globin gene.
Another possible way in which the HSV-1 tk gene could 
influence the expression of the human epsilon globin gene 
is over the competition for factors involved in the 
initiation of transcription. However in pSX (Fig. (43)) 
the distance between the two promoter regions of the genes 
is over 500 bp's. Thus it would seem that pSX is not a 
suitable recombinant to investigate this phenomenon, a 
plasmid in which the promoters were close to each other 
however would be purposeful. Fig. (43) shows such a 
recombinant, pSXAB, in which the 560 bp's Bam H1 fragment 
spanning the intergenic regions between the two genes has 
been excised leaving both promoters adjacent to one 
another. This plasmid was constructed by performing a 
partial Bam H1 of pSX and isolating by low melting point 
agarose gel electrophoresis the deleted fragment in which 
the two Bam H1 sites covering this intergenic DNA had been 
cut. This fragment was re-sealed at a low j/i ratio to
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Figure 43
Cloning ' strategy employed in deleting 
sequences upstream of the epsilon globin 
promoter in the construction of A pMXA4 and 
BpSXAB. pMX and pSX differ in the orientation 
of the HSV-1 tk gene.
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favour circularisation, positive colonies were selected 
for on the disappearance of the Bam H1 560 bp's fragment 
to give pSXAB.
3:2:5(111) S1 Nuclease Mapping of 5' Termini of Human 
Epsilon Globin Gene Transcripts of pTKHeG,
pMX, pSX, pMXA4, pMXAH and pHR11 in Acutely 
Transformed Mouse LAtk- Cells
As depicted in the line diagram Fig. (44), pTKHeG,
pMX, pSX, pMXA4, pSXAH and pHR11 were transiently 
expressed in mouse LAtk- cells and the 5' termini
determined by S1 Nuclease mapping as shown in Fig. (45). 
An inconsistent feature regarding the cap: -200 ratio for 
pMX has arisen. This as depicted in Fig. (40) should be 
around 4:1. This cannot be readily explained by failing to 
attain probe excess conditions since this has been 
achieved for 5 ug of K562 RNA. Moreover the pMX tract 
Fig. (45), lane 3 also diplays a strong protected probe 
band.
Despite this, pMX and pHR11 display the same general 
pattern differences as obtained in Fig. (40), lanes 3 and 
5. Removal of- the 5'-Eco Rl/HindIII-3* 550 bp's fragment 
from pMX does not appear to significantly alter its
activity, compare Fig. (45) lanes 3 (pMX) and 5 (pMXAH).
The influence of any HSV-1 tk gene read-through on the 
expression of the human epsilon globin gene seems to be 
minimal as judged by the similarity between pMX and pSX as
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Figure 4 4
Line diagram illustrating the structural 
differences between the recombinant plasmids 
pHR11, pTKHeG, pMX, pMXA4, pMXAH, pSX and 
pSXAB. The open box represents the epsilon 
globin gene, the thin black line depicts 
epsilon globin flanking DNA, the solid black 
line is the HSV-1 tk gene and flanking DNA, 
pAT153 DNA is represented by the broken line. 
The epsilon globin promoter is depicted in 
green, the HSV-1 tk promoter is blue. 
Restriction enzyme sites shown are H=HindIII, 
X = Xbal, E = Eco RI, B = Bam H1 , P = PvuII 
and Bg = Bglll.
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S1 Nuclease mapping of the 51 termini of 
epsilon globin mRNA prepared from mouse LAtk- 
cells acutely transformed with pHR11, pTKHsG,
pMX, pMXAH, pSX and pSXAB. Acute trans­
fections and hybridisation conditions were as 
outlined in the legend to Fig. (37).
5 ug K562 RNA and 25 ng probe.
30 ug LA/pTKHsG RNA and 25 ng probe.
30 ug LA/pMX RNA and 25 ng probe.
30 ug LA/pHR11 RNA and 25 ng probe.
30 ug LA/pMXAH RNA and 25 ng probe.
30 ug LA/pMXA4 RNA and 25 ng probe.
30 ug LA/pSX RNA and 25 ng probe.
30 ug LA/pSXAB RNA and 25 ng probe.
30 ug yeast tRNA and 25 ng probe.
Lane M depicts the positioning of Phi X/Hinfl 
end labelled markers.
Lane 1 
Lane 2 
Lane 
Lane 
Lane 
Lane 
Lane 7 
Lane 8 
Lane 9
- 182 -
depicted in Fig. (45) (lanes 3 and 7).
Particularly striking is the difference between the 
mutant templates pMXA4 (lane 6 ) and pSXAB (lane 8 ). With 
the former, cap site initiated transcripts are present 
although the vast majority of the RNA population extend 
from the plasmid moiety as determined by the strong 
plasmid/epsilon globin gene boundary signal (See Fig. 
(31 )).
However with pSXAB in which the promoters of the HSV-1 
tk and human epsilon globin gene are in an adjacent back 
to back arrangement very little major cap site initiated 
transcripts are observed. In addition as would be 
predicted on the basis of the orientation of the two genes 
there is no signal corresponding to the epsilon globin 
gene/plasmid boundary. This suggests that the HSV-1 tk 
gene promoter is a more effective competitor for 
transcription factors than the epsilon globin gene 
counterpart under these conditions. But whether this 
phenomenon has any bearing on the central investigation of 
the difference between pMX and pHR11 is unclear. Finally 
the 466 bp's 5'-Hindlll/Xba 1-3 1 fragment has been 
inserted into the Xbal site of pSVODe-3 (Fig. (38)) by Mrs 
G. J. Grindlay and Dr M. Allan in this laboratory (Pers 
Comm) and transiently expressed in COS 7 cells. No 
differences were observed in the S1 Nuclease product 
profiles between these two plasmids.
To conclude these series of S1 Nuclease mapping 
experiments by a process of elimination and implication
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suggest that the 1468 bp's 5'-Eco Rl/XbaI-3' fragment of 
pHR11 acts as inhibitor or down regulator of major cap 
site expression of the human epsilon globin gene under 
these particular experimental conditions.
3:2:6 Trans Activation of The Human Epsilon Globin Gene 
in Stably Transformed K562 Cells
It has been established that the 3.751 kb epsilon 
globin gene fragment of pHR11 is responsive to the 
presence of a cis linked viral enhancer both in short term 
[91] and long term transformed mammalian cells 
(3:2:4(IV)). Does this result from the absence of an 
endogenous enhancer from pHR11? or does it in fact contain 
an enhancer which is tissue specific in its expression. 
Alternatively, does pHRl1 have a recognition sequence for 
trans activators which are only expressed in the 
appropriate erythroid tissue? To investigate some of 
these possibilities required the introduction of pHR11 
into cultured cells which are actively expressing the 
epsilon globin gene, i.e. K562 cells. This required using 
an epsilon globin gene recombinant which could be 
distinguished from the active endogenous counterpart in 
the K562 cell. This experimental strategy was formulated 
in collaboration with Dr M. Allan in this laboratory, the 
results of which have been published [265].
The PvuII site at the 3' end of the human epsilon
globin gene of pSVODe-3 (Fig. (36)) was converted to a Kpnl
1
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site by Dr M. Allan and Mrs G. J. Grindlay to give 
pSVKe-3. The wild type and "marked" gene could be 
distinguished by S1 Nuclease mapping. With the 371 bp's 
MboII probe the endogenous gene will give a protected 
fragment of 109 bp's while the "marked" genes S1 product 
is 138 bp's. For long term transformation experiments it 
was decided to link pSVKe-3 to the bacterial neomycin gene 
which allows the selection of transformed colonies by 
growth in the presence of geneticin. For a separate study 
(3:3:2), the neomycin gene was available in the 
recombinant pNV (Fig.(49)). From this the 1.7 kb fragment 
containing the neomycin gene was cloned into pSVKe-3 as 
depicted in Fig. (46) to give pSVKNe-3.
pSVKNe-3 was stably introduced into human 143 tk- , COS 
7, MELtk- and K562 cells. Geneticin resistant colonies 
were pooled and expanded as a mixed population for 
reasons, already alluded to ( 3 :2 :4 (IVB)) . The S1 Nuclease 
mapping of the 5' termini of the transcripts were
performed by Dr M. Allan and shown in Fig. (47) reproduced
from [265]. Transformed human 143 tk-, COS 7 and MELtk-
cells, Fig. (46), lanes A, C and E, produce transcripts 
which originate from the -200 promoter, lanes B, D and F 
represent the non-transformed cell lines. With
transformed K562 cell, lane H in addition to the
endogenous cap signal at 109 bp's there is a strong signal 
corresponding to a RNA molecule extending from the cap 
site of the "marked" gene. Moreover, the cap: -200 ratio
of both the endogenous and exogenous epsilon globin genes
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Figure 46
Schematic outline of the cloning strategy 
employed in the construction of pSVKNe-3, 
reproduced from [265]. The promoter PvuII 
site of the pHR11 derived recombinant 
pSVODe-3 containing the SV40 origin [91] was 
converted to a Kpnl site. The neomycin 
resistance gene Tn5 aph (II) driven by the 
HSV-1 tk promoter is encoded in the plasmid 
pAGO.60 [176]. The Bglll site adjacent to the 
structural gene was converted to a Hindlll 
site. This 3.9 kb Hindlll fragment was 
partially digested with PvuII and the 
isolated 1.7 kb Hindlll/PvuII fragment 
inserted into pSVKe-3 as shown in the above 
diagram.
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Figure 47
S1 Nuclease mapping of the 5' termini of 
epsilon globin mRNA from 143tk-, COS 7, 
MELtk- and K562 cells stably transformed with 
the 'marked' epsilon globin gene recombinant 
pSVKNe-3. Cells were transfected with 40 yg 
of plasmid DNA per 75 cm flask. After G418 
selection the transformed colonies were 
pooled and expanded. 20 yg of total RNA was 
hybridised to the 371 bp MboII probe under 
conditions of probe excess for 16 hours at 
57° C. The hybrids were digested with 2000 
units S1 Nuclease for 1.5 hours at 40°C. Lane 
A, 20 yg 143/pSVKNe-3 RNA. Lane Bf 20 yg 
143tk- RNA. Lane C, 20 yg COS 7/pSVKNe-3 RNA. 
Lane D, 20 yg COS 7 RNA. Lane E, 20 yg 
MEL/pSVKN£-3 RNA. Lane F, 20 yg MELtk- RNA. 
Lane Gf 20 yg K562 RNA. Lane H, 20 yg 
K562/pSVKNe-3 RNA. Lane M shows the 
positioning of Phi X/Haelll end-labelled 
markers. Reproduced and modified from [265].
- 187 -
in K562 cells is virtually identical.
These findings Indicate the 3.75 kb Eco Rl fragment is 
recognised by an embryonic erythroid trans factor(s) which 
by some unknown nechanism increases major cap site 
expression. Equivalent factors are absent in the other 
cell lines examined.
To conclude it vould appear that the human epsilon 
globin gene fragment in pHR11 derived recombinants can be 
transcriptionally activated by two fundamentally different 
mechanisms, i.e. a cis linked viral enhancer and by trans 
activation in the K562 cell.
3:3 The Effect of Globin Genomic Fragments on Tn5aph(II) 
Expression in a Variety of Stably Transformed Animal 
Cell Lines
3:3:1 Background Experiments on HSV-1 tk Based 
Recombinants
The aims o f (3:3)were two-fold. First, to examine the 
comparative strength of the human epsilon globin gene 
promoter in relation to a defined set of other promoters 
and secondly to scan the human 3 globin gene locus for 
putative regulatory elements. The experimental strategy 
considered appropriate for both studies was the fused gene 
technique. This involves testing DNA fragments to support 
expression of a covalently linked selectable gene. Under 
these conditions it can be contended that the relative
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increase or decrease in the activity of the linked gene is 
a function of the inserted fragment.
Initially the tk gene of HSV-1 [209] was chosen as the 
selectable marker. The recipient cell lines were the 
mouse LAtk“ and the human 143tk- , the latter to account 
for the possibility of species specificity. The first 
task in the development of a functional assay system was 
the construction of HSV-1 tk based vectors which would be 
suitable for long term transformation experiments. As 
shown in Fig. (9) the sixteen Eco Rl fragments spanning 
the entire human 3 globin gene cluster were cloned into 
pAT153.
Fig. (48) diagramatically illustrates the two single 
Eco Rl site vectors employed to assay these Eco Rl globin 
genomic DNAs. One contains the human epsilon globin gene 
promoter fused to the HSV-1 tk gene viz peV, the other 
pTV is promotorless. A third recombinant termed pTMo in 
which the HSV-1 tk gene is driven by the (MoMuSV) was 
employed as a further internal contrQl.
These recombinants were stably introduced into mouse LAtk” 
and human 143tk“ cells as described in (2:4:3(111)). The 
transforming abilities of these plasmids is expressed as a 
transformation ratio, i.e. the number of HAT resistant 
colonies relative to pTK-1 for the promoter series of 
experiments and peV for the Eco Rl globin genomic 
recombinants transfections. Two interesting phenomena 
emerged from these studies. First as shown in Table (4), 
the activity of the human epsilon globin gene promoter
- 189 -
SV40 ENHANCER
A
pTK-1 
7 *2  kb
B
B
E
p£V 
5-908 kb
/
D
B
/
pTMo
4-64kb
\
P
e e
pTV
4 -99 kb
P
igure 48
TK— 1 based recombinants: pSVeTK, peV, pTMo 
nd pTV. A  pTK-1 contains a 3.5 kb Bam H1 
fragment encoding the HSV-1 tk gene in 
E d itio n  to 5' and 3' flanking DNA cloned 
into the Bam H1 site of pAT153 [209]. B  
PSVeTK, the tk gene is driven by the 197 bp's 
Psilon globin promoter and contains 420 bp's 
■40 fragment within which maps the enhancer 
}<?ion [231 ] . C PeVf the tk gene is driven 
the epsilon globin promoter and contains a 
^gle Eco Rl site was derived from a
re~existing plasmid peP1 kindly donated by
r; J. Lang [232], 0 pTMO, the tk gene is
riven by the 180 bp's MoMuSV promoter and 
'as c lo n e d  into the Bara H1 /Hindlll sites 
 ^PTV. £ pTV is a promoterless plasmid
rived from a pre-existing plasmid pTK-10 
JP p lie d  by Dr. Lang [231 ].
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Table (4)
The effect of the promoters of the HSV-1 tk, human
epsilon globin and MoMuSV genes on HSV-1 tk
expression in stably transformed mouse LAtk- and
human 143tk- cells.
p
Transformation Ratio ±SD (No of Observations)
i
Donor
DNA
Recipient Cell Line 
Mouse LAtk- Human 143tk-
pTK
peV
pTMo
pTV
1.000 (4)
0.46 ± 0.22 (5) 
0.57 ± 0.15 (2) 
0.017 ± 0.008 (5)
1.000 (7) 
0.05 ± 0.05 (7) 
1 .25 ± 0.28 (2) 
0.03 ± 0.03 (7)
1 - Donor DNA's, 25 ng-1 yg for mouse LAtk- cells 
and 2 - 10 yg for human 143tk- (the human 143tk- 
cells have a relatively low transformation 
efficiency) were mixed with high MW carrier salmon 
sperm DNA at a final concentration of 20 yg/ml in 
calcium phosphate as detailed in (2:4:2). 
Transformations in duplicate or triplicate were 
performed in 25 cm flasks in 5 ml of medium (2:4:3) 
under HAT selection (2:4:31). After the appropriate 
selection period, for mouse LAtk- cells 1 4 - 2 1  days, 
human 143tk- cells 1 0 - 1 6  days, the HAT resistant 
colonies were stained and quantitated as described in 
(2:4:3IV).
2 - Each observation refers to one experiment carried 
out in duplicate or triplicate.
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recombinant peV is relatively low in the human 143tk“ 
cell. Secondly, inspection of Table (5) suggests that 
peV10 increases HSV-1 tk expression significantly above 
the value obtained for the promoter itself, i.e. peV. 
The transformation ratio of 3.45 is close to that observed 
for the activity of human epsilon globin gene promoter 
driven HSV-1 tk expression when covalently linked to SV40 
enhancer i.e. pSVeTK-2 (Fig. (48)). In addition this 
enhancing effect was maintained when fragment 1 0  was 
inserted into the MoMuSV promoter recombinant pTMo (Table
(5)).
Many of the transformations and the insertion of 
the Eco Rl fragments into peV and pTV were performed in 
collaboration with Mrs G. J. Grindlay. Experimental 
details have not been elaborated upon since these two 
observations formed the preliminary basis for a more 
detailed study.
These two phenomena prompted an investigation into the 
following questions:
(1) Was the apparent repression of the human epsilon 
globin gene promoter in the human 143tk~ cell a property 
common to all other non-erythroid cell lines?
(2) Would the repression be released in the K562 cell in 
which the endogenous promoter is active?
(3) Would other globin gene promoters behave in a similar
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Table (5)
The influence of Eco Rl globin genomic fragments on 
epsilon globin and MoMuSV promoter driven HSV-1 tk 
expression in mouse LAtk- cells.
1
Donor
DNA Transformation Ratio± SD (No of Observations)^
peV 1.000 (4)
pTV 0.017 ± 0.008 (5)
pSVeTK 2.015 ± 0.18 (3)
peV1 0 3.45 ±0.125 (3)
peV11 1 .312 ± 0.095 (4)
peV1 4 1.509 ± 0.317 (4)
peV15 0.879 (1)
peV1 7 1.110 ± 0.365 (4)
peV1 8 0.558 (1)
peV1 9 0.753 ± 0.204 (4)
peV20 1.41 ± 0.310 (2)
peV21 1 .273 ± 0.425 (3)
peV22 1 .719 ± 0.279 (4)
peV23 1.801 ± 0.095 (4)
peV25 1.625 ±0.105 (3)
peV26 1.73 ± 0.425 (2)
pTMo 1 . 0 0 0 ( 1 )
pTMol0 4.5 (1)
pTMo2 3 1.28 ( 1 )
1 - Experimental details were as described in Table (4)
2 - The discrepency in the No. of observations
reflects the relative availability of the 
recombinants
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manner in the 143tk cell to the human epsilon globin gene 
promoter?
(4) The series of experiments (Table (5)) in which 
fragment 10 elevates expression of the HSV-1 tk gene 
independent of promoter source could infer that this 6.67 
kb stretch of DNA located ~ 2 kb upstream of the human 
epsilon globin gene possesses some kind of non-erythroid 
enhancer element. To extend these studies by examining its 
activity in the K562 cell and in other non-erythroid cell 
lines it became necessary to engineer recombinants based 
on the geneticin selection system.
To follow these lines of inquiry required changes in 
the assay system. The cell lines of interest to 
investigate points (1), (2) and (4) were not available as 
tk” mutants. To circumvent this the bacterial gene 
neomycin aph (II) encoded on the transposon Tn5 was 
employed as a selectable marker [176].
3:3:2 The Construction of a Series of Tn5 aph (II) Gene 
Based Recombinants
The initial aim was to engineer a promoterless 
neomycin vector into which promoters of interest could be 
cloned. As illustrated in Fig. (49) pAG060 [176] contains 
the neomycin structural gene driven by the HSV-1 tk 
promoter which maps in a 252 bp's 5'-PvuIl/BglII-3'
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Schematic outline in the construction of the promoterless 
neomycin vector pNV. The recombinant plasmid pAGO.60 
encodes the bacterial gene Tn5 aph (II) [176] is driven by 
the 252 bp's 51-Pvull/Bglll-3' HSV-1 tk promoter 
represented as a blue box. HSV-1 tk also provides the 
signals for termination and polyadenylation as a 627 
bp's Smal/PvuII-3' fragment shown as a hatched box. The 
Bglll HSV-1 tk site was converted to a Hindlll site and 
the gel isolated 3.9 kb Hindlll fragment was partially 
digested with Pvull to liberate the promoterless 1.7kb 
fragment. This was cloned into the Hindlll/PvuII sites 
of pTV to generate pNV. The solid black line is 5' 
flanking HSV-1 tk DNA. The broken line is pAT153 DNA.
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fragment. The signals for eucaryotic termination and 
polyadenylation lie within a 5'-Smal/PvuII-3' 627 bp's tk 
fragment. Since the promoters of immediate interest ie
from the human epsilon globin gene and HSV-1 tk were 
available in existing plasmids as Hindlll fragments viz 
peV (Fig. (48)) and pTK - 8  [232] it was planned to 
construct a basic neomycin vector which had a single 
Hin dill site at the beginning of the bacterial gene 
which would serve as a cloning site for promoter DNAs.
I. Construction of the promoterless vector pNV
The cloning strategy is schematically outlined in Fig. 
(49). pAGO60 was linearised with Bglll, flush-ended by 
treatment with Klenow enzyme and ligated to a Hindlll 
linker. On Hindlll digestion, the tk promoter is separated 
from the neomycin structura1 gene which is now bounded by 
a single Hindlll site. This fragment was gel purified. The 
internal Pvull site necessitated the isolation of the 
1653 bp's fragment by partial digestion. This Hindlll/ 
Pvull fragment was covalently linked to the Hindlll/PvuII 
digested, alkaline phosphatase treated pTV (Fig. (48)) to 
give the 4837 bp's vector pNV.
II and III Construction of pNTV and pNeV
The cloning strategy for the insertion of the HSV-1 tk 
and human epsilon globin gene promoters into pNV is
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diagramatically illustrated in Fig. (50). The 197 bp's 
5 '-Bam H1/PvuII-3' human epsilon globin gene promoter was 
available as a Hindlll fragment in the HSV-1 tk 
recombinant peV (Fig. (48)). The 252 bp's 5' Pvull/Bglll- 
3' promoter fragment of HSV-1 tk was likewise available as 
a Hindlll fragment in the HSV-1 tk plasmid pTK - 8  [232]. 
The promoter fragments were isolated by 6 % polyacrylamide 
gel electrophoresis. These were ligated to Hindlll 
linearised alkaline phosphatased treated pNV giving pNTV 
and pNeV. The orientation of the promoter with respect to 
the neomycin gene was determined by Eco Rl digestion ofpNTV 
and Hinfl treatment of pNeV.
IV Construction of pNMBV
The murine 8 maj globin gene promoter was available as 
a Hindlll/HincII 369 bp fragment in a recombinant
constructed by Dr R. S. Gilmour in this laboratory. This 
fragment was isolated from a 6 % polyacrylamide gel as 
depicted in Fig. (51). This was blunt ended by treatment 
with Klenow enzyme (HincII already has flush ends). The 
termini were extended by Hindlll linkers and ligated to
Hindlll digested, alkaline phosphatase treated pNV to give 
pNMBV. To determine the orientation of the insert the
recombinants were cut with Haelll.
V Construction of pNBV
This recombinant was engineered by Mrs G.J. Grindlay
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gure 50
A schematic outline of the construction of
neomycin based vectors driven by the epsilon 
globin promoter A pNeV and the HSV-1 tk 
promoter B pNTV. A The epsilon globin
promoter contained within a 197 bp's 
Hindlll fragment was isolated from peV 
and inserted into pNV. The orientation was
determined by performing a H i n  fl digest. 
BpTK-8 contains the HSV-1 tk promoter as a 
Hindlll 252 bp's fragment was supplied by 
Dr. J. Lang [232]. This fragment was isolated 
and cloned into pNV. The orientation was
confirmed by an Eco Rl digest.
KEY o n  £ PROMOTER
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Figure 51
A schematic outline of the construction of 
the neomycin vector pNMftV driven by the 
mouse 3 globin promoter. The mouse 3 globin 
promoter contained within a 369 bp's 
5'-HindIIl/HincII-31 fragment was kindly 
supplied by Dr. R.S. Gilmour. This was 
converted to a Hindlll fragment and inserted 
into pNV. The orientation was determined by 
a Haelll digest.
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in this laboratory. A 258 bp's 5' - Sau3A /Ncol - 3' 
fragment was converted to a Hindlll fragment and inserted 
into pNV to give pN0V.
VI Insertion of Globin Genomic Fragments Nos. 10 and 11 
into pNeV
In addition to cloning fragment 10 into pNeV for
reasons already elaborated on, fragment 11 was included as 
an internal control. As outlined in Fig. (52) these Eco Rl 
fragments were liberated from the recombinants pHR10 and 
pHR11 by sequentially treating the plasmids with Thai and 
Eco Rl (2:3:3111). The former enzyme has the recognition
signal 5'-CG+CG-3', a sequence which is not found often in
eucaroyctic DNA but is frequent in procaryotes. These 
double digestion mixtures were ligated to Eco R I f alkaline 
phosphatased pNeV to give pNeV10 and pNeV11.
3:3:3 The Effect of the Promoters of HSV-1 tk. Human
Epsilon Globin, Mouse B Globin and Human B Globin 
Genes on Tn5 aph (II) Expression in a Variety of 
Cell Lines
Table (6 ) shows the collated data of a series of mouse 
LA tk~ and human 143 tk“ transformation experiments with 
pNV, pNTV and pNeV.
The data is expressed as a mean transformation ratio 
(±) standard deviation relative to the HSV-1 tk promoter.
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A schematic diagram of the cloning strategy 
employed in the construction of pNeV 10 and 
pNeV11. pHR10 and pHR11 were sequentially 
digested with Thai and Eco Rl to liberate 
the globin genomic fragments and inserted at 
the Eco Rl site of pNeV. The orientation in 
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Table (6)
The effect of the human epsilon globin and HSV-1 tk 
promoters on Tn5 aph (II) expression on the mouse 
LAtk- and human 143tk- cells.
Transformation Ratio±SD (No of Observations)
Donor*!
DNA
Recipient Cell Line 
Mouse LAtk- Human 143tk-
pNTV
pNV
pNeV
1.000 (4) 
0.080 ± 0.035 (4) 
1 .940 ± 0.475 (4)
1.000 (7) 
0.005 ± 0.015 (7) 
0.205 ± 0.090 (7)
1 - Experimental details were as outlined in Table 
(4) except for the selection conditions which were 
G418
- 202 -
The general pattern initially observed for the tk based 
vectors viz pTK-1, peV and pTV (Table (4)) is maintained 
for the equivalent neomycin recombinants. Tables (4) and 
(6 ) confirm that the low activity of the human epsilon 
globin promoter in the 143tk“ cell is not a feature 
peculiar to HAT selection. Nevertheless there is definite 
shift in the overall efficiency between the different 
selection systems. It would appear the human epsilon 
globin gene promoter driven expression increases around 
four fold in the mouse LAtk- cell under geneticin 
selection, the transformation ratio increases from 0.46 
(Table (4)) to 1.94 (Table (6 )). This trend is also 
observed in the 143tk~ cell which increases from —  0.05 
(Table (4)) to 0.2 (Table (6 )).
These differences are difficult to account for. A 
possible explanation is that the HSV-1 tk promoter has 
been uncoupled from its "natural" structural gene in the 
pNTV recombinant and accordingly can now be regarded as 
heterologous as is the human epsilon globin gene promoter. 
Subsequently both promoters maybe compared more directly 
in the neomycin based vectors than the HSV-1 tk plasmids.
The previous series of experiments suggests that 
the epsilon globin promoter contains some structural feature 
which is recognised by a cellular factor which of all the 
lines tested is only present in the human 143tk“ cell. The 
measurable outcome of this is a dramatic reduction in the 
number of cells which survive the appropriate selection 
conditions. The human and mouse 3 globin genes share a
- 203 -
similar promoter structure to the epsilon globin gene 
promoter. Subsequently it seemed reasonable to ascertain 
if the 143tk“ cell "factor" would recognise the sequence 
counterpart in the adult globin genes.
To test this the human and mouse adult 3 globin 
promoter recombinants pN3V and pNM3V in addition to pNV, 
pNTV and pNeV were assayed for neomcyin expression in
mouse LAtk-, 143tk-, K562, HeLa and EJ cell lines. The 
results for a series of transformations are presented in 
Table (7) No consistent pattern emerged from these studies 
relating to the activity of the adult globin gene promoter 
plasmids. The mouse recombinant pNM3V is reasonably 
active in the human 143tk“ cell line as it is in the other 
cell types examined. This seemingly contradicts the 
sequence homology model• However the behaviour of the 
adult 3 globin gene promoter plasmid pN3V is somewhat 
difficult to interpret. Although its activity is as low 
as the epsilon globin gene promoter in the 143tk- cell, it 
is also correspondingly low on all the other cell types
and maybe a weak promoter per se,of possible relevance to 
this is the recent finding proposing that regulatory 
sequences of the human and rabbit 3 globin transcriptional 
unit are located within the body of the gene [173] [174].
But this of course does not directly explain the
discrepancy between the activity of these two
adult 3 globin genes.
It is interesting that the level of epsilon globin 
gene promoter driven expression in the K562 cell is not
- 204 -
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significantly higher than in other lines. An obvious but 
possibly oversimplified interpretation is that sequences 
upstream of the promoter are required for optimal 
expression. With regards to this it would be interesting 
to test the effect of covalently linking the 350 bp's 5'- 
Xbal/Bam H1-3' fragment into pNeV and examining its 
expression in K562 cells.
3:3:4 The Effect of Eco Rl Globin Genomic Fragments Nos, 
10 and 11 on Human Epsilon Globin Gene Promoter 
Driven Tn5 aph(II) Expression in a Variety of Cell 
Types
The transforming abilities of the recombinants pNeV10 
and pNeV11 were tested against pNeV in the following cell 
lines, human 143tk~, mouse LAtk-, EJ, HeLa and K562. 
pNTV was included as an internal control to monitor the 
relative behaviour of pNeV. The transformation data for a 
series of experiments is summarised in Table (8 ).
These results imply that fragment 10 elevates Tn5 aph 
(II) expression relatively independent of the cellular 
environment. This effect ranges from about a four-fold 
increase in mouse LAtk- cell to an eight-fold increase in 
the K562 cell. Moreover its presence apparently releases 
the block on the epsilon globin promoter repression in the 
human 143tk~ cell. This effect is much more dramatic than 
that recorded for the tk equivalent recombinant viz 
peV10 which although higher in tk expression than peV it
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did not elevate tk expressionto the level it does under 
geneticin selection. This observation is difficult to 
account for and represents a major inconsistency in the 
behaviour of an identical fragment under different 
selection systems. Despite this a definite pattern has 
emerged from these transformation studies concerning the 
activity of the 6.535 kb epsilon globin DNA fragment in a 
variety of cell types suggesting that it contains a 
structural element which under these assay conditions 
displays an enhancing type of activity.
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4:1 The Transcriptional Profile of the Human Epsilon
Globin Gene - The Differential Pse of Promoters
The human epsilon globin gene provides a suitable 
experimental system to study the various phenomena 
associated with differential gene expression. Two 
outstanding questions arise from such an investigation. 
Firstly, what are the regulatory events leading to the 
production of a haemoglobin synthesising erythrocyte from 
a pluripotential haematopoietic stem cell? Secondly, what 
are the mechanisms which ensure that the human epsilon 
globin gene is only expressed in embryonic erythroid 
tissue?
Globin genes are primarily regulated at the level of 
the initiation of transcription (1:2:2). Accordingly, by 
studying the transcriptional pattern of the human epsilon 
globin gene under a variety of conditions some insight 
into the controls governing its regulation may be 
obtained.
Detailed studies by Allan et al [10] [8 6 ] [163] have
shown that the human epsilon globin gene has a defined 
number of transcription initiation loci located upstream 
of the canonical cap site. Of these minor RNA species, 
the transcripts originating from the - 2 0 0  promoter 
located within a region of S1 hypersensitivity [91] are 
the most abundant comprising of around 5% of the total 
epsilon globin gene specific transcript population, giving 
a cap: -200 ratio of 20:1. This ratio was also observed
- 210 -
with RNA prepared from human embryos of 5-10 weeks 
gestation [8 6 ]. Thus despite the neoplasticity and the 
mixed myeloid and erythroid phenotype, the K562 cell can 
be considered a suitable model for regulated epsilon 
globin gene expression with the cap: - 2 0 0  ratio of 2 0 : 1  
indicative of maximal epsilon globin gene expression.
In contrast to epsilon globin gene expression in the 
K562 cell, its activity in stably and acutely transformed 
animal cells differs markedly with a distinct tendency 
towards greater use of the -200 promoter. These findings 
suggest that the major and - 2 0 0  promoters can act in a 
independent manner. Further evidence for this uncoupling 
phenomenon comes from a study by Allan et al [91]. In a 
number of non-erythroid cell lines epsilon globin gene 
specific transcripts were identified by S1 Nuclease 
mapping.
Interestingly, all the RNA molecules were synthesized 
from the -200 promoter. No epsilon globin gene- specific 
transcripts were found in RNA prepared from different 
non-erythroid tissue including 3 month foetal kidney, 
foetal brain and foetal muscle. Cultured animal cells 
have a greater RNA complexity than corresponding tissue 
possibly reflecting a relaxation of control of gene 
expression for certain sequences. Such a condition may 
account for the above 1 leaky transcription' witnessed in a 
number of defined cell lines. This observation could mean 
that the - 2 0 0  promoter is not as tightly regulated as the 
major promoter which for maximal expression may require
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the presence of an embryonic erythroid specific trans 
factor(s)•
Why these promoters should be governed by separate
controls is unknown. It may well be the case that the 
- 2 0 0  promoter is active during the early stages of
embryonic erythopoiesis where the red blood cell precursor 
is essentially in a 'non-erythroid1 environment, a 
condition which transformed cell lines and even some
non-transformed cells appear to mimic to varying degrees.
Further evidence for this differential use of the 
promoters is seen in the way the major and the - 2 0 0  
promoters respond to exogenous cis linked viral regulatory 
sequences.
As detailed in [91] when we inserted the SV40 origin 
of replication in the opposite direction to the human 
epsilon globin gene, transcription solely increased from 
the -200 initiation site in transiently expressed COS 7 
cells. In sharp contrast only the major promoter responds 
to the presence of the SV40 enhancer in an orientation 
independent manner. This somewhat contradicts the 
observations of de Villiers et al [142] who reported that 
enhancer containing vectors in transient assays will 
preferentially stimulate transcription from the nearest 
promoter.
During the preparation of this discussion an 
interesting finding has been reported by Kollias et 
al [266] on the activity of the - 2 0 0  promoter in vitro. 
Using an in vitro HeLa cell whole extract transcription
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run-off system, they have shown that transcripts 
originating from the - 2 0 0  promoter are insensitive
to a amanitin concentrations of 1 0 0  ug/ml, suggestive of 
RNA Polymerase III activity. In comparison RNA molecules 
initiating from the canonical cap site are sensitive to 
2 ug/ml a amanitin indicative of RNA Polymerase II 
transcription. But as reported by Allan et al [8 6 ] there 
is no obvious Pol III recognition site around the -200 
region. However such a correlation is witnessed in the in 
vitro expression of the human 3 globin gene [165] where 
the Pol III transcripts are initiated from a Pol III
consensus promoter.
4:2 Putative Control Sequences
What sequences of the human epsilon globin 
transcription unit are involved in this differential use 
of promoters? Does the DNase I hyper-sensitivity map 
constructed by Zhu et al [89] and Tuan and London [90]
provide regulatory landmarks to focus attention in an
effort to identify the control regions of DNA? The 
possible significance of these sites which correspond to 
the upstream promoters at -4500, -1480, -900 and -270
bp's 5' to the canonical cap site in addition to a DHS at 
-6500 bp's which contains a potential Z-DNA element are 
discussed in light of the data obtained from this study.
The role of these cis acting sequences for the purpose 
of distinction is broadly divided into a discussion on the
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sequences which influence the activity of the major 
promoter as defined by the 5 1 - Bam H1/PvuII - 3*fragment
and those putative regulatory regions upstream from this.
4:2:1 The Major Promoter
Compared to the activity of pMX, the promoter mutant 
templates gave low levels of transcripts originating from 
the major cap site.
McCafferty [267] performed S1 Nuclease mapping 
experiments on circular templates of pMX and a 
series of deletion mutants using a whole cell extract in 
vitro assay system. In marked contrast to the in vivo data 
in addition to transcripts mapping to the epsilon globin 
gene/plasmid boundary all recombinant templates gave S1 
products corresponding to RNA species extending from the 
canonical cap site, these transcripts were the most 
abundant of the human epsilon globin gene specific 
population. Moreover, McCafferty [267] observed that 
pMXA4 which lacks the -100 region showed a decrease in cap 
site expression compared to others which contained this 
putative functional domain. Of further interest was the 
finding that pMX itself gave the lowest level of cap site 
initiated transcripts of all the tested DNAs. This 
differs from; its activity in the stably transformed BHKtk” 
cell where over half the transcripts are synthesized from 
the major cap site.
These differences in the activity of the human epsilon
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globin promoter in stable transformed BHKtk” cells (this 
thesis) and in vitro [267] may not be peculiar to this 
gene but may be related to the different assay conditions. 
For example,the above differences are also reflected in 
some ways on the expression of the rabbit 8 globin gene in 
long and short term transformed cells, where the presence 
of the CCAAT Box provides sufficient cis sequences for 
optimal expression in stably transformed mouse Ltk~ cells 
[268] while in transiently expressed HeLa [130] or mouse 
3T6 cells [132] in addition to a covalently linked 
enhancer, all three promoter elements are required.
On the physiological suitability of the transient 
assay system,it is interesting to note that the human 6 
and 8 globin genes which are expressed at a ratio of 
approximately 1:40 in normal adult erythrocytes are 
transcribed at a similar ratio when each of these genes is 
covalently linked to a viral enhancer in short-term 
transfected monkey kidney cells [262]. It is presumed that 
the exogenous sequences under these conditions are in an 
episomal form and are considered to be fully 'open1 and 
accessible to the cellular transcription machinery. This 
contrasts with the integrated donor DNA which may have 
structural constraints imparted on it.
Despite these difficulties in comparing different 
assay systems and different genes the data from the pMX 
promoter deletion mutant experiments tend to support the 
idea for the existence of a putative regulatory element 
located upstream of the major promoter.
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Possible regulatory significance of this 350 bp's 
5'-Xbal/Bam H1-3' fragment has been suggested from a study 
by Paul et al [269] and Allan et al [270]. This DNA which 
contains the -200 promoter was inserted into a CAT plasmid 
driven by the HSV -1 immediate early promoter. CAT 
activity in COS 7 cells was assayed 48 hours after 
transfection.
The HSV-1 immediate early/CAT recombinant gave an 
arbitary CAT value of 10 which increases to 200 in the 
presence of co-transfected E1A. These respective values 
were maintained when the 5'- Xbal/Bam H1-3' fragment was 
covalently linked to the basic construct. However, in the 
opposite orientation, CAT activity was essentially 
abolished. A possible interpretation is that the -200 
promoter may compete with the major promoter for 
transcriptional factors, the balance of which may change 
throughout embryonic erythropoiesis. Alternatively this 
phenomenon might arise by repressor binding at the 5' end 
of the '5-Xbal/Bam H1-3' fragment which when in the 
reverse orientation is positioned adjacent to the major 
promoter.
A possible prediction from the pMX promoter deletion 
S1 Nuclease mapping studies is that the '5-Bam H1/PvuII-3' 
fragment would be a weak promoter in non-erythroid cells. 
However when the promoters of the HSV-1 tk and 
mouse 6 globin genes in addition to the epsilon globin 
promoter were linked to the selectable Tn5 aph (II) gene 
no significant changes in the level of expression between
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these promoters was observed in a variety of non-erythroid 
cell lines.
However rather surprisingly, this was not the case in 
stably transformed human 143tk~ cells where the activity of 
the human epsilon globin promoter drops by around 80% 
compared to its expression in all other cell lines tested. 
Furthermore this was not a globin related effect since the 
mouse 8 globin promoter was active in the 143tk” cell. In 
addition this phenomenon is not peculiar to the long term 
assay system. In collaboration with Dr. Gary Sibbet 
(Beatson Institute), the activity of the human epsilon 
globin promoter and the HSV-1 tk promoter were relatively 
assessed by their ability to drive expression of the CAT 
gene in transiently expressed human 143tk“ and mouse LAtk- 
cells. The same pattern emerged (data not shown). However, 
this effect was relieved by the presence of the 6.535 kb 
Eco RI fragment of pHR10 or by the covalent linkage of the 
SV40 enhancer.
That only the human 143tk~ cell derived from an 
osteogenic sarcoma-transformed cell line represents a true 
non-erythroid cell type although appealing seems very 
unlikely to be of any physiological significance. Bearing 
this in mind it is difficult to assess if it is worthwhile 
to investigate this phenomenon any further. For example it 
may be feasible to, at least ascertain, if the effect is a 
result of repressor binding by performing DNase I mapping 
or footprinting studies [271]. In addition competition 
experiments could be undertaken using the CAT system by
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co-transforming in the presence of increasing amounts of 
pNeV.
Caution should be excercised when comparing the S1 
Nuclease mapping studies with the pMX deletion mutants 
with the activity of different promoters driving the 
expression of a selectable gene. S1 Nuclease mapping 
gives a measure of the steady state RNA levels, while the 
functional assay is a quantitative measure of the 
expression of a selectable gene but may only be 
proportional to transcriptional activity over a limited 
defined range.
4:2:2 Upstream Regulatory Regions
The difference in activity between pHR11 and its 5' 
deletion mutant pMX appears to be due to the presence of 
the 1468 bp's 5'-Eco Rl/XbaI-3' fragment of pHRl1 within 
which maps the -900 promoter and the proximal Alul repeat 
element which is transcribed from the -1480 bp's promoter. 
This stretch of DNA seems to repress transcription from 
the major promoter. This down regulation effect may be 
due to non-erythroid repressor binding, alternatively the 
transcripts originating from these two upstream promoters 
may repress RNA synthesis from the canonical cap site by 
some sort of read through inhibition mechanism.
Evidence for the existence of another upstream 
putative regulatory element comes from the functional 
studies performed with the 6.535 kb Eco RI fragment of
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pHR10• The ability of this genomic DNA to increase 
expression of two selectable genes (HSV-1 tk and Tn5 aph 
(II)) from the promoters of two different genes (human 
epsilon globin and MoMuSV) in a variety of cell types 
provides evidence for the existence of a sequence with 
enhancer like properties.
In an extension of these studies in collaboration with 
Mrs G.J. Grindlay we attempted to localise this 'enhancer1 
effect. Initially as depicted in Fig. (10) the two large 
subfragments of pHRlO, the distal 2.822 kb 5 '-Eco Rl/ 
HindIII-3' and the proximal 3.713 kb 5'-HindIIl/ 
Eco RI-3* fragments were subcloned at the Eco RI site of 
pNeV and assayed under standard assay conditions. 
Surprisingly there was no increase in Tn5 aph (II) 
expression with any of the large sub-fragments. 
Furthermore and consistent with this finding, when the 
subfragments of the proximal 3.713 kb 5'- Hindlll/ 
Eco RI-3* fragment were molecularly cloned into the Eco RI 
site of pNeV (Fig. (50)) none of the recombinants mimicked 
pNeV1 0 activity (data not shown).
Of further concern was the lack of any difference 
between pNeV10 in transiently expressed mouse LAtk~ cells. 
In a quantitative S1 Nuclease mapping assay performed by 
Mrs G.J. Grindlay with both 5' and 3* end labelled probes, 
no discernible difference in signal intensity was 
recorded. This failure to reproduce the 'enhancing' 
phenomenon in acutely transformed mouse LAtk“ cells is of 
considerable concern and contrasts with an observation of
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Spandidos and Anderson [272]. These workers using the 
expression vector pNeV (termed pNel in the publication) 
identified an 8 kb fragment containing the human X 
immunoglobin enhancer which increased expression of the 
Tn5 aph (II) gene upto 10 fold in a tissue specific 
manner. Moreover this increased level of activity was 
observed in both long and short termed transformed cells. 
(It is of interest regarding the credibility of the assay 
system that this recombinant did not increase the activity 
of pNeV in mouse LAtk“ and human 143tk“ cells while pNeV10 
did).
Can these inconsistencies be adequately explained? As 
depicted in Fig. (10) the 6.535 kb fragment 110 1 contains 
two putative regulatory elements. Located within the 
distal 2.822 kb 5'-Eco Rl/HindIII-3' fragment is 722 bp's 
SstI fragment which contains a stretch of alternating 
purine/pyrimidine residues indicative of a potential Z-DNA 
forming element. In the proximal 3.713 kb 5 '-Eco RI/ 
HindIII-3' fragment maps the -4.5 kb upstream promoter 
which arguably corresponds to the 5* end of the 
transcriptional unit. This promoter is contained within 
the 1.48 kb 5'-Xbal/TaqI-3' fragment which also has an 
enhancer 'core* sequence. Thus the failure to localise the 
'enhancing' activity of pNeVIO may result from a 
requirement for the presence of each of these putative 
regulatory elements. In such a scheme the Z-DNA sequences 
may alter the superhelical density of the -4.5 kb promoter 
in such a way as to increase transcription from this 
region. Alternatively some other mechanism may be involved
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in causing a change in the activity of the epsilon globin 
gene promoter or/and procaryotic sequences as a result 
to a change in the conformation of the upstream 
promoter. The failure to reproduce the *10' effect in 
short term transfections is difficult to explain. A 
possible case to argue follows along the lines previously 
raised on the differences between the activity of globin 
genes in stable and acutely transformed cells in which it 
was proposed that sequences may adopt a different 
conformation whether integrated or free form. This however 
is by no means a satisfactory account of the discrepancy 
between these two assay systems and accordingly must 
question the activity of fragment 1 1 0 1 under these 
particular experimental conditions.
4:2:3 trans Acting Sequences
In addition to the previously discussed cis sequences 
which influence the expression of the human epsilon globin 
gene several lines of evidence show that trans acting 
sequences also play an important part in its expression.
Allan et al [91] demonstrated trans activation of the 
epsilon globin gene by co-transformation with a 
recombinant encoding the viral protein EIA. This product 
is thought to be involved in the activation of 
transcription of the late adenovirus genes by a catalytic 
mechanism possibly involving the assembly of stable 
transcriptional complexes [273]. In these experiments,
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transcription was reduced from the - 2 0 0  promoter by around 
2 0  fold with a corresponding increase in the number of 
transcripts synthesised from the major cap site involving 
some sort of redirection mechanism.
To summarise several lines of evidence as presented 
suggest that the major and the - 2 0 0  promoters of the human 
epsilon globin transcriptional unit can be regulated 
independently in response to a variety of both cis and 
trans operating mechanisms. These studies propose that 
these upstream promoters particularly the - 2 0 0  promoter is 
transcriptionally active during early embryonic 
erythropoetic development. The switch from the upstream 
promoters including the - 2 0 0  occurs in later development. 
This redirection mechanism is mediated at least in part by 
a specific embryonic trans factor, the action of which can 
be mimicked by EIA or the presence of a cis linked viral 
enhancer, albeit by a fundamentally different mechanistic 
process.
In a study by Allan et al [265] as described in detail 
in this thesis we demonstrated trans activation of the 
pHR11 derived recombinant pSVKNe-3 in both acutely and 
stably transformed K562 cells. In all other cell lines 
tested the cap: - 2 0 0  ratio remained 1 : 2 0  compared to the 
20:1 value in the K562 cell. However this in many ways 
contrasts to the apparent failure of the human epsilon 
globin promoter to relatively increase the expression of 
selectable Tn5 aph (II) gene in the K562 cell. This 
possibly suggests that the trans operating embryonic
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erythroid specific factors do not recognise the 5'- Bam H1 
/PvuII-31 promoter fragment alone, implying that further 
recognition sequences may be located upstream or possibly 
encoded within the structural gene. In addition, as 
previously discussed,the fundamental differences of the 
assay systems must be taken into account when comparing 
these phenomena.
A recent study by Young et al [274] demonstrated 
induction of an exogenous epsilon globin gene recombinant 
in K562 cells. In this series of experiments the epsilon 
globin gene was covalently linked to the SV40-neomycin 
vector pSV2-Neo [191] and stably introduced into the K562 
cell line variant Bos. These cells display a very low 
activity of the endogenous epsilon globin gene. After 
induction by treatment with 20 yM haemin the transcripts 
were S1 mapped with the 371 bp's MboII probe. Only the 
level of transcripts originating from the major cap site 
increased. This finding is consistent with the 
observation made in this study on the failure to co-induce 
the human epsilon globin gene in stably transformed 
MELtk- cells as was the case with two other independent 
groups [170] [171 ].
These various studies imply the human epsilon globin 
gene is subject to trans acting factors. In addition it 
would appear that the -200 region does not markedly 
respond to these diffusible molecules which may explain 
the non regulated expression of the human epsilon globin 
gene in transformed cells due to the lack of expression of 
those embryonic erythroid trans acting genes.
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4:2:4 Conclusion - the Spatial and Functional Overlap of 
Regulatory Elements
What exactly these experiments say about the
regulation of the human epsilon globin gene is difficult 
to evaluate coherently. Moreover how valid are these data 
in that can the study of one component of the
transcriptional unit be assessed independently of other 
cis sequences, both coding and flanking DNA? Along these
lines Serfling et al [275] have recently suggested that
the promoter and other regulatory sequences may overlap 
both physically and functionally. They extend their idea 
that upstream regulatory regions are composed of some sort 
of modular arrangement of short sequence stretches which 
are recognised by trans acting factors which in the case 
of the human epsilon globin gene would be involved in 
conferring tissue specificity, developmental regulation, a 
general enhancement of transcription and induction during 
red blood cell maturation.
4:3 The Regulated Expression of the Human Epsilon Globin 
Gene - A Hypothesis Involving Both Proximal and 
Distant Sequences
The S1 Nuclease mapping studies on the human epsilon 
globin gene in K562 and transformed cells clearly imply
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the existence of putative regulatory sequences upstream of 
the major promoter. Moreover some of the work described 
in this thesis has identified the possible loci of these 
control regions. Does this information tell us anything 
about how this gene is regulated? A somewhat speculative 
model is presented.
The human 8 globin gene family in non-erythroid tissue 
is in an inactive chromatin conformation generally 
associated with the 300 A solenoid higher order structure 
[113]. In contrast this locus is more sensitive to DNase 
I in the erythroleukaemic cell lines K562 and HEL than non 
erythroid tissue [194], moreover in the haematopoietic 
promyelocytic leukaemic cell line HL60 it is also DNase I 
insensitive [194]. This difference in DNase I digestion 
pattern possibly reflects a conformational change common 
to all erythroid precursor cells which can be envisaged as 
a transition from the inaccessible 300 A solenoid 
structure to the more open 100 A 'beads on a string* fibre 
form [113]. Accordingly this may represent the initial 
event in globin gene activation and is only a feature of 
haematopoietic cell populations which are committed to the 
erythroid lineage.
It is not known whether the globin genes are repressed 
by a general or specific mechanism. Considering that a 
typical higher eucaryote contains around 10,000 tissue 
specific genes and in an erythroid cell most of these 
sequences will not be expressed it is likely that the 
dominant repression mechanism will be of general type. A
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favoured model involves the non-core histone H1 which has 
been proposed to function in the maintenance of the higher 
order 300 A structure [276]. The mechanism responsible 
for the depression of the human 8 globin gene is unknown. 
However studies with activation of globin genes from 
fibroblasts in MEL somatic cell hybrids would argue that 
these trans acting factors are not restricted in their 
activity to early erythroid precursors. This constitutive 
type of expression may imply that they may also be 
involved in the maintenance of the derepressed state in 
non erythroid tissue. Tuan et al [194] have DNase I mapped 
the human 8 globin gene cluster in K562, HEL, HL60 and 
marrow tissue. They distinguish two types of DHS's. Minor 
sites reflect the particular ontogenic stage and vary in 
K562, HEL and bone marrow cells. In addition they have 
identified four major DHS's which are present in all 
erythroid tissue irrespective of the development period 
and are totally absent in the myeloid HL60 cells. Three of 
these are located 5* to the epsilon globin gene at -6.5 
k b f -11 kb and -17 kb. The other maps around -20 kb 
downstream of the 8 globin gene.
Each of these major DNase I hypersensitive sites are 
located in regions in DNA containing one or more enhancer 
core elements and stretches of alternating purines and 
pyrimidines which under certain physiological conditions 
can form Z-DNA. A possible function of these major DNase I 
hypersensitive sites might be to organise and ensure the 
structure of the 8 globin gene locus in chromatin is in a
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transcriptionally preactivated conformation which is
receptive to erythroid specific signals which in turn 
modulates expression of the individual genes.
The next series of events envisaged involve local
changes in the chromatin structure of the 10 kb or so of 
the epsilon globin gene domain. A possible candidate 
involved in this is the most proximal of the Z-DNA 
elements described by Tuan et al [194] located -6.5 kb 
upstream of the major cap site. Despite the observation
that the effect of such a B -*■ z transition becomes weaker
with increasing distances from the target DNA it could be 
the case this transition only represents the initial event 
of a sequential mechanism involved in the transcriptional 
activation of the epsilon globin gene domain. Once unwound 
other regulatory cis acting sequences may be subject to 
regulatory interaction with trans acting factors. This 
Z-DNA element is located about 2 kb upstream of the most 
distal promoter at -4.5 kb. It is interesting that 
the Eco RI genomic fragment of pHR10 which increases 
expression of the Tn5 aph (II) in a range of cell types 
encodes for both of these putative regulatory elements. 
Excluding the possible involvement of this Z-DNA element, 
the epsilon globin gene of an already derepressed 
human 8 globin gene cluster undergoes a conformational 
change, the result of which is the appearance of a 
constellation of DHS's which correspond to the siting of 
upstream promoters. These changes are presumed to be 
mediated by the action of embryonic early
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erythroid trans factors, one of which possibly binds to 
the Z-DNA element.
It is not known if transcriptional activity 
immediately follows this or whether some further 
structural modification is required. At these stages of 
early development the upstream promoters are active 
especially the -200 promoter. Evidence supporting this 
notion as described throughout this text includes the 
lower cap: -200 ratio observed in transformed cells,
'leaky' transcription involving exclusive use of the -200 
promoter in certain non-erythroid cell lines [10], its 
failure to be activated in induced K562 cells [273] and 
the influence of the cis linked SV40 origin of replication 
on transcription from the -200 start site [91]. This 
final point is particularly suited to this model since 
during early erythropoietic differentiation the cells are 
dividing rapidly upto the pro-erythroblast stage. Finally 
during late maturation the embryonic erythrocyte which for 
the purposes of this model can be represented as an 
erythro-leukaemic K562 cell alters its use of promoters 
resulting in the majority of transcripts initiating from 
the major cap site giving the characteristic cap: -200
ratio of 20:1. This transition is arguably mediated by 
the action of late embryonic erythropoietic specific trans 
acting factors as suggested by comparing the cap: -200
ratio of the 'marked' epsilon globin gene recombinant in 
the K562 cell and a variety of other cell types.
A possible mechanism of action responsible for this
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differential use of promoters during ontogeny is the 
phenomenon of transcriptional interference. How can 
transcription per se exert a regulatory influence on 
epsilon globin gene expression?
Paul et al [269]have suggested a number of ways in 
which transcription could exert an influence. 
Transcription may increase the accessibility of the 
chromatin template to regulatory diffusible molecules. 
RNA molecules originating from upstream promoters could 
inhibit the binding of transcriptional factors at the 
major promoter, such a scheme has been proposed to account 
for the action of the bacterial 1SI insertion element 
[277]. A similar type of mechanism may be involved in the 
apparent repression of major cap site useage of the 1468 
bp's 5'-Eco Rl/XbaI-3' fragment in pHRl1 and an 
unpublished observation of Allan and Grindlay (Pers Comm) 
that the 1480 bp 5'-Xbal/TaqI-3' fragment containing the 
-4500 promoter down regulates the major promoter. 
Transcriptional interference of the longest epsilon globin 
gene transcript may arise from the expression of the 
distal Alul Pol III promoter which is transcribed from 
the opposite strand. This proposal is strengthened by the 
observation that this sequence is only expressed in K562 
cells[163].
Continuing on this theme Johnson et al [278] have 
presented firm evidence that the putative termination 
signal of the sea urchin H2A histone gene can efficiently 
terminate the transcription of the human a globin gene
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when inserted into the third exon in a HeLa cell transient 
assay system. Moreover when this fragment was placed 
between the two human a globin genes and assayed as above 
using S1 Nuclease mapping the activity level of the second 
gene increased by around three-fold. These results imply 
that transcriptional interference can occur between 
adjacent genes in the absence of an active terminator. 
Partially based on these findings these authors have 
argued a case on the possible role of termination in the 
developmental expression of the human 8 globin genes. In 
this positive control type of mechanism Proudfoot et al 
[279] have speculated on the existence of two terminator 
regions which are only activated in response to erythroid 
trans factors. It is proposed that one is positioned 
between the embryonic and foetal domains, the other 
between the foetal and adult regions. All genes 
downstream of the expressed gene are repressed in part by 
a transcriptional readthrough interference mechanism. At 
specific stages each terminator is activated so 
attenuating these long transcripts and concomittantly 
allowing expression of the downstream gene.
Lastly it has been suggested that these upstream 
regions may be RNA Polymerase II entry sites, a mechanism 
proposed to explain the action of enhancers. This scheme 
predicts that upon entry the transcriptional complex will 
scan the template until it recognises the major promoter, 
however because of a lack of late embryonic erythroid 
specific trans factors the complex does not recognise the
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major promoter and subsequently will initiate at these 
entry sites.
4:4 Tissue Specific and Developmental Expression of 
Adult B Globin Genes - A Critical Role for Sequences 
Close to and/or 5' to the Cap Site
In the previous sections evidence was presented which 
strongly favoured an important role for sequences upstream 
of the major promoter in the regulated expression of the 
human epsilon globin gene. But how does this 
interpretation of a wide range of phenomena fit in with 
current thinking on how globin genes are regulated? Is it 
realistic to expect the upstream promoters of the 
foetal and adult globin gene to have an analagous 
physiological role to that proposed for these sequences in 
the epsilon globin gene? Do the mechanisms which regulate 
expression vary for different globin genes or are the 
complex genetic programmes responsible for committment, 
tissue specificity, coordinate and temporal regulation 
highly conserved? Such conservation as indicated by 
homology in the 54 flanking DNA is not too evident. 
Sequence comparison of this region from a range 
of 8 globin type genes show little homology extending 
beyond the promoter region. Moreover the 8 globin 
promoter has been classified as enhancer dependent (1:5:1) 
and replication independent as shown by its lack of 
expression in the frog oocyte while the a globin gene
- 231 -
categorised as enhancer independent is actively expressed 
in the frog oocyte [138]. Interestingly the human epsilon 
globin gene displays both properties, albeit via different 
promoters. The -200 region responds to the presence of 
the origin of replication while only the major cap site 
activity increases when cis linked to a viral enhancer 
[91 ].
The transcriptional activity of the adult 8 globin 
genes of human [170], [173], rabbit [174] and mouse [280] 
with templates of various sizes and with hybrid templates 
were examined in stably transformed induced MEL tk~ cells. 
These series of experiments point to at least two non­
contiguous cis putative regulatory regions of the adult 
8 globin transcriptional unit associated with the tissue 
specific expression of this gene. One is positioned 
within the tripartite promoter region and the other 
located 3' to the cap site possibly encoded in the 
structural gene.
Can long term transformation experiments such as the 
above co-induction studies be equated with how an adult 8 
globin gene behaves during normal ontogeny considering our 
ignorance of the physical status of the foreign DNA in the 
animal cell?
An approach to counter the important criticisms 
against globin gene transformation experiments involves 
the use of transgenic mice in which the exogenous gene 
becomes a stable and inheritable component of the mouse's 
genotype [206]. Early experiments with plasmid and
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bacteriophage recombinants failed to produce transgenic 
mice in which the exogenous DNA was correctly expressed
[281] [282]. But in subsequent experiments in which the
amount of procaryotic sequences were reduced, erythroid 
specific expression of a mouse/human adult 8 globin hybrid 
gene was demonstrated by Chada et al [283]. An extension 
of this study by Magram et al [284] provided evidence that 
this hybrid globin gene was also expressed at the correct 
developmental stage. Although these studies confirmed 
tissue specificity and developmental regulation of a 
foreign globin gene, the level of globin hybrid message 
was low, between 2 and 4% of endogenous activity.
Townes et al [285] introduced a cloned human 8 globin 
gene containing 4300 bp's of 5' flanking sequences and 
1700 bp's of 3 1 flanking DNA up to the pronuclei of mice 
as a plasmid free linear fragment. Around 75% of the 
transgenic mice expressed the globin gene in a 
tissue-specific and developmental manner. In contrast to 
the previously described findings of Chada et al [283] and 
Magram et al [284] these workers found that the level of 
foreign 8 globin gene expression was comparable to the 
endogenous mouse adult 8 globin gene.
But in transgenic mice carrying the human 8 globin
gene recombinant covalently linked to plasmid sequences 
the level of exogenous globin gene activity dropped to 
between 100 and 1000 fold of that of the pure globin DNA 
linear fragment. This phenomenon of procaryotic sequence 
interference may account for some of the earlier
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transgenic experiments which failed to obtain regulated 
expression.
Of further interest from this series of transgenic 
experiments was the observation that only 48 b p 1 s of 5' 
flanking sequence was required for tissue specific and 
temporal regulation of the human 8 globin gene. Although 
qualitative expression was observed the level of 
transcriptional activity was lower on average than 
measured for templates with flanking sequences beyond the 
promoter.
These examples clearly demonstrate that the use of 
transgenic mice can be a rewarding system in the 
identification of cis sequences in the regulated 
expression of globin genes. A popular criticism levelled 
against globin gene transfer experiments is that the 
normal events leading to gene activation and expression 
are bypassed, accordingly sequential regulation cannot be 
monitored. Despite the success of transgenic mice in 
terms of tissue specificity and developmental regulation 
of adult globin genes, as an in vivo expression system is 
not immune to criticism particularly on the chromosomal 
location of the foreign DNA.
A notable feature of these experiments is the 
significant proportion of transgenic mice with integrated 
copies of the donor globin genomic sequences which are 
transcriptionally silent. A possible explanation for this 
is that these exogenous globin genomic fragments are 
integrated into chromosomal regions which are incompatible
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with expression. Presumably in those animals which 
readily express the foreign globin gene, the donor DNA is 
integrated into an active region of the chromatin possibly 
near a housekeeping gene. It is not known if the 
conformation of the neighbouring globin gene is 
significantly influenced by the presence of this 'active' 
gene. Transcriptional readthrough and changes in the 
degree of superhelicity may have profound effects on the 
expression of the exogneous DNA. Such an influence could 
conceivably perturb the sequential regulated expression of 
the foreign globin gene. It could now be out of phase 
with those mechanisms governing the expression of the 
endogenous globin gene. The events leading to the initial 
activation of the mouse 8 globin gene cluster may not 
recognise the foreign globin DNA due to topological 
influences of active genes in its vicinity.
The combined studies with MEL transformed cells and 
transgenic mice carrying foreign adult globin genes 
support the hypothesis that sequences both in the promoter 
region and downstream of the cap site are an integral 
component of the mechanism responsible for the regulated 
expression of the human 8 globin gene. An extension of 
this is that much of the DNA of the 8 globin domain is 
redundant. This is in striking contrast to the proposed 
explanations for some cases of the thalassaemic condition 
known as HPFH (hereditary persistence of foetal 
haemoglobin) which implicate distant sequences in the 
expression of the y globin genes, however this may be non-
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regulated or abnormal expression. In addition these 
findings possibly call for a reassessment of work of 
Emerson and Felsenfeld [116] on the existence of the 
chicken erythroid specific factor which is only expressed 
in adult erythroid cells and binds to a region upstream of
the ATA box of the adult 8 globin gene.
4:5 Prospects
In many respects these results on the in 
vivo expression of adult globin genes issue a challenge to
the findings reported in this thesis on the behaviour of
the human epsilon globin gene in transformed cells. The 
identification of sequences near to or possibly encoded 
within the structural gene involved in the regulated 
expression of the human 8 globin gene differs markedly 
from the implied importance of sequences extending well 
beyond the major promoter of the human epsilon globin 
gene. The experiments on the human epsilon globin gene 
lag behind those performed on the adult 8 globin genes of 
man, rabbit and mouse where the fine mapping of sequences 
to the nucleotide level involved in tissue specificity and 
temporal regulation are likely to be determined in the 
near future. Mapping of equivalent regions within the 
transcriptional unit of the human epsilon globin gene 
seems far off at present. This rather pessimistic 
prediction is based on unpublished findings by Constantini 
(Oxford) [Pers Comm] who failed to produce transgenic mice
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which expressed the human epsilon globin gene in a 
regulated fashion. This observation, albeit of a 
preliminary nature, is somewhat unexpected considering the 
mouse embryonic 8 globin genes are active at the 
appropriate time during normal ontogeny. A possible 
explanation is that the embryonic 8 type globin genes of 
man and mouse are expressed in mechanistically different 
ways. In this respect it would be interesting to know if 
the embryonic murine gene is highly expressed or inducible 
in the K562 cell. Perhaps the human foetal locus is more 
comparable to the mouse embryonic domain suggesting that 
throughout the course of 8 globin gene evolution different 
globin genes are expressed at different developmental 
stages. This hypothesis would possibly predict that the 
human y globin genes would be expressed in the embryonic 
erythroid tissue of transgenic mice.
Is there another animal in which transgenic 
experiments could be performed with? Examples such as the 
goat [286] which have an embryonic globin gene domain, 
would in theory seem to be good candidates. However there 
may be technical and operational difficulties in 
establishing such a system at this juncture.
What experimental strategies should be followed to 
identify regulatory sequences of the human epsilon globin 
gene, particularly those involved in tissue specificity 
and developmental regulation?
The studies on human 8 globin gene expression in 
transformed induced MEL tk~ cells and transgenic mice
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display a similar sequence requirement for co-induction 
and regulated expression. Similar induction experiments 
could be undertaken with the 'marked' epsilon globin gene 
recombinant pSVKNe-3 [265] by generating a series of 
linker scanner mutants and examining their expression in 
haemin treated K562 cells.
The chromosome transfer experiments discussed in 
(1:6:2) are indicative that globin genes from 
non-erythroid cells in which the globin gene loci are 
assumed to be in the depressed state , are activated and 
expressed in a regulated manner in the terminally 
differentiated erythroid cell. Presumably the presence of 
the whole chromosome is not required for regulated 
expression. These ideas inevitably lead back to gene 
transfer experiments. But as discussed throughout this 
thesis, gene transfer experiments represent an artificial 
system in which the exogenous globin gene may be 
influenced by other sequences. Therefore can the 
'marked' epsilon gene be introduced into a cell such that 
the gene is effectively isolated from the interference of 
non-epsilon globin gene sequences? Stable transformation 
experiments require the presence of a selectable gene in 
addition to the test DNA. As an initial step in 
minimising this non-globin sequence interference, the test 
and selectable eg. neomycin gene should ideally be 
spatially separated in the recipient cell genotype. This 
may be attained by introducing each of these DNAs in the 
absence of carrier DNA to the recipient cell line in a
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staggered fashion to permit them to integrate separately 
into the host's chromosome. Suitable transformed cell 
lines for study would be selected on the basis of a low 
epsilon globin gene copy number. This condition is desired 
since our knowledge of the physical form of DNA in 
transformed cells is somewhat limited. If a mixed 
population is envisaged and there is a high copy number of 
donor DNA it would be very difficult to determine which 
form of donor DNA was responsible for expression.
The recent work by Johnson et al [278] with the sea 
urchin H2A histone terminator on the posible importance of 
transcriptional interference as a regulatory phenomenon, 
can be exploited by employing this terminator to act as a 
buffer against sequences which potentially interfere with 
the expression of the human epsilon globin gene in 
transformed cells. Thus the positioning of the terminator 
at both termini of the epsilon globin gene fragment might 
satisfy the aim of examining the gene in isolation. 
Experiments along these lines with varying template 
ranging in size from promoter deletion to the whole domain 
and possibly even the entire 8 globin gene cluster in a 
variety of erythroleukaemic cell types such as K562, HEL 
and KMOE which represent all stages of developmental 
expression in addition to non-erythroid cell lines may be 
a rewarding approach in the identification of regulatory 
signals important to the in vivo expression of the human 
epsilon globin gene.
Another possible approach to circumvent this potential
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problem of transcriptional interference is to direct the
cloned epsilon globin gene into its normal chromosomal
location at the expense of the endogenous equivalent by
homologous recombination. Smithies et al [287] recently
demonstrated using a rationale and technique initially
developed in yeast [288], the homologous exchange between
a human 8 globin test gene and the endogenous gene. The
test plasmid in addition to carrying the neomycin gene to
allow the selection of transformed colonies also encodes
for a bacterial supF gene. This provides a means of
selectively propagating the exchanged DNA in bacterial
cells after rescue from the transformed animal cells
[289]. This functions as an assay to check for homologous
recombination among the transformed population carrying
exogenous globin sequences. However the rate of
_ o
homologous recombination was estimated to be around 10 
of the transformed cells, this figure was independent of 
whether the endogenous globin gene was active or 
repressed. Such analogous experiments although 
theoretically possible with the human epsilon globin gene, 
the low transformation efficiency of the K562 cell would 
demand an initial series of long term transformations on a 
massive scale to generate a few thousand colonies before 
it would be worthwhile screening for homologous 
recombination.
addendum |Since completing this Discussion, Chada et 
al [290] have introduced a cloned human globin gene
into the mouse gene line and demonstrated that this foetal 
gene is solely expressed during murine embryonic 
development in erythroid cells.>
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